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Introduction  
 
The objective of this study was to investigate the incidence and quality of palliative 
care in the terminal phase of patients in Dutch nursing homes (NHs).  
 
Background 
Palliative care has its origin in the modern hospice movement and palliative 
medicine was born as a new strategy of management for those patients whose 
illness is chronic and who are in the last stages of life, that is the terminally ill.(1) 
Palliative care is concerned with the physical, psychological and spiritual care of 
patients with a life-threatening disease and their families, with both the quality of 
the remaining life of the patient and with support of the family. In the year 1967, 
Cicely Saunders founded the first professional hospice, the St. Christopher’s 
hospice in Sydenham, London.(2)  
 
What is palliative care? 
Palliative care has been defined by the World Health Organization in 2002(3) as: 
‘An approach that improves the quality of life of patients and their families facing 
the problems associated with life-threatening illness, through the prevention and 
relief of suffering by means of early identification and impeccable assessment and 
treatment of pain and other problems, physical, psychosocial and spiritual’.  
 
Palliative care  
- provides relief from pain and other distressing symptoms  
- affirms life and regards dying as a normal process  
- intends neither to hasten nor postpone death  
- integrates the psychological and spiritual aspects of patient care  
- offers a support system to help patients live as actively as possible until 
death 
- offers a support system to help the family cope during the patient’s illness 
and in their own bereavement 
- uses a team approach to address the needs of patients and their families, 
including bereavement counselling, if indicated 
- will enhance quality of life, and may also positively influence the course of 
illness 
- is applicable early in the course of illness, in conjunction with other 
therapies that are intended to prolong life, such as chemotherapy or 
radiation therapy, and includes those investigations needed to better 
understand and manage distressing clinical complications.(4)  
 
Palliative care in nursing homes 
Populations in European and other developed countries are ageing and most 
deaths occur in people  aged over 65, and increasingly also over 80. Almost 25% 
of Americans die in NHs.(5) These numbers indicate that in the near future, the 
nursing home (NH) will increasingly be the site of terminal care and the place of 
death for many of the elderly and those with dementia, because this group 
8
 11 
accounts for a significant majority of decedents.(6-8) From comparative studies 
between the US and the Netherlands the conclusion can be drawn that (most) NHs 
in the Netherlands are comparable with (most) in the US. One salient difference is 
the short-stay rehabilitation, which is much less known in NHs in the US (except for 
a few specialised NHs).(9) Another difference between the two countries is that the 
staff in Dutch NHs include specially trained NH physicians (in general one full-time 
physician per 100 patients), who provide medical care and are employed by the 
NH.(10) 
 
With an ageing population, the pattern of disease also changes. Traditionally, 
palliative care has focused on patients with cancer, but this type of care is needed 
for a much wider range of terminal illnesses and should be integrated more broadly 
across the health care services, as was stated by the World Health Organization 
(WHO).(11) Most elderly people do not die from cancer and the available data 
suggest that the pattern of their symptoms in the terminal phase differs from that of 
cancer patients. Older people very clearly have special needs, because their 
problems are different from and often more complex than those of younger 
people.(12) They mostly die from 'old age' and/or complications in the end-stage of 
chronic disease rather than from acute illnesses. Dementia, cardiac disease and 
respiratory disease, in particular, are frequent causes of death,(13) but the nature 
and burden of symptoms associated with the terminal phase of these diseases is 
still unclear. Nevertheless, they also need palliative care, a type of care which 
should be based on patient and family need, rather than on prognosis.(12) In the 
last 48 hours of the life of NH patients, pain and respiratory symptoms have been 
found to be the most prevalent symptoms, but the pattern of symptoms may be 
determined by the underlying disease.(14) There has been growing recognition 
that comparatively little research has been carried out on older people’s needs for 
palliative care, because they do not represent the traditional palliative care 
population. Despite the prevalence and importance of the elderly in NHs, health 
care policies in general have little concern with regard to the quality of care that is 
provided for them. This could be cause or consequence of the fact that NHs are 
less well studied than hospices or hospitals as a setting for terminal care.(15) 
Therefore, more research is needed on patients admitted to NHs, with common 
serious illnesses other than cancer.  
 
Development of palliative care in the Netherlands 
In the Netherlands, there has always been concern about appropriate care for the 
dying. The first efforts to improve care for the dying date back to the 1970s and 
1980s(16) with the Antonius Ysselmonde in Rotterdam, which started in 1977 
(informal source: Marinus van den Berg, Antonius Ysselmonde. Rotterdam, June 
2006) as the first NH in the Netherlands to offer professional terminal care. The 
Netherlands is also the only country in the world with a systematic review of end of 
life decisions. From 1990 on, the government commissioned every five years a 
large scale study on medical end-of-life decisions, namely alleviation of pain and 
symptoms, non treatment decisions and physician assisted death (euthanasia and 
physician assisted suicide).(17;18) In the late sixties/early seventies terminal care 
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received growing attention and became the subject of research.(19) Until then 
medical developments, including advanced medical technologies prevented or 
postponed death in patients who formerly would have died.(20;21) 
 
The rapid development of palliative care in the Netherlands started in the beginning 
of 1990 and was inspired by the work of Dame Cicely Saunders. Improving care for 
the terminally ill was the mainspring of the Dutch hospice pioneers. Dying should 
be no longer disturbed by medical-technical domination, but regarded as a normal 
phase of life. The first hospice in the Netherlands was situated in Nieuwkoop. One 
of the first independent hospices was the hospice Kuria in Amsterdam, founded in 
1992. In 1994 the hospice Rozenheuvel followed. All these hospices stemmed from 
religious commitment. In a number of NHs a special unit for palliative care was 
established; a pioneer in this field was the Antonius Ysselmonde, which opened its 
first units in 1993.(22)  
During the nineteen-nineties the social and political priority given to the palliative 
care of terminally ill patients increased substantially. The Minister of Health, 
Welfare and Sport initiated in 1998 a stimulation programme during this period, 
based on the expectation that the need for palliative care will increase further in the 
coming decades and intended to support initiatives in the sector. This stimulation 
programme encompassed three specific separate programmes: 
- encouragement of research and innovative projects under a programme of 
the Health Research and Development Council/Medical Sciences (ZonMw) 
- promotion and guidance of palliative care by six university centres: the 
Centres for the Development of Palliative Care (COPZs) 
- stimulation of the integration of hospice facilities in regular health care by 
the Hospice Care Integration Project group (PIH)(23) 
 
As a result of reports of the examination commission COPZ and the Hospice Care 
Integration Project group, the Minister of Health, Welfare and Sport formulated a 
governmental framework regarding palliative care. One basic principle was that 
palliative care should be a general, and not a separate, part of Dutch regular health 
care system (generalist approach).(24) 
The COPZs played a crucial role in the further development of palliative care in the 
Netherlands. These centres initiated many research projects e.g. on epidemiology, 
ethics and informal care.(23) 
One of these research projects concerned nursing homes, and resulted in this PhD 
thesis. 
 
In the near future the need for palliative care will increase due to the growing 
number of people living to an old age. The Netherlands currently has a population 
of approximately 16.2 million. The number of people aged over 65 in the 
Netherlands is presently 13.3% of the population, but will rise to 25% in 2040.(22) 
Currently, a wide range of palliative care services is available in the Netherlands. 
The principle behind these is that good quality palliative care has to be accessible 
and available to every terminally ill patient and his or her family. In the intramural 
care services, various specialised locations for palliative care can be distinguished.  
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Probably the largest, location of palliative care services are the Dutch NHs, 
because a large number of people die in these institutions: in 2000 this was 
approximately 18% (n=25.568)(25;26), in 2004 21.9% (n=29.890), and in 2005 
22.2% (n=30.264) of all deaths (informal source: Statistics Netherlands [CBS], 
June 2006). This indicates that terminal care is provided for a large number of 
dying people, whether or not according to the principles of palliative care, a subject 
which is investigated in this study.  
A special palliative care service within the Dutch NHs is the unit for short-term 
palliative care (PCU’s) for patients who can no longer be cared for at home, 
because of high demands of care and/or lack of family support. In April 2006 
approximately 63 NHs with a total of 255 beds comprised PCU’s.(22) and it is likely 
that in these units care is provided according to the principles formulated by the 
World Health Organization (WHO).(3) In 2004 the number of deaths in 30 units was 
n=1858 (informal source: Netherlands Institute for Health Services [NIVEL], June 
2006). Other numbers of deaths in palliative care units are not available yet, since 
deaths in NHs are not separately specified by the CBS (Statistics Netherlands). 
However, these units were not subject of this study, because patients admitted to 
PCU’s do not represent the general NH population. They are non-residents of the 
NH they are admitted to, mostly diagnosed with cancer and of a lower mean 
age.(27) 
 
Background of this thesis 
Most of the patients admitted to a NH will enter a terminal phase and eventually will 
die in the NH. There were no representative data available about the incidence of 
palliative terminal care and quality of care for the terminally ill in Dutch NHs. 
Therefore, the COPZ initiated a research project to investigate these aspects. This 
thesis is the first epidemiological study in the Netherlands to gain insight into the 
end of life care of a non-cancer population, namely palliative care for the long-term 
care NH patients. However, to measure a concept of quality of (palliative) care is 
complicated. In this study it is done indirectly by observation by proxy in daily 
practice, and therefore relies on observational instruments rather than self-reports.  
 
The major emphasis of this thesis has been placed on the provision of palliative 
care with regard to patients’ physical, psychosocial and spiritual needs. A 
description is given of diseases in and prognosis of the terminal phase, of 
symptoms (without symptom management), psychosocial and spiritual problems, 
and end-of-life decisions. To our knowledge this has not been investigated earlier 
on a national level. The aspects discussed (symptoms, psychosocial and spiritual 
problems, end-of-life decisions) represent four of the ten care domains of palliative 
(and terminal) care(28), as originally formulated by the American Geriatrics 
Society.  
The results of this thesis may be a starting point for a comprehensive discussion 
regarding the palliative care of those dying in nursing homes in the Netherlands. 
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Aims and research questions  
This thesis addresses a variety of aspects of the terminal phase, the quality of 
palliative care, and is aimed at improving the quality of dying in NHs.  
 
 
The main questions addressed in this thesis are:  
 
Part 1 Identification and prognostication of the terminal phase 
 
  Research question 1 (chapter 2) 
What symptoms, signs, problems and diseases are the direct causes of the 
terminal phase and what is the incidence of terminal care in nursing 
homes? 
 
Research question 2 (chapter 3) 
How does the estimated length of survival accord with the actual survival 
period? 
 
Part 2  Problems, symptoms and quality of palliative care  
Research question 3 (chapter 4) 
What are the psychosocial and spiritual problems found in the terminal 
phase? 
 
Research question 4 (chapter 5)  
What is the quality of palliative care in the terminal phase in a nursing 
home? 
 
   Research question 5 (chapter 6)  
What morbidity and symptoms are present in the last two days of life of 
nursing home patients?  
 
Part 3  End-of-life decisions 
 
Research question 6 (chapter 7) 
What is the frequency and character of end-of-life decisions in terminally ill 
nursing home patients? 
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Method 
The methodology related to each research question is addressed in greater detail 
in the separate chapters. 
 
Design and population 
To answer the research questions, a prospective observational cohort study was 
conducted during a 16-month period from November 2001 until March 2003 in 16 
NHs, representative of the Netherlands.  
All long-term care patients, assessed by a NH physician to have a maximum life-
expectancy of 6 weeks or less, were included in the study with a subsequent 
follow-up until death. Patients who were admitted for rehabilitation and patients 
who died a sudden and unexpected death were excluded from the study.  
 
Sampling of nursing homes  
In the Netherlands three types of NHs can be distinguished: those exclusively for 
physically ill patients, those for psychogeriatric patients, and NHs for both 
categories with separate wards for physically ill and for psychogeriatric patients. In 
2004, there were approximately 345 NHs, with around 27,400 beds for physically ill 
patients and 35, 650 beds for psychogeriatric patients.(29) All patients benefit from 
the different NH functions, mainly rehabilitation and long-term care. Most of the 
psychogeriatric patients have dementia (96%) and will stay in a NH until they 
die.(30) The care in NHs is provided by a multidisciplinary team that comprises 
specially trained NH physicians (in general one full-time physician per 100 
patients), who provide medical care and are employed by the NH,(10) nurses, 
physiotherapists and occupational therapists, among others. Other disciplines are 
available on demand to assist with the care. 
The NHs in the present study were deliberately sampled to be representative of all 
Dutch NHs. Firstly, the proportion of the three types of NHs was calculated.(31) 
This proportion was 3:1:1 ( combined versus physically versus psychogeriatric). 
Therefore, the aim was to include nine combined NHs, three NHs for physically ill 
patients, and three NHs for psychogeriatric patients. Secondly, the mean number 
of beds for physically ill and psychogeriatric patients per NH was calculated, and 
the NHs were arranged in order of this calculated mean. Finally, the nearest NHs 
above and below the mean were invited to participate in the study. During the 
course of the data collection, due to organisational and capacity problems, one 
nursing home for physically ill patients stopped collecting the data. For the 
remaining time of the data collection, another one from the same stratum replaced 
this NH. Hence, the total number of participating homes was 16. In this study the 
average number of NH beds was 103 for physically ill patients, 156 for 
psychogeriatric patients, and 157 for combined care.  
 
Instruments 
On inclusion, the regular NH physician and one attending nurse both completed a 
questionnaire for each patient, on basic demographics, clinical characteristics  
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(e.g., stage of dementia, direct cause and underlying disease of terminal phase, 
main direct cause of death). The patients were monitored weekly, until death or 
exclusion, with an identical questionnaire.  
At the time of patient death, the NH physician completed a questionnaire for all 
long-term care patients. For patients who had not been included in the study a 
shorter version of this questionnaire was completed. NH-physicians and nurses 
made their assessments by reporting information they collected as part of their 
usual care observations. Therefore, informed consent was not required. Neither the 
patients nor members of their family were interviewed. The stage of dementia was 
assessed by the NH physician according to the validated Global Deterioration 
Scale (GDS).(32) The validated Classification Codes of Diseases for Nursing 
Home Medicine (CvZ-V)(33) was used by the NH physician to classify diseases of 
the terminal status on inclusion and at the time of death. 
Quality of care was assessed by the nurses and measured with the validated 
Palliative care Outcome Scale (POS).(34) Symptoms were measured with the 
validated Edmonton Symptom Assessment Scale (ESAS)(35) and the 
observational Resident Assessment Instrument Minimum Data-Set Palliative Care 
(RAI MDS-PC draft 1.8).(36) This instrument has recently been developed for 
inclusion in the RAI instruments. Draft 1.8 was prior to the final validation of this 
instrument, but changes were negligible. Spiritual needs were also measured with 
this instrument.  
 
Structure of this thesis 
 
Following this Introduction, the chapters 2-7 of this thesis are based on articles of 
which four have been published or are in press and two have been submitted. This 
implies that in particular the methods sections overlap, so each chapter can be 
read independently.  
 
Chapter 2 describes the symptoms, signs, problems, and diseases and, diseases 
that are associated with the terminal disease phase. In the same chapter the 
incidence of patients who require palliative terminal care is closely described. 
Chapter 3 examines the prognostication ability of NH physicians with regard to 
survival time. The estimated survival, assessed by the NH physician, was 
compared to the actual survival. Information about psychological and spiritual 
needs in the last days of life is discussed in chapter 4. In chapter 5, the 
assessment of key domains in the provision of palliative care with the Palliative 
care Outcome Scale (POS) is addressed. The outcomes of the POS are evaluated 
including patients with dementia. In chapter 6 the last two days of life are studied 
with respect to cause and symptom burden. Furthermore, in chapter 7, medical 
end-of-life decisions are discussed. Finally, in chapter 8 the results are 
summarised and discussed. Also the implications of these results for health policy 
and practice and for further research are described.  
4
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Abstract 
 
Background 
Nursing homes (NHs) are less well studied than hospices or hospitals as a setting 
for terminal care. For more targeted palliative care more information is needed 
about the patient characteristics, symptoms, direct causes and underlying 
diseases, and incidence of terminal ill NH patients. These aspects are examined in 
this study. 
 
Methods  
Prospective observational cohort study in 16 NHs representative of the 
Netherlands. All long-term care patients assessed by an NH physician to have a 
life expectancy of 6 weeks or less were enrolled in our study. 
 
Results  
The terminal disease phase was marked with symptoms of low fluid and food 
intake, general weakness, and respiratory problems or dyspnea. Direct causes of 
these conditions were diseases of the respiratory system (mainly pneumonia), and 
general disorders (eg, cachexia). The 2 main underlying diseases of the terminal 
phase were mental and behavioral disorders and diseases of the circulatory 
system. Cancer was the underlying disease in only 12% of the patients. Patients 
with cancer showed a different pattern of symptoms than those without cancer. Per 
100 beds per year, 34 NH patients entered the terminal phase. Most patients 
(82.9%) died within 7 days of inclusion. 
 
Conclusion 
For patients without cancer in Dutch NHs, the terminal disease phase is difficult to 
predict, and once diagnosed, patient survival time is short. A better identification of 
the symptom burden might improve the prognostication of life expectancy in elderly 
patients. 
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Introduction 
 
The number of people living to an old age in Western countries is rapidly 
increasing. Consequently, the pattern of diseases that cause the most morbidity 
and mortality is also changing.(1) In the near future, the nursing home (NH) will 
increasingly be the site of terminal care and the place of death for many elderly 
people and people with dementia.(2-5) Before death, NH patients enter a terminal 
phase in which optimal palliative care should be provided. Traditionally, palliative 
care has focused on patients with cancer, but this type of care is needed for a 
much wider range of terminal illnesses, and should be integrated more broadly 
across the health care services, as was recently stated by the World Health 
Organization.(1)  
Nursing homes have been less well studied than hospices or hospitals as a setting 
for terminal care.(6) We do not know whether NHs provide good care for the dying, 
or how comfortably people die in a NH. Moreover, little is known about the 
symptoms and disorders that are associated with the terminal phase of these 
patients’ lives. To our knowledge, there are no reports on the incidence of NH 
patients who require palliative terminal care. Knowledge about the number of 
patients who will enter the terminal phase is required for the planning and 
organization of palliative terminal care. As the role of NHs in providing end-of-life 
care continues to expand, these facilities will be challenged to meet residents’ and 
families’ expectations and to achieve adequate outcomes of care.(7) Knowledge of 
the symptoms and disorders that are associated with the terminal phase in NH 
patients’ lives will help to improve the quality of dying. Physicians who, for 
example, do not realize how little time is left for the patient may miss the chance to 
devote more efforts to improve the quality of the patient’s life in the remaining 
period.(8) This study examined patient characteristics, symptoms, direct causes 
and underlying diseases, and incidence of the terminal phase in terminally ill 
patients in the Netherlands.  
In Dutch NHs, curative, supportive, or palliative care is provided for all patients 
according to the course of their illness. 
 
Methods 
 
Setting and Design 
A prospective observational study was conducted in 16 Dutch NHs during a 16-
month period from November 2001 until March 2003. Unlike most other countries, 
the Netherlands employs specially trained physicians to provide medical care in 
NHs.(9) Three types of NHs can be distinguished: those for physically ill patients, 
those for psychogeriatric patients, and combined types with separate wards for 
each category. Both the physically ill and the psychogeriatric patients benefit from 
the different nursing home functions, mainly rehabilitation and long-term care. This 
type of care can be characterized as continuous, long-term, systematic, and 
multidisciplinary.(10) Most (96%) of the psychogeriatric patients have dementia and 
will stay in the NH until they die.(11) In 2000, there were 334 NHs in the 
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Netherlands with a total of 58778 beds, which accounted for approximately 18% of 
the total mortality of Dutch inhabitants.(12,13) 
The NHs in the present study were purposefully sampled to be representative of all 
Dutch NHs. First, the proportion of the 3 types of NHs was calculated.(14) This 
proportion was 3:1:1 in order of combined, those for solely physically ill patients, 
and those for solely psychogeriatric patients. Therefore, the aim was to include (9) 
combined NHs, 3 NHs for physically ill patients, and 3 NHs for psychogeriatric 
patients. Second, the mean number of beds for physically ill and psychogeriatric 
patients per NH was calculated, and the NHs were arranged in order of this 
calculated mean. Finally, the NHs closest above and below the mean were invited 
to participate in the study. 
The beginning and end dates of the data-collection varied per NH. Each 
participating NH included all patients as soon as the estimated life expectancy 
became 6 weeks or less; follow-up was until death, with a maximum of 12 weeks. 
Each patient included was given a unique identification number by the local 
research coordinator, who supervised the data-collection. 
 
Patients 
The treating physician was responsible for the inclusion of patients in the study if 
they met the following criteria: (1) remaining life expectancy of 6 weeks or less; (2) 
admitted for long-term care; and (3) admitted for rehabilitation, but during their 
admittance it became obvious that the patient would not leave the NH. The 
exclusion criteria were (1) admitted for rehabilitation and expected to be discharged 
from the NH and (2) sudden and unexpected death (ie, with no clear terminal 
palliative phase).  
The period of 6 weeks is based on prior consultation with NH physicians who 
participated in our study. Admittance to NHs for terminal care is handled differently 
in different countries. In the Netherlands, it is set at 3 months because of 
administrative reasons, such as refunding by health care insurance companies. 
For practical reasons, the NH physicians perceived a weekly follow-up registration 
of 3 months with a maximum follow-up of 6 months as not feasible. We agreed on 
a weekly follow-up registration of  6 weeks with a maximum follow-up of 12 weeks
 (3 months). On the basis of their clinical experience, NH physicians decided 
whether  a patient had a life expectancy of 6 weeks or less. 
 
Measurements 
On inclusion, the nursing home physician completed a questionnaire on basic 
demographics, illness characteristics (eg, stage of dementia), symptoms, direct 
cause and underlying disease of the terminal phase. The stage of dementia was 
assessed according to the validated Global Deterioration Scale.(15) This 
instrument identifies 3 major clinical phases: a forgetfulness phase, a confusional 
phase, and a late dementia phase. These phases are further sub-divided into 7 
clinically identifiable stages, ranging from stage 1 (no cognitive decline) to stage 7 
(very severe cognitive decline). Stage 5 represents the phase of early dementia, 
and patients in this stage can no longer survive without some assistance.  
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Symptoms were measured according to a list of 25 symptoms (with 1 additional 
open question). This list was developed in cooperation with experienced NH 
physicians, who on the basis of their clinical practice included the main common 
symptoms present in NH patients. On inclusion, the NH physicians were also 
asked to give a maximum of 3 symptoms in order of magnitude, on which they 
based their estimated life expectancy of 6 weeks or less for that particular patient 
(1 indicates most important; 2, second most important; 3, third most important).  
The validated Dutch Classification Codes of Diseases for Nursing Home Medicine 
(CvZ-V) (16) were used for registration of the direct cause of the terminal phase 
(disorder that directly caused the symptoms on which the NH physician based an 
estimated life expectancy of 6 weeks or less) and the underlying disease (disease 
that was the underlying cause of the disorder on which the NH physician based the 
limited life expectancy). The CvZ-V is a Dutch standard, based on the International 
Classification of Diseases, 10th Edition (ICD-10),(17) which gives a classification of 
diseases, intercurrent diseases, disorders, injuries, other problems and causes of 
death in NH patients. However, unlike the ICD-10, it contains a general section with 
codes for diseases, disorders, and problems which supersede one particular organ 
system. 
We aimed to check all eligible patients by screening all deaths that occurred in the 
participating NHs. At the time of patient death, the NH physicians completed a 
questionnaire for all long-term care patients, including patients who had not been 
included in the study, for whom a short questionnaire was completed. In this short 
questionnaire, we checked the reason for noninclusion. (1) “a sudden and 
unexpected death (no or very short terminal phase)”; (2) “the patient should have 
been included earlier”; or (3) “other, namely….”. The patients included under point 
2 were “missed” patients who were identified afterwards. For these patients, the 
NH physician was asked in a separate question why these patients were not 
included earlier. The alternatives could be (1) “forgotten (to be included),”  
(2) “pressure of work,” (3) “organizational reasons (eg, should have been included 
during the weekend),” 4. “family had objections for inclusion in our study,” and (5) 
“other, namely .…” 
We went to great lengths to ensure that all eligible patients were included or at 
least identified. A check was made per NH to ensure that all deaths of long-term 
care patients were registered. At the end of the data-collection, the local research 
coordinator of each NH was asked in a personal interview for a number or estimate 
of patients incorrectly omitted. This number included the missed patients who were 
identified afterward. 
 
Statistical analysis 
All analyses were performed with SPSS statistical software, version 10.1 (SAS 
Institute Inc, NC) for Windows. The Pearson χ2 and Fisher exact tests were used 
to detect statistically significant differences (P<.05) in categorical data between 
groups.  
The Fisher exact test was chosen when the number in the cells was small or zero. 
The incidence was calculated from 16 selected NHs, most of which participated 
from January 2002 to March 2003. For the numerator, we counted all patients who 
3
 26 
entered the terminal phase, whether included or missed and irrespective of 
outcome (ie, died or survived within the maximum duration of follow-up of 12 
weeks, including second inclusions). The denominator was calculated separately 
for each participating NH, and the results were added together. The total number of 
beds was multiplied by the mean bed occupancy of the home in 2002 (if the 
number of beds changed during the inclusion period, the average was calculated) 
and the inclusion period. The lengths of the inclusion period varied among the 
NHs. Because of this, we corrected data to the 1-year period.  
 
Ethical review 
The study was approved by the Medical Ethics Committee of the VU University 
Medical Center. Confidentiality of the data was guaranteed by providing coded 
information only to the researcher. Informed consent was not necessary, because 
the physicians and nurses were simply reporting information collected as part of 
the usual care provided. As required by Dutch law, the patients and their families 
were informed about the study through an informational flyer and were given the 
option of refusing the transfer of data. 
 
Results 
 
A total of 544 patients were included. For 516 of these patients, NH physicians 
completed questionnaires on inclusion, which were used for analysis. An additional 
272 patients were found to have been incorrectly omitted from the study. These 
patients were considered to be missed patients who were identified afterwards. 
The main reasons for noninclusion, given in the questionnaire in order of sequence 
by the NH physicians, were pressure of work, organizational reasons (eg, should 
have been included during the weekend), forgotten (to be included), other reasons, 
and family had objections for inclusion in our study. 
Representative sampling in this study was checked against 2 parameters; the 
distribution of  physically ill and psychogeriatric patients and sex. No significant 
differences were found between the national NH population and the study 
population for either parameter. 
The incidence was calculated as follows:  
 
Included Patients + Missed Patients (Identified Afterward) / Beds X Mean Bed 
Occupancy X Mean Inclusion Period.  
 
Taking into account the duration of follow-up during the 1-year period, we identified 
544 patients (474 first inclusions, 12 second inclusions, 57 exclusions, 1 at end of 
follow-up) plus 272 missed patients, which divided by the number of beds (2429.6) 
equaled 0.34 long-term care patients who met the inclusion criteria. This is 
equivalent to 34 patients per year in an NH with 100 beds. After inclusion, most 
patients (82.9%) died within 7 days, and 92.3% died within 14 days.  
The median duration of survival was 3 days, with a 10th and 90th percentiles of 0 
(death within 24 hours) and 12 days, respectively. Fifty-seven (11.0%) of the 516 
patients recovered and were excluded. Of these patients, 26 (46%) of 57 died later 
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during our study (21.0% after the second inclusion and 24.6% between 5 and 228 
days after exclusion).  
 
Table 1   Demographics and disease characteristics in 516 patients* 
 
 Frequency, % 
Variable   
 Male   29.1 
 Female  70.9 
Age on inclusion, mean ± SD (range), y  83.5 (45 – 100; 8.1) 
Marital status    
 Never married  9.2 
 Married  27.6 
 Widowed  59.6 
 Divorced  3.5 
No. of months in nursing home, median (range)   14 (0 - 215) 
Reason for admission to nursing home    
 Chronic care  75.6 
 Rehabilitation  15.7 
 Terminal care  5.7 
 Other (eg, special care)  2.9 
Ward on inclusion    
 Physically ill   37.7 
 Psychogeriatric   56.4 
 Others  5.8 
Stage of dementia (Global Deterioration Scale15)    
 Stage 1, no cognitive decline  33.5 
 Stage 2 – 4, very mild to moderate cognitive decline  5.2 
 Stage 5, moderately severe cognitive decline  8.1 
 Stage 6, severe cognitive decline  27.0 
 Stage 7, very severe cognitive decline  26.0 
* Data are presented as percentage unless otherwise indicated 
 
 
Table 1 presents the demographics and disease characteristics of patients on 
inclusion in the study. Most of the patients were female (70.9%) and mostly 
widowed (59.6%), with a mean ± SD age of 83.5 years ± 8.1 years. Patients were 
predominantly admitted to the NH for chronic care (75.6%), and most (56.4%) 
stayed in a psychogeriatric ward. Of all the patients included, 33.5% had no 
cognitive decline, 5.2% had very mild to moderate cognitive decline, 8.1% had 
moderately severe cognitive decline, 27.0% had severe cognitive decline, and 
26.0% had very severe cognitive decline. Possible selection bias was evaluated by 
testing differences between included patients and patients who were found to be 
incorrectly omitted from the study for 3 parameters: age, sex, and ward. No 
significant differences were found for sex and ward between the included and 
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omitted patients. For age, a significant difference was found (mean age, 83.5 years 
for included patients vs 81.9 years for the omitted ones; P=.04). Since the mean 
age of both groups differed by 1.6 years, we considered this difference acceptable.  
 
Table 2   Most important symptoms, signs, or problems perceived by nursing home 
physicians as indicative of a life expectancy of 6 weeks or less* 
 
Symptoms 
 
Total, 
 
%† 
Most 
important, 
%‡ 
Second most 
important, 
% 
Third most 
important, 
% 
(Very) little/no fluid intake 42.6 17.2 17.2 8.1 
Generalized weakness 31.8 10.7 10.3 10.9 
(Very) little/no nutritional intake 24.8  13.6 9.9 
Respiratory problems/dyspnea 21.3 9.9 6.6 4.8 
Somnolence 17.8 5.2 4.3 8.3 
Recurrent fever 17.6 6.6 5.8 5.2 
Cachexia/anorexia 14.5 2.9 5.2 6.2 
Difficulty swallowing 11.4 3.5 5.0 2.9 
Dehydration 10.3 3.7 3.3 3.3 
(Extreme) tiredness 9.7 3.1 4.5 2.1 
Other symptoms§ 9.7 5.2  2.7 
Patient gives up 9.5 3.3  4.8 
Severe stage of somnolence 9.1 5.4  2.1 
Sub-coma 8.5 5.8  2.1 
(Worsening) pressure ulcer 7.8 2.3  4.1 
Medication not successful 7.4  2.7 2.7 
Confusion/delirium  5.4   2.5 
Refusal of liquid 3.9    
Loss of appetite 3.7  2.3  
Refusal of medication 3.7    
Coma 3.3 2.5   
Refusal of food 3.1    
Feeling sick 2.9    
Vomiting 2.5    
Nausea 2.1    
Rare symptoms  1.9 1.0 0.4 0.6 
* Nursing home physicians were asked to list at maximum 3 of the most important symptoms, signs, or 
problems in order of magnitude that are reasons for the physician to discuss limited life expectancy (6 
weeks or less) with this particular patient 
† Only symptoms with a frequency higher than 2% are presented 
‡ Nursing home physicians were asked to give a maximum of 3 problems in order of magnitude:  
1 indicates most important; 2, second most important; and 3, third most important 
§ Symptoms reported by nursing home physician that were not listed in the questionnaire (eg, diarrhea, 
pain, or constipation) 
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Table 2 gives the most important symptoms, signs or problems on study inclusion, 
in order of magnitude, perceived by the NH physician as indicative of a limited life 
expectancy. In 42.6% of all cases, the problem of “(very) little/no fluid intake” was 
reported as a reason for the NH physician to estimate the life expectancy to be  
6 weeks or less. “Generalized weakness” was reported in 31.8% of the cases, 
“(very) little/no nutritional intake” in 24.8%, and “respiratory problems/dyspnea” in 
21.3% of the cases. The percentages of other symptoms, signs or problems were 
less than 20%. “(Very) little/no fluid intake” (17.2%) and “generalized weakness” 
(10.7%) were the symptoms that were most frequently reported as most important. 
“(Very) little/no fluid intake” (17.2%) and “(very) little/no nutritional intake” (13.6%) 
were most frequently reported as the second most important symptoms or 
problems. The third most important symptoms were “generalized weakness” 
(10.9%) and “(very) little/no nutritional intake” (9.9%). 
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Table 3   Direct cause and underlying disease of the terminal phase in 516 patients 
according to the nursing home physician*    
 
 
 
Variable  
Direct cause of the  
terminal phase,  
No.             (%)† 
Underlying disease of the 
terminal phase,  
No.                  (%)‡ 
Diseases of the respiratory system 126 (24.4) 42 (8.1) 
 Pneumonia  106 (20.5) 21 (4.1) 
 Malignant neoplasms  7 (1.4) 7 (1.4) 
General disorders  123 (23.8) 36 (7.0) 
 Cachexia  29 (5.6)   
 Malaise 24 (4.7)   
 Coma 18 (3.5)    
 Fever 18 (3.5)   
 Septicaemia 14 (2.7)   
 Malignant neoplasms 2 (0.4) 10 (2.0) 
Diseases of the circulatory system 72 (14.0) 106 (20.5) 
 Cerebrovascular accidents 40 (7.8) 48 (9.3) 
 Heart failure  27 (5.2) 11 (2.1) 
 Malignant neoplasms     
Endocrine, nutritional and metabolic 
diseases 
50 (9.7) 14 (2.7) 
 Disorders of electrolyte and 
 fluid balance, not 
 elsewhere classified 
 (dehydration) 
48 (9.3)   
 Malignant neoplasms     
Diseases of the digestive system  44 (8.5) 34 (6.6) 
 Dysphagia  14 (2.7)   
 Malignant neoplasms 8 (1.6) 20 (4.0) 
Diseases of the genitourinary 
system 
34 (6.6) 24 (4.7) 
 Renal failure 19 (3.7)   
 Malignant neoplasms 1 (0.2) 2 (0.4) 
Mental and behavioral disorders 18 (3.5) 156 (30.2) 
 Dementia 12 (2.3) 151 (29.3) 
Diseases of the skin and 
subcutaneous tissue 
11 (2.1)   
 Malignant neoplasms     
Remaining systems 23 (4.6) 48 (9.4) 
 Malignant neoplasms 12 (2.4) 21 (4.1) 
Missing 15 (2.9) 55 (10.7) 
Malignant neoplasms (including 
secondary malignant neoplasms) 
within all systems 
30 (6.0) 60 (12.0) 
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* The Dutch CvZ-V codes16 are used for classification of diseases. For direct cause, only data higher 
than 2.0% of the total study population are presented, excluding malignant neoplasm 
† The question was, “What disorder is the direct cause of the limited life expectancy?  
‡ The question was, “What is the underlying disease of the health problems?”  
 
 
As given in Table 3, the terminal phase was directly caused by a disease of the 
respiratory system, predominantly pneumonia, in 24.4% of the study population, 
“general” disorders (disorders that supersede one particular organ system) in 
23.8% of the patients, and diseases of the circulatory system (such as 
cerebrovascular accidents and heart failure) in 14.0% of the patients. “Endocrine, 
nutritional, and metabolic disorders” (such as dehydration) were reported in only 
9.3% of the cases. With regard to the underlying disease of the terminal phase, the 
2 main categories were mental and behavioral disorders (30.2%), almost 
exclusively dementia, and diseases of the circulatory system (20.5%). The third 
category was cancer (12%). 
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Table 4   Symptoms, signs and problems for the 2 main underlying diseases of the 
terminal phase and malignant neoplasms* 
 
 
 
 
 
 
Symptom 
Group 1 
(Mental 
and 
behavioural 
disorders),  
%  (n=156) 
Group 2 
(Diseases 
of the 
circulatory 
system), 
%  (n=106) 
Group 3 
(Malignant 
neoplasms 
including  
Metastases), 
%..(n=60) 
Group  
1 vs 2, 
 
 
χ2 
P Value 
Group  
1 vs 3, 
Fisher 
exact 
test 
P Value 
Group  
2 vs 3, 
Fisher 
exact 
test  
P Value 
(Very) little/no 
fluid intake 
49.4 45.3 21.7 .52 <.001 .003 
(Very) little/no 
nutritional intake 
32.7 19.8 21.7 .02 .14 .84 
Generalized 
weakness 
28.8 28.3 46.7 .92 .02 .03 
Recurrent fever 23.7 12.3 10.0 .02 .02 .80 
Cachexia/ 
anorexia 
17.3 10.4 26.7 .12 .13 .009 
(Worsening) 
pressure ulcer 
16.0 3.8 0.0 .002 <.001 .30 
Respiratory 
problems/ 
dyspnea 
12.2 31.1 13.3 <.000 .82 .01 
Difficulty 
swallowing 
12.2 17.9 5.0 .20 .14 .02 
Sub-coma 10.3 9.4 0.0 .83 .007 .01 
Refusal of liquid 7.7 0.9 1.7 .01 .12 >.99 
Severe stage of 
somnolence 
6.4 17.0 3.3 .007 .52 .01 
Medication not 
successful  
3.8 12.3 1.7 .01 .68 .02 
Other 
symptoms† 
3.2 9.4 20.0 .03 <.001 .06 
(Extreme) 
tiredness 
3.2 10.4 26.7 .02 <.001 .007 
Loss of appetite 1.3 3.8 10.0 .19 .006 .17 
Vomiting 1.3 0.9 11.7 .80 .002 .004 
Nausea 1.3 0.9 13.3 .80 .001 .001 
Feeling sick 0.6 1.9 10.0 .35 .002 .03 
* Including secondary neoplasms                                                                               
† Symptoms reported by NH physicians that were not listed in our questionnaire 
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Table 4 gives reported symptoms on inclusion for the 2 main underlying diseases 
of the terminal phase (mental and behavioral disorders and diseases of the 
circulatory system) and malignant neoplasms (including secondary malignant 
neoplasms). For 9 of the 26 symptoms, significant differences were found between 
the 2 main underlying diseases. Most frequently reported symptoms in the group of 
patients with mental disorders (mostly dementia) were problems regarding “fluid 
intake” (49.4%), “nutritional intake” (32.7%), “generalized weakness” (28.8%), 
“recurrent fever” (23.7%), “cachexia/anorexia” (17.3%) and “(worsening) pressure 
ulcer” (16.0%). Patients with diseases of the circulatory system more often had 
“respiratory problems/dyspnea” (31.1% vs 12.2%). They more often experienced 
“(extreme) tiredness” (10.4% vs 3.2%), severe stage of somnolence (17.0% vs 
6.4%), and “other symptoms” (9.4% vs 3.2%). Included in this group was 
“medication not successful” (12.3% vs 3.8%), but there were fewer problems with 
“nutritional intake,” “recurrent fever,” “(worsening) pressure ulcer,” and “refusal of 
liquid.” 
The frequencies of reported symptoms for patients with cancer show a different 
pattern when compared with the 2 main underlying diseases (Table 4). Significant 
differences between patients with cancer and those with mental and behavioral 
disorders and diseases of the circulatory system were found for 11 and 12 (of 26) 
symptoms, respectively. 
Compared with patients with mental and behavioral disorders, those with cancer 
more often experienced “generalized weakness” (46.7% vs 28.8%), “other 
symptoms” (20.0% vs 3.2%), “(extreme) tiredness” (26.7% vs 3.2%), “loss of 
appetite” (10.0% vs 1.3%), “vomiting” (11.7% vs 1.3%), “nausea” (13.3% vs 1.3%), 
and “feeling sick” (10.0% vs 0.6%). They less frequently had “(very) little/no fluid 
intake” (21.7% vs 49.4%), “reccurent fever” (10% vs 23.7%), “(worsening) pressure 
ulcer” (0.0% vs 16.0%) and “sub-coma” (0.0% vs 10.3%). 
When compared with patients who had diseases of the circulatory system, patients 
with cancer more often experienced “generalized weakness” (46.7% vs 28.3%), 
“cachexia/anorexia” (26.7% vs 10.4%), “(extreme) tiredness” (26.7% vs 10.4%), 
“vomiting” (11.7% vs 0.9%), “nausea” (13.3% vs 0.9%), and “feeling sick” (10.0% 
vs 1.9%). They less frequently had “(very) little/no fluid intake” (21.7% vs 45.3%), 
“respiratory problems/dyspnea” (13.3% vs 31.1%), “difficulty swallowing” (5.0% vs 
17.9%), “sub-coma” (0.0% vs 9.4%), ‘’ severe stage of somnolence” (3.3% vs 
17.0%), and “medication not successful” (1.7% vs 12.3%). 
 
Discussion 
 
To our knowledge, this is the first nationwide study to provide insight into the 
symptoms, the direct causes, and underlying diseases of the terminal disease 
phase in NH patients. Furthermore this study estimated the incidence of NH 
patients who entered the terminal phase. The strengths of this study are the large-
scale design, the representativeness of the NHs, and the prospective character, 
which enhances the validity and reliability of the findings. 
However, the study has some limitations. The underlying disease of the terminal 
phase was assessed with a question analogue to the cause-of-death question on 
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Dutch death certificates.(13) The NH physicians who participated in the study might 
have had difficulties in reporting the underlying disease of the terminal phase and 
therefore may have incorrectly registered the cause of death on the death 
certificates.(18) Problems occur mainly with regard to the sequence of the primary 
and secondary causes of death, and the primary cause (underlying disease) 
cannot always be determined.  
There was also missing information about a large number of terminally ill patients. 
These patients should have been included. Although we did not find substantial 
differences between the study sample and the omitted group in the demographic 
variables (age, sex, and ward), we cannot, in case physicians selectively missed 
patients, exclude a possible bias on the outcome variables of this study. Also, no 
separate incidence of patients (eg, with and without cognitive impairment) who 
would enter a terminal disease phase could be calculated.  
In addition, although sudden and unexpected death was an exclusion criterion, 
different physicians may differently read the signs in the phase before death and 
may miss signs of nearing death. It is possible that physicians missed the signs of 
nearing death and mistakenly described patients as having died suddenly. 
However, we believe that physicians did not deliberately misclassify patients. 
Furthermore, individual interpretation was possible regarding the data on having a 
limited life expectancy of 6 weeks or less; however, this factor was decided on the 
basis of clinical daily practice.  
The 4 most frequently reported symptoms, signs or problems in the terminal 
disease phase of NH patients, which physicians identified as related to terminal 
illness, were problems with fluid and nutritional intake, generalized weakness, and 
respiratory problems or dyspnea. The patients were frequently in a state of 
somnolence and experienced recurrent fever. These symptoms alone might be 
highly predictive of approaching death and could be an indication for the physician 
and all others involved that the patient is dying. However, this must be confirmed in 
future research on predictive models. Since the identified period of terminal illness 
is limited, the question is whether palliative care is sufficiently addressed. 
Direct causes of the terminal phase, according to the NH physicians, were 
diseases of the respiratory system, mostly pneumonia, and disorders of a general 
nature, such as cachexia, malaise, coma, fever, and septicemia. Diseases of the 
circulatory system were less frequently reported by the NH physicians. Hanson et 
al6 found that NH deaths are preceded by a slow trajectory punctuated by acute 
and reversible illnesses, such as pneumonia, sepsis, or dehydration. The results of 
the present study are in line with this observation. Health care professionals are 
therefore challenged with providing care for patients with diseases that have 
trajectories of slow decline with periodic crises and a less well-defined terminal 
phase.(19) 
Diseases of the circulatory system and mental or behavioral disorders dominate as 
the underlying diseases in the terminal phase of NH patients. However, regardless 
of the underlying disease, symptoms of “(very) little/no fluid intake,” “generalized 
weakness,” “somnolence” and “cachexia/anorexia” were common in both groups. 
For other symptoms, different patterns could be determined between these 2 main 
groups. For patients with mental disorders, mainly dementia, the beginning of the 
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terminal phase was marked with problems of nutritional intake, and they 
experienced recurrent fever. This group was most likely to refuse liquid and to 
develop a (worsening) pressure ulcer. In these NH patients, it appeared that low 
food and fluid intake, together with episodes of fever, led to a deterioration in their 
overall condition, which may have caused (worsening of) pressure ulcers. In 
patients with disorders of the circulatory system, mainly caused by poor heart 
function, the presence of respiratory problems or dyspnea can be expected. 
Extreme tiredness and severe stage of somnolence can be the consequences of a 
circulatory disease. A low level of oxygen in the blood, due to insufficient heart 
function, causes tiredness, and the mental state of patients in the severe stage of 
somnolence can probably be explained by the high prevalence of cerebrovascular 
accidents (9.3%) in the study population. In this group of patients, medication was 
significantly less successful than in the group of patients with mental disorders.  
The findings of the present study reflect a (mainly) noncancer population. Only 
12% of the patients had cancer as the underlying disease. Those patients showed 
a different pattern of symptom prevalence with regard to the noncancer population. 
These characteristics are in line with the findings of Addington-Hall et al,(20) who 
reported a difference in the prevalence of symptoms between patients with and 
without cancer. 
It is estimated that in an NH with 100 beds, 34 patients will enter the terminal 
phase of life each year. In other words, for every 3 beds, an NH can expect 1 
patient per year to reach a terminal disease phase that requires palliative care. 
This information is useful for policy making and assessment of the required 
terminal care. Although the estimated incidence of the terminal phase is high, the 
duration of this phase, as noticed by the physicians, is most often limited to a 
couple of days. 
The study demonstrates that most of the patients were considered to be terminally 
ill only when death was actually already very near. After inclusion most patients 
died within 7 days, and after 14 days almost all patients were dead. This finding 
highlights the late identification of terminally ill patients by NH physicians. On the 
other hand, 1 of 10 patients recovered. Nevertheless, almost half of these patients 
died later during the inclusion period. Even the advantage that the physicians are 
employed by the NH and therefore know their patients very well is no guarantee of 
an accurate prediction of life expectancy. The difficulty of defining patients without 
cancer as terminally ill or predicting their life expectancy has been recognized in 
several studies.(21-23) An estimation of the possible survival period is importance 
for the patients, their families, and the NH physicians and nurses and also has 
implications for the planning of appropriate medical care. Therefore, improving 
prognostication of life expectancy for patients without cancer is needed. 
In conclusion, it is perhaps even more difficult to provide appropriate palliative care 
for elderly patients with chronic diseases than for patients with cancer. The course 
of chronic diseases is more difficult to predict because it shows a more gradual 
decline when compared with patients dying of cancer.(24)  
As our study shows, when patients were identified as entering a terminal disease 
phase, death was only a few days off. This indicates that the traditional focus of 
palliative terminal care on patients with cancer needs to be extended and adopted 
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to the specific needs of elderly patients without cancer. This public health challenge 
was recently adopted by the World Health Organization.(1) 
Our study also highlights how ineffective NH physicians are at determining 
prognosis with regard to life expectancy and poses the question of whether this 
limited time is adequate for the implementation of palliative terminal care, if this has 
not already been provided. High-quality symptom control and organization of 
palliative care in NHs is needed owing to the apparent speed of deterioration and 
therefore a steep increase in symptoms.  
 
The findings of this study stress the difficulty of estimating incidence of palliative 
care needs of the terminally ill patients in NHs. Further research to estimate these 
needs is desirable. 
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Abstract  
 
Studies on the prediction of survival have mainly focused on hospital and hospice 
patients suffering from cancer. The aim of this study was to describe the predicted 
vs. the actual survival in terminally ill, mainly noncancer, patients in Dutch nursing 
homes (NHs). A prospective cohort study was conducted in 16 NHs, representative 
for The Netherlands. A total of 515 NH patients with a maximum life expectancy of 
6 weeks, as assessed by an NH physician were included.  
NH physicians were accurate in more than 90% of their prognoses for terminally ill 
- mainly noncancer - NH patients, when death occurred within 7 days. For a longer 
period of time, their predictions became inaccurate. In the category of patients who 
were expected to die within 8-21 days, predictions were accurate in 16.0%, and in 
the category of patients expected to die within 22-42 days, this was 13.0%. 
Predictions in these categories were mainly optimistic (patient died earlier) in 
68.6% and 52.2%, respectively.  
The findings of this study suggest that accurate prediction of survival of (mainly) 
noncancer patients in NHs is only possible when death is imminent and seems to 
be dependent on an intimate knowledge of patients. Prognostication over a longer 
period of time tends to be less accurate, and, therefore continues to be a 
challenging task for NH physicians.  
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Introduction 
 
The prediction of survival is one of the most important, but also one of the most 
difficult issues in daily clinical practice for the terminally ill. Nevertheless, the issue 
of length of survival remains important both for patients and their families when 
they are confronted with end-of-life issues, like deciding about further burdensome 
treatment options, joint decision making with regard to starting or forgoing 
supportive care, preparing for death, ending a relationship with loved ones, etc. 
The physician is expected to provide patients and their families with accurate 
information about future expectations. 
Studies on the prediction of survival have mainly focused on hospital and hospice 
patients suffering from cancer.(1-5) Their results suggest that it is very difficult to 
make an accurate prognosis for terminally ill cancer patients, that the predictions 
remain controversial, and that physicians are often, but not always, too optimistic. 
Nevertheless, many, mainly elderly, dependent people die from the end-stages of a 
chronic disease, such as a vascular disease or dementia, and it is well known that 
the nursing home (NH) population consists of more patients with chronic diseases 
than patients with cancer. The course of an illness due to cancer can often be 
predicted, but there is uncertainty for other common chronic diseases.(6) 
Prognostic errors have detrimental effects on patient care, and predicting and 
staging the end of life continues to be difficult, especially for NH residents with 
diseases other than cancer.(7) 
The purpose of this study is to evaluate the prediction of survival at the beginning 
of the terminal phase in a general NH population.  
 
Methods 
 
Setting and design 
A prospective observational study was carried out in 16 Dutch NHs from November 
2001 to March 2003.(8)  
In the Netherlands, three types of NHs can be distinguished as follows: NHs solely 
for physically ill patients, NHs solely for psychogeriatric patients, and combined 
NHs with separate wards for each of these categories. All patients benefit from the 
different NH functions, mainly rehabilitation and long-term care (admitted to the NH 
permanently). The NHs in the present study were purposefully sampled to be 
representative of all NHs in the Netherlands. First, the proportion of the three types 
of NHs was calculated: nine combined NHs, three for physically ill patients, and 
three for psychogeriatric patients. Secondly, the mean number of beds for 
physically ill and psychogeriatric patients per NH was calculated, and the NHs were 
arranged in order of this calculated mean. Finally, the nearest NHs above and 
below the mean were invited to participate in the study. During the course of the 
data collection, due to organizational and capacity problems, one NH for physically 
ill patients stopped collecting the data. For the remaining time of the data 
collection, another one from the same stratum replaced this NH. Hence, the total 
number of participating homes was 16. In this study, the average number of NH 
beds was 103 for physically ill patients, 156 for psychogeriatric patients, and 157 
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for combined care. The physically ill patients and the psychogeriatric patients all 
benefit from the various different NH functions, mainly rehabilitation and long-term 
care. Dutch NH care is organized differently than in most other countries. However, 
differences concern mainly structural aspects, and are limited concerning 
characteristics of patient populations. An important difference between Dutch NHs 
and NHs in other countries is the patient population admitted for rehabilitation.(9) 
As the majority of these patients are usually discharged after 4-8 weeks of 
treatment, these patients were not included in our study. Most salient difference in 
Dutch NHs compared to other countries is the presence of specially-trained NH 
physicians (in general one full-time physician per 100 patients), who provide 
medical care and are employed by these homes.(10) 
 
Selection of patients 
This study was introduced in each NH by the authors (HB, MEO). Written and 
verbal instructions were given to the NH physicians in how to fill in the 
questionnaires. They were asked to include on daily basis all consecutive 
(physically ill and psychogeriatric) patients who met the following criteria:  
(1) maximum life expectancy of 6 weeks, according to clinical assessment by the 
NH physician, and (2) admitted for long-term care; or (3) previously admitted for 
rehabilitation, but transferred to long-term care during their stay (i.e. it became 
obvious that the patient would not leave the NH).  
Based on their clinical experience, NH physicians decided whether a patient had a 
maximum life expectancy of 6 weeks. Patients who died suddenly, that is, with no 
clear terminal palliative phase, who recovered unexpectedly, or who survived the 
maximum follow-up period of 12 weeks (84 days), were excluded from the study.  
The maximum life expectancy of 6 weeks is based on prior consultation with the 
NH physicians who participated in the study. After the pilot study, the NH 
physicians considered that a weekly follow-up registration of 6 weeks with a 
maximum follow-up of 12 weeks, was the longest possible period over which any 
meaningful prediction could be made.  
 
Measurements 
On inclusion, the NH physician completed a questionnaire for each patient 
concerning basic demographics, clinical characteristics (e.g., stage of dementia, 
underlying disease on inclusion), and prediction of survival. The patients were 
monitored weekly, with an identical questionnaire on inclusion (except basic 
demographics), until death or exclusion. 
The stage of dementia was assessed by the NH physician according to the 
validated Global Deterioration Scale (GDS), on the basis of their clinical 
experience.(11) This instrument identifies three major clinical phases: 
forgetfulness, confusion, and a late phase of dementia. These phases are further 
subdivided into seven clinically identifiable stages, ranging from Stage 1 (no 
cognitive decline) to Stage 7 (very severe cognitive decline). Stage 5 represents 
the phase of early dementia, and patients in this stage can no longer survive 
without some assistance.  
0
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The validated Classification of Diseases for Nursing Home Medicine (CvZ-V)(12) 
was used by the NH physician to classify the underlying disease on inclusion 
(disease which was the underlying cause of the disorder on which the NH 
physician based the limited life expectancy). The CvZ-V is a Dutch standard 
assessment, based on the International Classification of Diseases, 10th Edition 
(ICD-10),(13) with codes for the classification of diseases, intercurrent diseases, 
disorders, injuries, other problems, and causes of death in NH patients. However, 
unlike the ICD-10, the CvZ-V contains a “general” section with codes for diseases, 
disorders, and problems that supersede one particular organ system, because this 
situation is common in NH patients. The strength of this instrument is that the 
Classification of Diseases is tailored to the average NH population. 
The NH physicians were asked to predict survival in a separate question on 
inclusion, with the following possible answers: death within 1 week (0-7 days), 
death within one to three 1-3 (8-21 days), and death within 4-6 weeks (22-42 days). 
This question on expected survival periods was analogous to a question in the 
Resident Assessment Instrument Minimum Data-Set Palliative Care (RAI MDS-PC 
draft 1.8)(14) and was fit to our study purpose. The original RAI MDS-PC question 
was “estimated length of life”: (0) death imminent (within days); (1) less than 6 
months to live; (2) 6 months or longer to live. The rationale behind the three 
intervals in this study was as follows: firstly, whether the included patient met the 
maximum life expectancy of six weeks, and secondly, were the NH physicians able 
to distinguish sub-categories among included patients. The NH physicians were 
given no assessment aid for prediction, which makes their assessment subjective 
and not replicable. However, accurate prognostic tools have not been 
developed,(15) and, therefore, the NH physicians had to rely on their clinical 
experience.  
After inclusion there was a weekly follow-up registration for a period of 6 weeks, 
with a maximum follow-up of 12 weeks (84 days). The occurrence and date of 
death was registered by the NH physician. An optimistic prediction indicates earlier 
death than predicted, and a pessimistic prediction indicates death later than 
predicted.  
 
Statistics  
The analyses were performed in SPSS for Windows, version 11.0, and descriptive 
statistics were used to characterize the patients. Eligible patients were those for 
whom the date of inclusion, the date of death, or the date of exclusion was 
confirmed. Survival curves were calculated according to the Kaplan-Meier method. 
Proportional hazard analysis was applied to investigate the potential modifying 
influence of diseases and the stage of dementia. 
 
Ethical review 
The Medical Ethics Committee of the VU University Medical Center approved the 
study protocol. Confidentiality of the data was guaranteed by providing only coded 
information to the researchers. No patients or members of their family were 
interviewed. Because the NH physicians were simply reporting information that was 
collected as part of their usual care observations, no informed consent was 
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required, according to the VU Medical Ethics Committee. As required by Dutch law, 
the patients and their families were informed about the study through an 
information flyer, and were given the option to refuse the transfer of data.  
 
Results 
 
A total of 515 patients were included, for whom data on inclusion were confirmed. 
Of these patients, 467 died within 6 weeks (data on death confirmed) and 48 
patients survived until the end of follow-up at 6 weeks. Patients and their families 
were informed about the study, which required no informed consent (see Ethical 
review). To the knowledge of the researchers, no patients refused data transfer. 
 
Table 1   Demographic and clinical characteristics of patients on inclusion (n=515)  
 
Demographics n % 
Gender (missing=1)   
 Male  150 29.2 
 Female 364 70.8 
Age on inclusion (years) (missing=6)   
 Mean age (min-max; SD) 83.5 (45-100; 8.1) 
Median survival of deceased patients (days) (N=467) 3.0 
Marital status (missing=2)   
 Never married 46 9.0 
 Married 141 27.7 
 Widowed 304 59.7 
 Divorced 18 3.5 
Clinical characteristics  
  
Stage of dementia (Global Deterioration Scalea)  
(missing=26) 
  
 Stage 1 no cognitive decline 165 33.7 
 Stage 2 – 4 very mild to moderate  
 cognitive decline 
24 4.8 
 Stage 5 moderately severe cognitive 
 decline 
38 7.8 
 Stage 6 severe cognitive decline 134 27.4 
 Stage 7 very severe cognitive decline 128 26.2 
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continue Table 1  
Main underlying disease on inclusionb  
(CvZ-V codes) 
  
 Mental and behavioral disorder 
155 30.1 
  malignant neoplasms 0 0.0 
 Diseases of the circulatory system  106 20.6 
  malignant neoplasms 0 0.0 
 Diseases of the respiratory system 42 8.2 
  malignant neoplasms 7 1.4 
 General disorders 36 7.0 
  malignant neoplasms 10 2.0 
 Diseases of the digestive system 34 6.6 
  malignant neoplasms 20 4.0 
 Diseases of the nervous system 21 4.1 
  malignant neoplasms 2 0.4 
 Remaining systems 66 12.9 
  malignant neoplasms 21 4.2 
 Missing 55 10.7 
Main direct cause of deathc (CvZ-V codes) (n=467)   
General disorders 
 (mainly cachexia) 
106 
(55) 
22.7 
(11.8) 
Diseases of the respiratory system 
 (mainly pneumonia) 
102 
(78) 
21.8 
(16.7) 
Diseases circulatory system 
 (mainly heart failure)  
 (mainly stroke) 
82 
(37) 
(17) 
17.6 
(7.9) 
(3.6) 
Diseases genitourinary system 
 (mainly renal failure) 
71 
(59) 
15.2 
(12.6) 
Endocrine, nutritional and metabolic diseases  
 (mainly dehydration) 
62 
(61) 
13.3 
(13.1) 
Remaining systems 39 8.3 
Missing  5 1.1 
SD = standard deviation 
a GDS11 was used to determine the stage of dementia 
b Only diseases with a minimum prevalence of 4% are presented 
c Only diseases with a minimum prevalence of 4% are presented. The total of patients (n=467) does not 
correspond with the total on inclusion (n=515), because all survivors are excluded 
 
Table 1 presents the demographics and clinical characteristics of the patients on 
inclusion. Most of the patients were female (70.8%), and widowed (59.7%), with a 
mean age of 83.5 years (SD 8.1). Of all the patients who were included, 33.7% had 
no cognitive decline, 4.8% had very mild to moderate cognitive decline, 7.8% had 
3
 46 
moderately severe cognitive decline, 27.4% had severe cognitive decline, and 
26.2% had very severe cognitive decline. The main underlying diseases on 
inclusion were mental and behavioral disorders (30.1%) and diseases of the 
circulatory system (20.6%). Malignant neoplasms (12.0%) occurred most frequently 
in the digestive system (4.0%). The most prevalent causes of death were general 
disorders (22.7%, mainly cachexia 11.8%), and diseases of the respiratory system 
(21.8%, mainly pneumonia 16.7%) and circulatory system (17.6%, mainly heart 
failure 7.9% and strokes 3.6%). 
 
Figure 1 Survival function of predicted and actual survival (n=515) 
 
 
 
+ 4-6 weeks (22-42 days)   
 1-3 weeks (8-21 days)  
 1 week (0-7 days).   
 
 
Figure 1 shows the actual survival in Kaplan-Meier curves for the three categories 
of predicted survival. According to the logrank test, the three curves are 
significantly different (P < 0.0001). The median duration of survival of all the 
included patients was 3.0 days (data not shown). The predicted survival was most 
accurate for patients who died shortly after inclusion (0-7 days).  
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Table 2   Data on predicted survival, actual survival and median survival (n=515) 
 
 
Actual survival 
 
Categories of 
predicted survival  
(Missing=4) 
Optimistic 
prediction 
(Earlier death) 
Accurate 
prediction  
Pessimistic  
prediction 
(Later death)  
Median survival 
 % % % Days 
Death within  
0-7 days 
(n=267) 
 
Not applicable 92.9 7.1 2 
Death within  
8-21 days  
(n=175) 
 
68.6 16.0 15.4 5 
Death within  
22-42 days 
(n=69) 
52.2 13.0 34.8 21 
 
Table 2 presents data on categories of predicted vs. actual survival. Prediction was 
accurate in 92.9% of the patients who were expected to die within 0-7 days 
(median survival 2 days). In the category of patients who were expected to die 
within 8-21days or within 22-42 days, the prediction was accurate in 16.0% and 
13.0%, respectively. But the overall predictions in these categories were mainly 
optimistic (patient died earlier) in 68.6% and 52.2%, respectively. In proportional 
hazard analysis, it appeared that the main underlying disease was not related to 
predicted and actual survival. The stage of dementia was of no importance with 
regard to the assessment of the NH physician (was neither a confounder nor a 
modifier for prognosis).  
 
Discussion 
 
To our knowledge, this is the first study that provides insight into prognostic 
assessment in the terminal stage of NH patients. It shows, that the survival of 
patients (with mainly noncancer diseases) is inaccurately predicted by NH 
physicians, except when death is imminent. 
 
One limitation of this study is that the patients were included if the NH physician 
expected that they were likely to die within 6 weeks. Although no substantial 
differences were found between the study sample and the patients who were not 
included with regard to demographic variables (age, gender and ward), if NH 
physicians selectively missed patients, we cannot exclude a possible bias on the 
outcome variables of this study. However, the strengths of this study are the large-
scale design, the representativeness of the NHs, and the prospective nature of the 
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research, which enhances the validity and reliability of the findings. It also provides 
data on a population that is relatively underinvestigated in end-of-life research, 
namely noncancer patients. 
 
The findings of this study show that NH physicians predicted the death of patients 
with mainly chronic diseases with an accuracy of more than 90% when death 
occurred within 7 days (imminent death). These findings are, despite a different 
group of patients, consistent with the findings of Oxenham and Cornbleet, who 
reported, in their study of survival in a hospice, that members of the clinical staff 
were able to predict imminent death of patients with diagnosis of advanced 
malignant disease, with significant accuracy, either based on increased knowledge 
of individual patients or based on increasing illness.(16) Christakis and Lamont in 
their prospective cohort study of hospice outpatients, concluded that prognostic 
inaccuracy was associated with a stronger doctor-patient relationship and that the 
majority of predictions were over-estimated (63%).(2) In Dutch NHs, where 
specially-trained physicians provide medical care, profound knowledge of the 
patient's condition can be assumed, as well as a strong doctor-patient relationship. 
This study cannot support the assumption that the latter aspect is an “obstacle” to 
accurate prediction. Nonetheless, predicted and actual survival became 
substantially less accurate over a period longer than 7 days, when death was not 
imminent. Accurate prediction decreased to 16%-13% (categories of 1-3 weeks 
and 3-6 weeks, respectively), and survival prediction was over-optimistic in these 
categories (68.6%-52.2%), which is consistent with the findings of Christakis and 
Lamont(2) and Morita et al.(17) One might expect a better prognostication of long-
term survival by the NH physician because of the profound knowledge of the 
patient. Nevertheless, the reason for the poor prognostication may be due to the 
fact that NH patients get frail and die from complex multifactorial causes 
(comorbidity and intercurrent diseases). Deterioration in one health domain 
influences other health domains, resulting in a cumulative negative effect on 
patients overall health condition and thus making prognostication difficult. Two-
thirds of the studied patients had dementia (stage 5-7 GDS),(11) a complicated 
disease with unpredictable course.  
Uncertainty of prognosis does not mean that the needs of these patients and their 
families are any less important. The application of the principles of palliative care 
should not be influenced by the estimate of survival. However, as a consequence 
of a more accurate survival prediction, a more frequent assessment and 
addressing of needs and demands of the patient is possible. Giving the apparent 
speed of deterioration, physical, psychosocial, and spiritual needs could be 
addressed better, all resulting in improved end-of-life care and improved quality of 
life for the remaining life time, how ever short it is. 
 
In conclusion, the findings of this study suggest that accurate prediction of survival 
of (mainly) noncancer patients in NHs is only possible when death is imminent and 
seems to be dependent on an intimate knowledge of the patients. Prognostication 
over a longer period of time tends to be less accurate, and, therefore, continues to 
be a challenging task for physicians.  
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Abstract  
 
The aim of this study was to assess psychological and spiritual needs in terminally 
ill nursing home (NH) patients. A prospective observational study was carried out in 
16 Dutch NHs among patients with a maximum life-expectancy of 6 weeks 
(N=426). These needs were assessed with the Resident Assessment Instrument 
Minimum Data-Set Palliative Care (RAI MDS-PC) and the Edmonton Symptom 
Assessment Scale (ESAS). The majority of NH patients showed psychological and 
spiritual needs in the last three days of life. However, healthcare providers had 
insufficient knowledge about these needs because they were unable to assess a 
significant portion of them. 
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Introduction 
 
Terminally ill elderly people often spend the last days of their life in a nursing home 
(NH).(1) It is therefore important that the long-term care physicians and the NH 
staff provide appropriate palliative care in this setting.(2) Only a few empirical 
studies have focused on end-of-life care for long-term patients in NHs (3-5) and 
research on the experience of dying is limited.(6) It has been acknowledged that 
good end-of-life care pays attention to psychological and spiritual issues.(7) 
However, it is suggested that physical pain continues to dominate the focus of care 
in dying residents,(8) whereby patients and their families are isolated from social 
and spiritual support.(9) Holtkamp et al. (2000) described in their study that about 
40% of the residents who needed help with family problems, feelings of sadness or 
depression did not receive care for these problems.(10) 
Palliative care is holistic care, and therefore attention must also be paid to 
psychosocial and spiritual issues. The National Council for Hospice and Specialist 
Palliative Care Services (1997) has defined psychosocial care as: being concerned 
with the psychological and emotional well-being of patients and their 
families/carers, including issues of self-esteem, insight into adaptation to the illness 
and its consequences, communication, social functioning and relationships.(11)  
Given the rather broad spectrum of these psychosocial needs, the present study 
will focuses on indicators for psychological needs such as mood, depression, 
anxiety, well-being. These indicators lend themselves well to specific psychological 
interventions during the care process.(12)  
Spirituality is an aspect of palliative care, that has been even less frequently 
investigated and defined differently by different authors.(13) At least in the recent 
literature, spirituality has been defined as a concept that is broader than religiosity 
alone.(14;15) One of these definitions describes spirituality as the quest for 
understanding life’s ultimate questions and the meaning and purpose of life; it 
emphasizes individual experience, and may or may not lead to participation in a 
community.(16) In this study, we aim to investigate both the religious and the non-
religious dimension of spirituality at the end of life. 
 
This study forms part of a large-scale palliative care study of mainly non-cancer, 
terminally ill patients in Dutch NHs.(17) At the end of the life of long-term care 
patients, their needs and the focus of the care that is provided may change, and 
psychological and spiritual issues may become more important.(18) Therefore, the 
aim of this study was to investigate the psychological and spiritual needs of 
terminally ill long-term care patients admitted to NHs in the Netherlands.  
 
Methods 
 
Setting and design 
A prospective observational study was carried out in 16 Dutch nursing homes 
(NHs) from November 2001 to March 2003, with an average inclusion period of 0.9 
years and 2429.5 bed-years.  
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In 2003, there were about 330 NHs in The Netherlands. Three types of NHs can be 
distinguished: those solely for physically ill patients, those solely for psychogeriatric 
patients, and combined types with separate wards for each of these categories. 
Most of the psychogeriatric patients have dementia (96%) and will stay in a NH 
until they die.(19) All patients benefit from the different NH functions, mainly 
rehabilitation and long-term care. The staff includes specially trained nursing home 
physicians: (in general one full-time physician per 100 patients), who provide the 
medical care and are employed by these homes.(20) 
The NHs in the present study were purposefully sampled to be representative of all 
NHs in the Netherlands. First, the proportion of the three types of NHs was 
calculated: nine combined NHs, three for physically ill patients, and three for 
psychogeriatric patients. Secondly, the mean number of beds for physically ill and 
psychogeriatric patients per NH was calculated, and the NHs were arranged in 
order of this calculated mean. Finally, the nearest NHs above and below the mean 
were invited to participate in the study. During the course of the data collection, due 
to organizational and capacity problems, one nursing home for physically ill 
patients stopped collecting the data. For the remaining time of the data collection, 
another one from the same stratum replaced this NH. Hence, the total number of 
participating homes was 16. In this study the average number of NH beds was 103 
for physically ill patients, 156 for psychogeriatric patients, and 157 for combined 
care.  
We included all patients (physically ill and psychogeriatric) who were admitted for 
long-term care with a maximum life-expectancy of 6 weeks, as assessed by the NH 
physician.  
 
Selection of patients 
This study was introduced during instruction sessions in each NH by the authors 
(HB, MEO), and written instructions were also provided. The NH physicians were 
asked to include all consecutive patients who met the following criteria:  
(1) maximum life-expectancy of 6 weeks, according to the NH physicians’ own 
clinical assessment; and (2) admitted for long-term care (admitted to the NH 
permanently), or (3) previously admitted for rehabilitation, but transferred to long-
term care during their stay (i.e. it became obvious that the patient would not leave 
the nursing home). Patients who died suddenly and unexpectedly (i.e., with no 
clear terminal palliative phase), who unexpectedly recovered, or survived the 
maximum follow-up period of 12 weeks, were excluded from the study. 
 
The maximum life-expectancy of six weeks is based on prior consultation with the 
NH physicians who participated in the study. Admittance to an NH for terminal care 
is handled differently in different countries. In the Netherlands the limit is set at 
three months, due to reimbursement by health care insurance companies. In the 
pilot study, the NH physicians considered that a weekly follow-up registration of 
three months with a maximum follow-up of six months was not feasible. After the 
pilot study, based on a maximum life-expectancy of six weeks, the participating 
(experienced) NH physicians agreed that this criterion was the longest possible 
period over which any meaningful prediction could be made.  
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Measurements 
On inclusion, the regularly attending NH physician and one attending nurse both 
completed a separate questionnaire for each patient. The patients were monitored 
weekly, until death or exclusion, with an identical questionnaire. At the time of 
patient death, the NH physician completed a questionnaire for all long-term care 
patients. NH-physicians and nurses did make their assessments by reporting 
information they collected as part of their usual care observations. Neither the 
patients nor members of their family were interviewed, regarding psychological or 
spiritual needs. 
 
Measurements by the NH physician 
The NH physician completed a questionnaire on the basic patient demographics, 
disease characteristics (e.g. stage of dementia, main underlying disease of 
terminal status), and psychological needs. The stage of dementia was assessed by 
the NH physician according to the validated Global Deterioration Scale (GDS).(21) 
This instrument identifies three major clinical phases: forgetfulness, confusion, and 
a late phase of dementia. These phases are further sub-divided into seven 
clinically identifiable stages, ranging from stage 1 (no cognitive decline) to stage 7 
(very severe cognitive decline). Stage 5 represents the phase of early dementia, 
and patients in this stage can no longer survive without some assistance.  
The validated Classification Codes of Diseases for Nursing Home Medicine  
(CvZ-V)(22) was used by the NH physician to classify the main underlying disease 
of the terminal status on inclusion (disease which was the underlying cause of the 
disorder on which the NH physician based the limited life-expectancy). The CvZ-V 
is a Dutch standard, based on the International Classification of Diseases, 10th 
Edition (ICD-10)(23), with codes for the classification of diseases, intercurrent 
diseases, disorders, injuries, other problems, and causes of death in NH patients. 
However, unlike the ICD-10, the CvZ-V contains a ‘General’ section with codes for 
diseases, disorders and problems that supersede one particular organ system, 
because this situation is common in NH patients. The strength of this instrument is 
that the Classification of Diseases is tailored to the average NH population. 
 
In this study psychological needs were measured by the NH physician in the 
domains of (A) mood disturbance, and (B) depression, anxiety and well-being. 
Assessment of other, more psycho-pathological disorders, such as personality 
disorders, was beyond the scope of this study. 
(A) Mood disturbance was assessed with the Resident Assessment Instrument 
Minimum Data-Set Palliative Care (RAI MDS-PC Draft 1.8.).(24) Draft 1.8 was prior 
to the final validation of this instrument, but subsequent changes were negligible. 
This psychological aspect was measured on inclusion and was weekly monitored 
(if patient was still alive). The mood questions consisted of 11 items and 
considered the previous three days. The alternatives for each item were:  
(1) “Indicator in the last three days not exhibited”,  
(2) “Indicator 1-2 times in the last three days exhibited”,  
(3) “Indicator exhibited on each of last three days”,  
(4) “Unknown/not assessed”.  
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The concepts of (B) depression, anxiety and well-being were measured with items 
of the Edmonton Symptom Assessment Scale (ESAS),(25) in the questionnaire 
which was completed by the NH physician at the time of death. In this 
questionnaire, the NH physician assessed retrospectively in all conscious patients, 
for the period 48-24 hours and 24-0 hours before death, a number of physical and 
psychosocial symptoms. The validated ESAS consists of nine 100 mm visual 
analogue scales (VASs) for pain, activity, nausea, depression, anxiety, drowsiness, 
appetite, well-being and shortness of breath. The scores range from 0-100 (higher 
scores reflect greater symptom severity.(25) Therefore, a score nearing 100 
indicates very depressed, very anxious, and poor well-being.  
Before every assessment of the psychological needs the NH physician could 
indicate in the questionnaire whether or not a patient was conscious. RAI MDS-PC 
items were assessed in conscious as well as unconscious patients, but ESAS 
items were only assessed in conscious patients.  
RAI MDS-PC scores of the last assessment before death of conscious patients 
with stage 1–5 dementia (GDS)(21) were included for analysis. Stage 5 was 
included, although reflecting the phase of early dementia, for these patients are still 
able to express their wishes. Patients with stage 6 and 7 dementia (GDS) were 
excluded, because of their severe cognitive impairment, which makes only non-
verbal communication possible. To prevent bias in the scoring of variables by the 
NH physician, the extra response category ‘unknown/not assessed’ was added to 
all RAI MDS-PC and ESAS items. Assigned non-scores (unknown/not assessed) 
are an indication for quality of palliative care. 
For deceased patients who had not been included in the study, the NH physician 
completed a shorter questionnaire at the time of death. In this short questionnaire, 
we checked the reason for non-inclusion: (1) sudden and unexpected death; (2) 
should have been included earlier; (3) other, namely. The patients included under 
point 2 were ‘missed’ patients of whom the NH physician was asked in a separate 
question why these patients were not included earlier (alternatives: 1. forgotten [to 
be included], 2. pressure of work, 3. organizational reasons [e.g. should have been 
included during the weekend], 4. family had objections to inclusion in the study,  
5. other reasons). 
 
Measurements by the nurses 
Spiritual needs were assessed by nurses on inclusion and monitored weekly (if 
patient was still alive), according to the RAI MDS-PC.(24) Alternative response 
categories were added, such as ‘unknown’ if the nurse did not have enough 
knowledge to assign a score and, ‘not applicable’, e.g. for unconscious patients.  
 
Statistics  
All analyses were performed in SPSS for Windows, version 11.0, and descriptive 
statistics were used to characterize the patients. Data of the last assessment 
before death of conscious patients with stage 1-5 dementia (GDS)(21) were 
included for analysis. Because most data were missing for the unconscious 
patients, the analyses were limited to the conscious patients. 
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The outcome variables of the ESAS were derived from the questionnaire 
completed at the time of death by the NH physician (Table 3), therefore the number 
of cases is not consistent with the other tables. The items depression, anxiety and 
well-being were screened for normality . Standard transformations were made, if 
necessary. Symptom development of the ESAS was analyzed in patients who were 
conscious on both time points, 48-24 hours and 24-0 hours before death (N=235). 
Differences in mean score were determined with the paired-samples t-test.  
Patients with no data on consciousness and/or cognitive decline were excluded 
from the analysis. 
 
Ethical review 
The Medical Ethics Committee of the VU University Medical Center approved the 
study. Confidentiality of the data was guaranteed by providing only coded 
information to the researchers. Neither the patients nor members of their family 
were interviewed. Because the NH-physicians and nurses were simply reporting 
information that was collected as part of their usual care observations, no informed 
consent was required, according to the VU Medical Ethics Committee. As required 
by Dutch law, the patients and their families were informed about the study through 
an information flyer, and were given the option to refuse the transfer of data.  
 
Results 
 
A total of 426 patients were included. For these patients we received a 
questionnaire on inclusion, a weekly questionnaire (dependently on survival time 
after inclusion), and a final questionnaire after death. Most patients died within the 
first week of inclusion (86.6%), therefore, most data were gathered from the 
questionnaire on inclusion. 
In the same period, an additional 272 deceased patients were found to have been 
incorrectly not included in the study. Those patients were considered as ‘missed’ 
patients. The main reasons for non-inclusion, given in the shorter questionnaire at 
the time of death, in order of sequence by the NH physicians, were pressure of 
work, organizational reasons (e.g. should have been included during the weekend), 
forgotten (to be included), other reasons (e.g. death not foreseen). 
 
Demographics 
Table 1 presents the demographics and disease characteristics of three groups of 
patients on inclusion: conscious patients with stage 1-5 dementia, patients with 
stages 6 and 7 dementia according to the GDS, and unconscious patients. In all 
categories, most of the patients were female (66% to 77%), and mostly not married 
(72% to 75%), with a mean age of 82.9 to 85.0 years. One fifth to a quarter had no 
children. The main religion was Catholic or Protestant. The median duration of 
residence in the NH was 7 to 21 months. On inclusion, unconscious patients were 
predominately admitted to a psychogeriatric ward (66%). A quarter of the 
unconscious patients had no cognitive decline (26%), whereas more than two third 
(65%) had severe or very severe cognitive decline. The main underlying cause of 
terminal status on inclusion for patients with stage 1-5 dementia were diseases of 
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the circulatory system (29%). For patients with stage 6 and stage 7 dementia, as 
well as for unconscious patients, the main underlying disease of terminal status 
were mental and behavioural disorders (53% and 37%). Malignant neoplasms were 
predominantly in conscious, not demented patients (18.0%). In the total population 
10% had cancer (data not shown). 
 
Psychological needs  
Table 2 shows the assessment by the NH physician of mood disturbance in 
conscious patients in the last three days of life. The most salient indicators in this 
last assessment, which were exhibited at least 1-2 time(s) and on each of the last 3 
days, were ‘sad, pained, worried facial expressions‘ (52%), ‘at peace with life’ 
(45%), ‘expressions of fear’ (36%), ‘feeling of sadness or being depressed’ (29%), 
‘insomnia/change in usual sleep pattern’ (21%), ‘anhedonia’ (19%), and ‘repetitive, 
anxious complaints and concerns’ (11%). The score for the indicator ‘not exhibited 
in the last three days’ was > 60% for 7 of the 11 items of mood disturbance. The 
score for ‘unknown’ was highest for the items ‘at peace with life’ (33%), ‘feeling sad 
or depressed’ (25%), and ‘anhedonia’ (19%).  
 
Table 1   Demographics and disease characteristics of patients on inclusion, 
according to the stage of dementia and consciousness (N=426) 
 
 Conscious Unconscious* 
Stage of dementia (Global 
Deterioration Scale21)† 
1-5 
(n=157) 
6 and 7 
(n=165) 
Stages 1-7  
(n=82) 
 % % % 
Demographics    
Gender     
 Male  31.8 23.5 34.1 
 Female 68.2 76.5 65.9 
Age on inclusion     
 Mean age  
 (min-max; SD‡ ) 
82.9 
(45-98; 9.0) 
85.0 
(65-100; 6.5) 
84.0 
(53-100; 8.2) 
Marital status     
 Married 27.7  33.3 
 Not married 72.3  66.7 
Number of children    
 Children 81.7  75.6 
 No children 18.3  24.4 
Religion    
 Catholic 42.2 37.1 50.0 
 Protestant 35.9 37.9 30.3 
 Other (e.g. Jehovah, 
 Humanist, Muslim) 
4.7 9.5 7.6 
 None 17.2 15.5 12.1 
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continue Table 1 
 Conscious Unconscious* 
Stage of dementia (Global 
Deterioration Scale21)† 
1-5 
(n=157) 
6 and 7 
(n=165) 
Stages 1-7  
(n=82) 
 % % % 
Disease characteristics    
Number of months in nursing home     
 Median (min–max) 7.1(0-199) 21.3(0-215) 14.8(0-164) 
Ward on inclusion     
 Physically ill  73.2 1.8 29.3 
 Psychogeriatric  17.8 94.5 65.9 
 Others 8.9 3.6 4.9 
Stage of dementia  
(Global Deterioration Scale21)  
   
 Stage 1 No cognitive 
 decline 
71.3 -.- 25.9 
 Stage 2 – 4 Very mild to 
 moderate cognitive decline 
12.7 -.- 2.5 
 Stage 5 Moderately severe 
 cognitive decline 
15.9 -.- 6.2 
 Stage 6 Severe cognitive 
 decline 
-.- 53.6 28.4 
 Stage 7 Very severe 
 cognitive decline 
-.- 45.8 37.0 
Main underlying disease of terminal status on inclusion § (Classification of Diseases for 
Nursing Home Medicine22) 
 Diseases of the circulatory 
 system 
29.3 10.8 20.7 
 General disorders  10.8 4.8 4.9 
 Diseases of the digestive 
 system 
8.9 5.4 -.- 
 Mental and behavioural 
 disorders 
7.6 53.0 36.6 
 Others  43.4 26.0 37.8 
 Malignant neoplasms 
 (including secondary 
 malignant neoplasms) 
  within all systems  
18.0 3.0 4.8 
* Missing=5 
† Missing=17  
‡ Standard deviation 
§ Only diseases with a prevalence above 4% are presented 
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Table 2   Mood disturbance* in the last three days of the life of conscious patients 
with stage 1-5 dementia Global Deterioration Scale (GDS)21, assessed by the 
nursing home physicians (N=153)† 
 
Indicator Exhibited 
1-2 times 
in last three 
days 
Exhibited 
on each  
of last 3 days 
Not exhibited 
in last 
three days 
Unknown 
 
 
 % % % % 
Sad, pained, worried facial 
expressions 
29.1 22.5 41.7 6.6 
At peace with life 20.0 24.7 22.0 33.3 
Expressions of fear 23.2 13.2 51.7 11.9 
Feelings of sadness or being 
depressed 
13.9 15.2 45.7 25.2 
Insomnia/change in usual sleep 
pattern 
11.3 9.9 68.9 9.9 
Anhedonia 11.3 7.3 62.9 18.5 
Repetitive, anxious complaints  
and concerns 
6.0 4.6 79.5 9.9 
Frustrated 7.3 2.7 78.0 12.0 
Repetitive health complaints 6.0 3.3 80.8 9.9 
Recurrent crying, tearfulness 6.6 2.6 82.1 8.6 
Persistent anger with self or 
others 
4.0 4.6 80.1 11.3 
* Mood disturbance measured with the Resident Assessment Instrument Minimum Data-Set Palliative 
Care (RAI MDS-PC Draft 1.8)24 
† 4 missing. At the last assessment, the total of all conscious patients with stage 1-5 dementia (GDS)21 
no longer corresponds with the total on inclusion (N=157), due to 4 additional unconscious patients 
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Figure 1   Number of mood disturbances* observed in conscious patients in the 
last three days of life (n=153) 
 
* Mood disturbances include all indicators presented in Table 2, with the exception of ‘at peace with life’ 
 
 
Figure 1 shows the number of mood disturbances observed in conscious patients 
in the last three days of life. For all indicators listed in Table 2, with the exception of 
‘at peace with life’, we counted how many times the nurses assessed the response 
categories ‘exhibited 1-2 times in the last three days’ or ‘exhibited on each of last 
three days’. A quarter of the patients (25.7%) showed no mood disturbance at all, 
one-fifth (18.8%) showed one mood disturbance, and less than 15.0% showed  
2-10 mood disturbances. 
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Table 3   Median score for depression, anxiety and well-being* 48-24 hours and 
24-0 hours before death in conscious†, non-demented‡ patients, retrospectively 
assessed by the nursing home physician (N=113)§ 
 
 48-24 hours before death 24-0 hours before death 
 Median score Unknown 
% 
Median 
score 
Unknown 
% 
P-value¶ 
Depression 12 18.6 8.0 28.3 0.000 
Anxiety 21 8.0 10 8.0 0.001 
Well - being 70 19.5 52 28.3 0.007 
* Assessed according to the Edmonton Symptom Assessment Scale (ESAS)25. A score nearing 100 
indicates very depressed, very anxious, and poor well-being 
† Conscious on both time points: 48-24 hours and 24-0 hours before death 
‡ Stage 1-5 Global Deterioration Scale21 
§ Occurrence and date of death was registered by the NH physician in a separate questionnaire, other 
than on inclusion. Therefore the number of cases is not consistent with the other tables 
¶ Differences in mean scores 48-24 hours and 24-0 hours before death  
 
 
Table 3 shows the median score for depression, anxiety and well-being two days 
before death in conscious, non-demented patients. The median scores for 
depression, anxiety and well-being decreased towards death (less depressed, less, 
anxious, and more well-being). The frequency of the score for ‘unknown’ increased 
towards death. Analysis for all patients (N=253, stage 1-7 GDS) showed the same 
results (data not shown). 
 
Spiritual needs 
Table 4 presents the spiritual needs in the last days before death of conscious, 
non-demented patients, as assessed by the nurses. More than one-third (44.8%) of 
all patients wished ‘ religious or spiritual guidance or support’. More than one-eight 
(15.8%) was ‘struggling with the meaning of life’. In half of the cases it was 
‘unknown’ to the nurses whether or not the patient was ‘struggling with the meaning 
of life’ (54.0%) or felt ‘anger toward God, religion or fate’ (52.1%). When spiritual 
needs were analyzed according to demographics (gender, marital status, actual 
living status before NH admittance, number of children, religion), the results 
showed that patients belonging to a religious denomination asked significantly 
more often for religious or spiritual guidance or support than non-religious patients 
(data not shown). 
 
2
 65 
Table 4   Spiritual needs in the last assessment before death by nurses of 
conscious, non-demented patients (N=153)* 
 
 No Yes Unknown 
Question % % % 
Patient wishes religious or spiritual guidance or support 22.8 44.8 32.4 
Patient is struggling with the meaning of life 30.2 15.8 54.0 
Patient feels anger toward God, religion or fate 46.5 1.4 52.1 
* 4 missing. At the last assessment, the total of all conscious patients with stage 1-5 dementia (GDS)21 
no longer corresponds with the total on inclusion (N=157), due to 4 additional unconscious patients 
 
Discussion 
 
To the knowledge of the investigators, this is the first nationwide study that gives 
insight into psychological and spiritual issues in the terminal phase of NH patients. 
Furthermore, an assessment was made of the prevalence of psychological and 
spiritual needs in terminally ill NH patients in the Netherlands.  
 
The findings of the present study reflect a (mainly) non-cancer population. Only 
10% had cancer as the underlying disease. In general, psychosocial and spiritual 
needs were present at high frequencies, but simultaneously NH physicians and 
nurses showed a lack of assessment of these needs, expressed in high assigned 
non-scores.  
Half of the patients showed sad, pained, worried facial expressions, one-third 
exhibited expressions of fear and expressed feelings of sadness or depression. 
One-fifth suffered from insomnia or change in the usual sleep pattern. At the same 
time , almost half of the conscious, non-demented (stage 1-5 GDS) patients was at 
peace with life in the last three days of their life and NH physicians reported 
significant improvement of depression, anxiety and well-being towards death. More 
than two-fifth (44.8%) of the patients wished religious or spiritual guidance or 
support, but 15.8% was struggling with the meaning of life. The results showed that 
aspects of spiritual needs like struggling with the meaning of life and anger towards 
God, religion or fate, were unknown to a majority of the attending nurses, which 
suggests potential for improvement of assessment of spiritual needs in end-of-life 
care. 
 
The study provides detailed information about various aspects of the terminal 
phase of elderly people with a chronic disease. The large-scale design of this 
study, its prospective character, and the representativeness of the participating 
NHs, all enhance the validity and reliability of the findings.  
However, the study has some limitations. Firstly, the data were obtained from the 
reports of proxies, namely professionals. These proxies may have under-reported 
or over-reported the psychological and spiritual issues. Hence, the patient’s 
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experiences can be biased. Several studies have evaluated the reliability of proxy 
reports on the quality of life, respectively the quality of care, in elderly patients with 
and without dementia.(26-30) In general, these studies evaluating the reliability of 
proxy ratings show different outcomes. Assessments made by significant others 
and health care providers are reasonably accurate, and nurses may even be the 
most suitable source of proxy information. Fairly good agreements between patient 
and proxy reports have been found with regard to physical functioning and 
cognitive status, but agreement is poorest for subjective aspects of the patient’s 
experience, such as pain, anxiety and depression. In patients with dementia, 
agreement decreased with increasing severity of the dementia, and therefore proxy 
assessments should be interpreted with caution.(28) 
Secondly, the main underlying disease of terminal status on inclusion was 
assessed with a question analogous to the cause of death question on the Dutch 
death certificates.(31) The NH physicians who participated in the study might have 
had difficulties in reporting the underlying disease and therefore may have 
incorrectly registered the cause of death on the death certificates.(32) Problems 
occur mainly with regard to the sequence of the primary and secondary causes of 
death, and the primary cause (underlying disease) cannot always be determined. 
Thirdly, when death is approaching, the assessment of consciousness is difficult. It 
is possible that physicians did misclassify the state of consciousness, which could 
have influenced the reliability of the data. Furthermore, there is missing information 
about a large number of terminal patients (n=272), who should have been included. 
Although no substantial differences were found between the study sample and the 
omitted group with regard to gender and type of ward, we cannot, in case 
physicians selectively missed patients, exclude a possible bias on the outcome 
variables of this study.(17) Finally, the retrospective assessment of depression, 
anxiety and well-being of the period 48-24 hours and 24-0 hours before death by 
the ESAS, cannot exclude recall-bias. Because the NH physicians were instructed 
to fill in the questionnaire soon after death, this has possibly been limited. The 
retrospective approach and the use of proxies is a solution to overcome the 
obstacles when evaluating care of the dying.(26) Again, when death is approaching 
assessments are difficult and could have influenced the reliability of the data.  
 
In this study feelings of sadness or depression were assessed in (29%) of the 
patients. These results contradict with the findings by Reynolds et al. (2002) In their 
study, family members and nursing home staff reported that 44% of the decedents 
were very sad or depressed during their final three months of life.(33) Our findings 
suggest that these feelings were either absent (indicator not exhibited) in almost 
half (46%) of the patients in the last three days of their life, or they were unknown 
to the carers. There are reasons to think that the latter suggestion is correct, since 
in 33% of the cases the NH physicians had no knowledge about whether or not 
patients were at peace with life and in 25% if they expressed feelings of sadness or 
depression. 
In the light of these results, it is not surprising that a quarter (26%) of the patients 
exhibited no mood disturbance in the last three days of their life. Approximately 
one-fifth of these patients (19%) had only one mood disturbance, and with the 
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increasing number of disturbances the number of patients with those disturbances 
decreased rapidly. Again, the question remains as to whether mood disturbances 
were absent or whether the NH physicians did not recognize them. A surprising 
result was that, regardless of their stage of dementia, the well-being of conscious 
patients increased significantly towards death. This may be due to intensification of 
the alleviation of pain and/or symptoms, but further investigation of the cause of 
this phenomenon was beyond the scope of this study.  
In half of the cases the spiritual needs as struggling with the meaning of life (54%) 
or anger towards God, religion or fate (52%) were unknown to the nurses. Not 
surprisingly, they had more knowledge of the more concrete wishes of the patient 
with regard to religious or spiritual guidance or support (45%). Very often spirituality 
is equated to religiosity, because variables such as religious practice seem easier 
to measure.(15) The findings of this study are supported by DeSilva et al. (2001), 
who found in their study from bereaved family members about quality of care in the 
last month of life of their loved one, that in only 15% of the cases referral to a 
spiritual leader by health care providers occurred, and a health care provider spoke 
to only 44% of family members about their religious or spiritual concerns.(34) 
Demographic parameters were not important for the spiritual needs of the patient, 
with one exception: patients belonging to a religious denomination asked 
significantly more often for religious or spiritual guidance or support than non-
religious patients.  
 
The major finding of this study is that staff were not able to include all the valid 
cases, and when they did include them, they were unable to assess a significant 
portion of them. The majority of NH patients showed psychological and spiritual 
needs in the last three days of life. However, healthcare providers had insufficient 
knowledge about these needs, which was expressed in the high frequency of 
assigned non-scores (unknown/not assessed). As an evaluation of palliative care 
these results give an indication of the quality of the provided care. The question 
remains, whether this was due to unawareness or the absence of feasible 
assessment instruments. This isn’t clear. Evaluation of palliative care relies on 
adequate tools, to develop high-quality end-of-life care. Also psychosocial and 
spiritual aspects of care should be more integrated in the continuing professional 
education of health professionals. Developing effective methods to assess the 
psychological and spiritual needs of patients very near the end of life is an 
important task. To judge from this study, it is also a difficult task. More research is 
needed to shed more light on why it is so difficult or how these challenges could be 
met.  
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Abstract 
 
The aim of this study was to assess the palliative care for terminally ill (NH) 
patients in the Netherlands with the Palliative care Outcome Scale (POS).  
 
Methods  
A prospective observational study of patients with a life-expectancy of 6 weeks or 
less in 16 Dutch NHs. NH staff rated the patient characteristics and measured 
palliative care with the POS, including items on physical, psychosocial, 
informational, spiritual, and practical aspects. 
 
Results  
POS non-scores (not applicable; unknown) were mainly found in the psychosocial 
and spiritual domains, particular in patients with dementia. Mean scores for non-
demented patients and patients with dementia were favourable for the majority of 
the POS items.  
 
Conclusion 
According to the NH staff, the assessed outcome of palliative care was fairly good, 
but the psychosocial and spiritual aspects of care need to be addressed more in 
the last days of the dying NH patient’s life. The results indicate that the POS is an 
appropriate instrument to assess not only cancer patients, but also non-cancer and 
(moderately) severely demented patients.  
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Introduction 
 
Most deaths in Western countries concern people who are over 65 years of age. 
Almost 25% of Americans die in nursing homes (NHs),(1) and in the Netherlands 
almost 20%.(2,3)  NHs provide a supportive environment for their residents and
 many of these patients receive palliative care until they die. Despite the
 magnitude and importance of elderly dying in NHs, health  policies in general
 have little concern with regard to the quality of care that is provided
 for older people.(4) Much research has been focused on younger patients
 with specific diseases (especially cancer), but very little attention has been paid
 to ‘typical’ NH patients, who usually die from the more common complications that 
are associated with the final stages of a chronic disease, such as pneumonia.(5-12)
 Little is known about the quality of care at the end-of-life of the elderly and 
a dearth of research is published on end- of-life care in the NH setting.(13-18) 
A Pubmed search on (‘terminal care’ [MeSH terms] or ‘life support care’ [MeSH 
terms] or ‘palliative care’ [MeSH terms]) and ‘nursing homes’ [MeSH terms] and 
‘quality of health care’ [MeSH terms] for patients aged 65+ years provides only 12 
reviews, two RCTs and three editorials in the last ten years. 
To gain insight into the various aspects of palliative care for terminally ill NH 
patients, a prospective observational study was carried out among NH patients with 
a life-expectancy of six weeks or less. The Palliative care Outcome Scale (POS) 
was used to evaluate palliative care, since it not only focuses on physical 
symptoms, but also pays ample attention to the psychosocial aspects of the dying 
patient.(19) The POS was developed as an outcome measure for patients with 
advanced cancer and their families, but has not been used in the assessment of 
patients with non-cancer diseases or dementia. As proxy instrument, caregivers 
can also assess the POS. The latter can be measured with a slightly adapted 
version to be completed by the staff. An acceptable agreement between staff and 
patient ratings has been found.(20) 
As communication with the patient and the family is hampered by the presence of 
cognitive disorders, it could be expected that differences will exist in the POS-
scores between patients with and without dementia. Patients with dementia are 
frequently non-communicative in the later stages and therefore certain items, such 
as being able to share feelings, may not apply. 
As in most countries, about half of the NH population in the Netherlands is 
principally physically disabled and the other half suffer from a psychogeriatric 
illness (mostly dementia).(21) The aim of this study was to assess the palliative 
care that is provided for terminally ill NH patients in the Netherlands, with and 
without dementia, with the Palliative care Outcome Scale (POS). 
 
Methods 
 
Setting and Design 
A prospective nationwide observational study was conducted in 16 Dutch nursing 
homes (NHs) from November 2001 until March 2003. 
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Selection of nursing homes  
The NHs in the present study were deliberately sampled to be representative of all 
Dutch NHs. First, the proportion of the three types of NHs was calculated.(22) This 
proportion was 3:1:1 in the order of combined, those for solely somatic patients, 
and those for solely psychogeriatric patients. Therefore, the aim was to include 
nine combined NHs, three NHs for somatic patients and three NHs for 
psychogeriatric patients. Secondly, the mean number of beds for somatic and 
psychogeriatric patients per NH was calculated and the NHs were arranged in 
order of this calculated mean. Finally, the NHs closest above and below the mean 
were invited to participate in the study. 
 
Selection of patients  
In each NH, verbal and written instructions were given to all the NH physicians and 
they were asked to include all patients (physically disabled and psychogeriatric) 
who met the following criteria: 1) remaining life-expectancy of six weeks or less, 
according to their own judgment; and 2) admitted to long-term care or admitted for 
rehabilitation, but previously transferred to long-term care (during the course of the 
admittance it became obvious that the patient would not leave the nursing home). 
Patients who died suddenly and unexpectedly (i.e., with no clear terminal palliative 
phase) were not included. Patients could be included in the study if a questionnaire 
was completed on inclusion and the death was registered. 
 
Measurements 
On inclusion, the regularly attending NH physician and one attending nurse both 
completed a questionnaire. The NH physicians registered basic demographics and 
clinical characteristics. If the patient lived longer than one week, the nurses 
completed a weekly questionnaire assessing the palliative care.  
 
The stage of dementia was assessed according to the Global Deterioration 
Scale.(23) This instrument identifies three major clinical phases: forgetfulness, 
confusion and late dementia. These phases are then further sub-divided into seven 
clinically identifiable stages, ranging from stage 1 (no cognitive decline) to stage 7 
(very severe cognitive decline). Stage 5 represents the phase of early dementia 
and patients in this stage need some assistance. This stage was defined as the 
cut-off point between non-demented and demented patients in the present study 
(stage 1-4: non-demented; stage 5-7: demented).  
The validated Dutch Classification Codes of Diseases for Nursing Home Medicine 
(CvZ-V) was used for the classification of underlying diseases on inclusion.(24) 
The CvZ-V is a Dutch standard, based on the International Statistical Classification 
of Diseases and Related Health Problems (ICD-10).(25) However, in addition to the 
ICD-10, it also contains a ‘General’ section that allows coding for diseases, 
disorders and problems that supersede a particular organ system. 
The outcome of care was measured with the validated Palliative care Outcome 
Scale (POS). This scale consists of two almost identical measures, one completed 
by the staff, and the other by the patient. Agreement between the two measures 
has proven acceptable.(20) On inclusion, and subsequently on a weekly basis, 
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nurses completed the POS-Staff version. These questionnaires on inclusion 
(completed by NH physicians and nurses) and the weekly questionnaire (only 
completed by nurses), including the POS, were piloted among the NH physicians 
and nurses over a two-month training period. The main finding of this pilot study 
was that it was difficult for nurses to give an answer to the POS-Staff questions for 
severely demented and comatose patients. To prevent bias, two extra response 
categories, ‘unknown’ and ‘not applicable (e.g., coma or severely demented)’, were 
added to questions 1-9 and the response category ‘unknown’ was added to 
question 10. 
Both versions (staff and patient) incorporate ten questions concerning the physical, 
psychological and spiritual domains of life within the field of palliative care. It 
assesses these domains over the previous three days of care. An eleventh 
question in both versions invites participants to describe their main problems in free 
text. Participants score each of the first eight POS-questions on a 5-point Likert 
scale, ranging from 0 (no problem) to 4 (overwhelming problem).(26) POS-
questions 9 and 10 are scored on a 3-point scale (0-2-4) from 0 (good) to 4 (bad). 
A mean score of 2.0 or below was considered as favourable. The main problems 
reported in free text (POS-question 11) were categorized by the authors. 
Information from the POS can be used to assess improvement or deterioration in a 
patient’s condition or circumstances in one single domain. The total score at the 
end of the assessment can help to assess and monitor overall well-being and care. 
The POS can be used to assess the palliative care provided.(27) The POS-Staff 
version was used in the present study (translated and translated back into Dutch by 
M. Echteld, psychologist and H. Brandt, social gerontologist) because it was not 
feasible to interview patients due to (rapid decline in) their physical or mental 
status.  
We made some adaptations in the presentation of the POS, namely we added the 
labels, e.g., pain, other symptoms, patient anxiety, to improve the readability of the 
text. The selection of the labels was based on labels previously presented by the 
authors of the POS.(20) 
The occurrence and date of death was registered by the NH physician. 
 
Statistical analysis 
SPSS 10.1 for Windows was used for the statistical analyses and descriptive 
statistics were used to characterise the patients. Non-parametric Mann-Whitney  
U-tests were used to test the differences between groups in the mean POS scores 
of patients with and without dementia because it appeared that several POS items 
were not normally distributed. 
The valid POS questionnaire data differed across the respective variables, with the 
number of variables marked as ‘not applicable (e.g., coma or severely demented)’ 
or ‘unknown’, if the staff did not feel confident in assigning a POS score (0 – 4). 
POS scores of the latest assessment before death of non-comatose patients, 
distinguishing between non-demented and demented patients, were included in the 
analysis. Comatose patients were excluded from the analysis because this group 
could consist of non-demented and demented patients, but also because it was 
unclear whether the POS scores referred to the comatose status or to the days 
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before the patient had become comatose. Patients with no data regarding the 
stage of cognitive decline and/or state of consciousness were also excluded. 
A mean total POS score was calculated if data on at least six out of a total of ten 
items were valid.  
 
Ethical review 
The Medical Ethics Committee of the VU University Medical Center approved the 
study. Confidentiality of the data was guaranteed by providing only coded 
information to the researchers. Patients or their families were interviewed. Because 
the NH physicians and nurses were simply reporting information collected as part 
of the usual care observations, including those needed to score the POS, informed 
consent was not required by the Medical Ethics Committee of the VU. The patients 
and their families were informed about the study through an information flyer and 
were given the possibility to refuse the transfer of data.  
 
Results 
 
In the inclusion period, we received a questionnaire at death from 471 included 
patients. In the same period, an additional deceased 272 patients were found to 
have been incorrectly not included in the study. The main reasons for non-
inclusion, as reported in a short non-inclusion questionnaire completed by the NH 
physicians, were in order of frequency: pressure of work, organisational reasons 
(e.g., should have been included during the weekend), forgotten (to be included), 
family had objections for inclusion in our study, and other reasons.(28) From 448 
patients a complete set of data (questionnaire on inclusion, the weekly 
questionnaire and the questionnaire at the time of death) was available for 
analysis. 
 
Table 1   Demographic and clinical characteristics of patients on inclusion (n=448)  
 
Demographic characteristics n % 
Age on inclusion (in years)   
 ≤ 60 4 0.9 
 61 – 69 26 5.8 
 69 - 80 98 21.9 
 80 - 90 227 50.7 
 90 - 100 88 19.6 
 100 > 5 1.1 
 Mean age (min-max; SDa) 83.7 (45 – 100; 8.0) 
Gender    
 Male  133 29.7 
 Female 315 70.3 
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continue Tabel 1  
Marital status    
 Never married 38 8.6 
 Married 124 27.9 
 Widowed 268 60.4 
 Divorced 14 3.2 
Actual living status before admittance to nursing home   
 Single 304 68.2 
 Together, with partner 142 31.8 
Number of children    
 Children 346 80.5 
 No children 84 19.5 
Clinical characteristics   
Number of days from inclusion until death    
 Median (min–max) 3.0 (0 - 62) 
 Comatose 89 20.5 
Stage of dementia (Global Deterioration Scaleb)    
 Stage 1 No cognitive decline 146 34.1 
 Stage 2 – 4 Very mild to moderate cognitive decline 23 5.4 
 Stage 5 Moderately severe cognitive decline 29 6.8 
 Stage 6 Severe cognitive decline 119 27.8 
 Stage 7 Very severe cognitive decline 111 25.9 
Underlying diseases on inclusion  (CvZ-V codesc) n % 
 Mental and behavioral disorders 137 30.6 
 Diseases of the circulatory system 92 20.5 
 Diseases of the respiratory system 33 7.4 
 General disorders 34 7.6 
 Diseases of the digestive system 27 6.0 
 Diseases of the nervous system 19 4.2 
 Diseases of the genitourinary system 17 3.8 
 Endocrine, nutritional and metabolic diseases 12 2.7 
 Breast and female genital organs disorders 8 1.8 
 Remaining systems 17 3.7 
 Missing 52 11.6 
 Malignant neoplasms within underlying diseases 47 10.2 
a SD = standard deviation 
b The Global Deterioration Scale (GDS) was used to determine the stage of dementia (Reisberg et al. 
1982: translation: Verhey F 1986) 
c Classificatie van Ziekten voor de Verpleeghuisgeneeskunde [Classification Codes of Diseases for 
Nursing Home Medicine] 
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The average age on inclusion was 83.7 years, ranging from 45 to 100 years  
(Table 1). Over two thirds (70.3%) of the decedents were female. Many patients 
were widowed (60.4%) or single (68.2%) before admittance to the NH. The 
majority, 80.5%, had children. The median time from inclusion until death was three 
days. Seven days after inclusion, 83.7% of the patients had died, increasing to 
93.5% after fourteen days (data not shown). Most patients (60.5%) had dementia 
(stage 5-7). The main underlying diseases on inclusion were mental and behavioral 
disorders (30.6%) and diseases of the circulatory system (20.5%). A malignant 
neoplasm was known to be an underlying disease in only 10.2% of the study 
population. 
 
The assessment of the POS varied considerably per POS-item from 29.4% to 
92.0% of patients (Table 2). Patients were rated least in the items patient anxiety 
(Q3), support (Q6), life worthwhile (Q7), self-worth (Q8) and personal affairs (Q10). 
Non-scores were more frequently ‘not applicable’ than ‘unknown’, except for family 
anxiety (Q4), self-worth (Q8) and personal affairs, which were more frequently 
‘unknown’. The number of missing for POS assessment was very low in all ten 
items, the highest of which was 2.2%.  
The assessed POS items of non-demented patients ranged from 45.5% to 96.2% 
and from 18.3% to 89.2% in patients with dementia. In addition, in patients with 
dementia the items were more frequently rated as ‘not applicable’. For all ten POS 
items non-demented patients had higher percentages of assessment. The 
assessment of POS items patient anxiety (Q3), support (Q6), life worthwhile (Q7) 
and self-worth (Q8) was for patients with dementia 50% lower than for non-
demented patients.  
Within the group of patients with dementia (stage 5, 6 and 7 of the Global 
Deterioration Scale) non-scores were, in order of sequence of the stage of 
dementia, for seven out of ten items highest in patients with stage 7 dementia. In 
patients with stage 5 dementia, the nurses were less knowledgeable about whether 
the patient’s illness-related personal affairs (Q10) had been adequately addressed, 
compared to patients with stage 6 or 7 dementia. However, in patients with stage 6 
dementia, compared to patients with stage 5 or 7 dementia, non-scores were 
higher for family anxiety (Q4) and the given information (Q5) (data not shown). 
 
Very little difference was found between the mean POS scores of non-demented 
and demented patients (Table 3). In only one of the ten items was there a 
statistically significant difference between these groups: patients with dementia 
scored half a point less favourable on ‘support’ (P=0.030). For ‘life worthwhile’ half 
a point higher (less favourable) for patients with dementia, but this difference was 
not statistically significant (P=0.069). 
Mean scores for non-demented and demented patients, equal to 2.0 and more 
favourable, were found for pain (Q1), other symptoms (Q2), patient anxiety (Q3), 
information Q5), support (Q6), wasted time (Q9) and personal affairs (Q10). 
Unfavourable mean scores were found for non-demented and demented patients 
for family anxiety (Q4), life worthwhile (Q7) and self-worth (Q8).  
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Nurses rarely described problems of patients in the free text area. They reported 
most frequently ‘medical problems’ (without specification), followed by pain, 
problems with the intake of fluid and nutrition and shortness of breath. 
The mean total POS score for non-demented patients was 1.53 (SD 0.57) and for 
patients with dementia it was 1.48 (SD 0.57) (P=0.575). When analysed for 
patients with dementia separately, i.e., stage 5, 6 and 7 of the Global Deterioration 
Scale, the mean total scores were 1.74 (SD 0.50), 1.43 (SD 0.52), 1.44 (SD 0.69), 
respectively (data not shown). 
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Table 3   Mean Palliative care Outcome scoresa for non-demented and demented 
patients20 (n=328) 
 
 Mean (SDb) 
Non-dementedd 
Mean (SDb) 
Dementede  
(n=range 35–173) 
P-valuec 
Over the past 3 days:    
Q1 Has the patient been affected by 
pain?  
(Item1: pain) 
1.8 (1.3) 1.9 (1.2) .565 
Q2 Have other symptoms e.g. nausea, 
coughing or constipation seemed to be 
affecting how well they feel? 
(Item2: other symptoms) 
1.6 (1.3) 1.4 (1.2) .221 
Q3 Have they been feeling anxious or 
worried about their illness or treatment? 
(Item3: patient anxiety) 
2.0 (1.3) 1.6 (1.4) .113 
Q4 Have any of their family or friends 
been anxious or worried about the 
patient? 
(Item4: family anxiety) 
2.9 (1.2) 2.9 (1.2) .431 
Q5 How much information has been 
given to the patient and their family or 
friends? 
(Item5: information) 
0.1 (0.3) 0.2 (0.6) .670 
Q6 Has the patient been able to share 
how they are feeling with their family or 
friends? 
(Item6: support) 
1.5 (1.5) 2.0 (1.5) .030 
Q7 Do you think they have felt life was 
worth living? 
(Item7: life worthwhile) 
2.3 (1.6) 2.8 (1.6) .069 
Q8 Do you think they have felt good 
about themselves? 
(Item8: self worth) 
2.7 (1.4) 2.9 (1.4) .523 
Q9 How much time do you feel has 
been wasted on appointments relating 
to the healthcare of this patient, e.g. 
waiting around for transport or repeating 
tests? 
(Item9: wasted time) 
0.3 (0.9) 0.3 (0.8) .822 
Q10 Have any practical matters 
resulting from their illness, either 
financial or personal, been addressed? 
(Item10: personal affairs) 
0.4 (0.9) 0.2 (0.7) .195 
79
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a Question 1–8: range 0 (no problems) to 4 (overwhelming problems). Question 9 and 10: scores 0,  
2 or 4, with higher scores indicating more practical problems 
b Standard deviation 
c By Mann-Whitney test 
d Stage 0–4 of the Global Deterioration Scale (GDS) 
e Stage 5–7 of the Global Deterioration Scale (GDS) 
 
Table 4  Palliative care Outcome Scale: mean total scores according to 
sociodemographic characteristics for non-demented and demented patients  
(n=266)20 
 
 Meana  
Non-dementedc 
(n=115) 
Meana  
Dementedd 
(n=99) 
P-valueb 
Age (years)    
 < 80 1.6  1.4  .128 
 > 80 1.5 1.5  .474 
Gender    
 Male 1.6 1.6 .969 
 Female 1.5 1.4 .775 
Marital status    
 Married 1.6 1.7 .717 
 Not married 1.5 1.4 .631 
Actual living status before admittance to nursing 
home  
   
 Together, with partner 1.7 1.7 .921 
 Single 1.5 1.4 .678 
Number of children    
 Children 1.5 1.5 .566 
 No children 1.5 1.7 .405 
a Question 1–8: range 0 (no problems) to 4 (overwhelming problems). Question 9 and 10: scores 0,  
2 or 4, with higher scores indicating more practical problems 
b By Mann-Whitney test 
c Stage 0 – 4 of the Global Deterioration Scale (GDS) 
d Stage 5 – 7 of the Global Deterioration Scale (GDS) 
 
No significant difference in sociodemographic characteristics was found between 
non-demented and demented patients (Table 4). In both groups all mean total 
scores were favourable, and below 2.0. The mean total scores for 
sociodemographic characteristics in non-demented patients varied only from 15  
to 17, and in demented patients from 14 to 17.  
0
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Discussion 
 
This is the first study that describes the provided palliative care in the last days of 
the life of nursing home (NH) residents, who were mainly non-cancer patients. The 
Palliative care Outcome Scale (POS) was used to assess the key domains in the 
provision of palliative care.(20) Furthermore, the usefulness of the POS was 
evaluated in a NH population including patients with dementia. For this specific 
study population, two extra options were added to the POS items, i.e., ‘not 
applicable’ and ‘unknown’. These ‘non-scores’ were often found in the POS-items 
patient anxiety, support, life worthwhile and self-worth, but it was also frequently 
unknown whether the patient’s illness-related personal affairs had been addressed.  
The assessment of the POS for demented patients was lower than that for non-
demented patients, especially for items as patient anxiety, support, life worthwhile 
and self-worth. The POS was originally developed to assess patients in the stages 
of advanced cancer. In spite of the opportunity to rate an item with two extra 
options (non-scores), the results of this study show that the POS can also be used 
to assess at least a considerable subgroup of demented patients. Further research 
is needed to determine to what stages of dementia can be assessed with the POS. 
The present data suggest that stage 7 of the Global Deterioration Scale (GDS) is 
questionable. For seven out of the ten POS items non-scores were higher for  
stage 7 dementia than for stages 5 and 6. 
 
Specific mean POS scores were favourable for both non-demented and demented 
patients. 
Pain (Q1) and other symptoms (Q2) seemed to be under control, the given 
information was sufficient (Q5), little time was wasted on health care (Q9) and 
personal affairs (Q10) were adequately addressed. Differences in mean POS 
scores between the two groups were small and most of the differences were 
observed in the items subjective aspects support, life worthwhile and self-worth. 
Regarding these items the nurses on average more often assigned a negative 
score to demented patients than to non-demented patients. An important 
statistically significant difference concerned the POS-item support (Q6): demented 
patients were less able to share their feelings with family and friends. This can be 
expected because of the inability of demented patients to communicate their needs 
and level of distress verbally. Volicer et al. remarked that evaluation of the care that 
is provided for cognitively impaired patients relies on non-verbal 
communication.(29) Equally unfavourable POS scores for both groups were found 
for family anxiety (Q4). When the mean total POS score was analysed according to 
sociodemographic characteristics for non-demented and demented patients, no 
significant differences were found between these two groups.  
This study has some limitations. The main limitation was that the study relied on 
the reports of proxies, namely care-givers. These proxies may have under-reported 
or over-reported the patient’s symptoms and preferences for palliative care and 
knowledge of the patient’s experiences relies on the reports made by these care-
givers. Several studies have evaluated the use of proxy reports on the quality of 
life, respectively the quality of care, in elderly patients with and without 
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dementia.(30-34) In general, these studies focusing on the reliability of proxy 
ratings show different outcomes. Assessments made by significant others and 
health care providers are reasonably accurate and nurses may be the most 
suitable source of proxy information. Fairly good agreements between patient and 
proxy are reported with regard to physical functioning and cognitive status, but 
agreement is poorest for subjective aspects of the patient’s experience, such as 
pain, anxiety and depression. In patients with dementia, agreement decreased with 
increasing severity of the dementia and therefore proxy assessments should be 
interpreted with caution.(32) However, the strengths of this study are its large-scale 
design and its prospective character, which both enhance the validity and reliability 
of the findings. 
The results of this study indicate that fairly good palliative care is provided in the 
last days of life of patients in Dutch NHs, irrespective of their cognitive status and 
other characteristics, such as gender and age. Symptom control, a key point of 
attention in palliative care, seemed to receive sufficient attention. This appears to 
contradict with the results from other studies concluding that nursing home 
residents do not receive optimal palliative care.(16) We acknowledge that there is a 
possibility that in our study staff may have over estimated the outcome of the care 
they provided and that older people tend to underreport their symptoms.(4)  
Whereas the physical aspects (pain and other symptoms) of palliative care were 
adequately addressed, most shortcomings occurred in the more subjective, less 
observable psychosocial (patient anxiety) and spiritual domains (support, life 
worthwhile and self-worth). Especially in the spiritual domain, there is known to be 
an unmet need among patients during the dying process. The low score on ‘life 
worthwhile’ can be expected. The view is probably subjective of a carer’s view of 
the deterioration of the patient and not necessarily the view of the patient. 
Reynolds et al. found in their study that 30% of dying NH residents needed more 
care for their emotional and spiritual needs.(17) 
 
This study underscores again the fact that greater attention must be paid to 
psychosocial and spiritual aspects in the dying process of NH patients. Policy- and 
decision-makers should pay more attention to these psychosocial and spiritual 
aspects of palliative care. In order to develop high-quality care towards the end of 
life, psychosocial and spiritual care should be more integrated in the continuing 
professional education of health professionals working with the dying patient. 
2
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Abstract  
 
Objectives 
The aim of this study was to identify the direct causes of death and to evaluate the 
presence of burdensome symptoms in the last two days of life of terminally ill 
nursing home (NH) patients.  
 
Methods 
Prospective study of patients with a maximum life-expectancy of six weeks in 16 
nursing homes representative for the Netherlands (n=463). Symptoms were 
measured after death in conscious patients with the Edmonton Symptom 
Assessment Scale (ESAS) and the Resident Assessment Instrument Minimum 
Data-Set Palliative Care (RAI MDS-PC draft 1.8). Direct causes of death were 
assessed in all patients. 
 
Results 
Most patients died from pneumonia, renal failure or dehydration. Loss of 
consciousness was common. The prevalence of burdensome symptom(s) at 48 
and 24 hours before death was 51.3 and 28.4% respectively.  
 
Conclusion 
In practice, it appears that, for many patients, the last days of life are spent 
unconscious or conscious with one or more burdensome symptom(s), which 
suggests the potential for improvement of symptom management. 
88
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Introduction 
 
The last days of life have been the subject of many studies, almost all concerning 
patients with cancer.(1;2) However, the majority of elderly people do not die from 
cancer, but from 'old age' and/or complications in the end-stage of chronic disease. 
Dementia, cardiac disease and respiratory disease, in particular, are frequent 
causes of death,(3) but the nature and burden of symptoms associated with the 
terminal phase of these diseases is still unclear.(4) Many non-cancer patients are 
cared for in long-term care facilities, such as nursing homes (NHs), but the 
available data suggest that the pattern of their symptoms in the terminal phase 
differs from that of cancer patients. In the last 48 hours of life of NH patients, pain 
and respiratory symptoms have been found to be the most prevalent symptoms, 
but the pattern of symptoms may be determined by the underlying disease.(5) For 
example, in demented patients, pneumonia, cachexia and dehydration are often 
the direct cause of death.(6-8) Unconsciousness may be the result of metabolic 
and physiological disturbances, directly or indirectly related to the underlying 
disease, or the intended or unintended result of medication.(9) Remarkably, there 
is very little literature on the prevalence of loss of consciousness in the terminal 
phase. 
 
The objective of this paper was to identify the direct causes of death and to 
evaluate the presence of burdensome symptoms in the last two days of life of 
terminally ill NH patients. Symptom management as such was not the scope of this 
paper. However, knowledge of the symptoms associated with the terminal phase in 
NH patients may help to improve the quality of dying.(10;11) In addition, attention 
was paid to the state of consciousness.   
 
Methods 
 
Setting and design 
A prospective, observational study was conducted from November 2001 to March 
2003. In 2000, there were 334 nursing homes (NHs) in the Netherlands, with a total 
of 58 778 beds.(12) Three types of NHs exist: physically ill, psychogeriatric 
patients, and combined types with separate wards for each category. The vast 
majority (96%) of psychogeriatric patients suffer from dementia, and will stay in an 
NH until they die.(13) All patients benefit from the different NH functions, mainly 
rehabilitation and long-term care (admitted to the NH permanently,[14]). The staff 
includes specially trained NH physicians (in general one full-time physician per 100 
patients), who provide medical care and are employed by the NH.(15) 
 
The NHs in the present study were purposefully sampled to be representative of all 
NHs in the Netherlands. First, the proportion of the three types of NHs was 
calculated: nine combined NHs, three for physically ill patients, and three for 
psychogeriatric patients. Second, the mean number of beds for physically ill and 
psychogeriatric patients per NH was calculated, and the NHs were arranged in 
order of this calculated mean. Finally, the nearest NHs above and below the mean 
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were invited to participate in the study. In order to obtain the participation of nine 
combined NHs, three NHs for physically ill and three NHs for psychogeriatric 
patients, the following numbers of NHs had to be approached: 30 combined NHs, 
eight for physically ill patients and seven for psychogeriatric patients.  
During the course of the data collection, due to organizational and capacity 
problems, one NH for physically ill patients stopped collecting the data. For the 
remaining time of the data collection, another NH from the same stratum replaced 
this NH. Hence, the total number of participating NHs was 16. In this study, the 
average number of NH beds was 103 for physically ill patients, 156 for 
psychogeriatric patients and 157 for combined care. The beginning and end dates 
of the data collection varied per NH, with an average inclusion period of 0.9 years 
and 2430 bed years.  
 
Selection of patients 
This study was introduced during instruction sessions in each NH by the first two 
authors (HB, MEO), written instructions were also provided. The NH physicians 
were asked to include all consecutive patients who met the following criteria:  
(1) Maximum life-expectancy of six weeks, according to the NH physician’s own 
clinical assessment; (2) Admitted for long-term care (admitted to the NH 
permanently[14]), or (3) Previously admitted for rehabilitation but, transferred to 
long-term care during their stay (ie, it became obvious that the patient would not 
leave the NH). Patients who died suddenly and unexpectedly (ie, with no clear 
terminal palliative phase) were not included. 
Admittance to a NH for terminal care is handled differently in different countries. In 
the Netherlands, the limit is set at three months, due to reimbursement by health 
care insurance companies. In the pilot study, the NH physicians considered that a 
weekly follow-up registration of three months with a maximum follow-up of six 
months, was not feasible. After the pilot study, based on a maximum life-
expectancy of six weeks, the participating (experienced) NH physicians agreed that 
this criterion was the longest possible period over which any meaningful prediction 
could be made.  
 
Measurements 
The occurrence and date of death was registered by the NH physician for all long-
term care patients, including patients who had not been included in the study, for 
whom a shorter questionnaire was completed. In this short questionnaire, we 
checked the reason for non-inclusion: (1) sudden and unexpected death; (2) 
should have been included earlier; (3) other, namely. The patients included under  
(2) were ‘missed’ patients of whom the NH physician was asked in a separate 
question why these patients were not included earlier. The main direct cause of 
death was assessed with a question analogous to the cause-of-death question on 
Dutch death certificates.(16) When a patient was included, the NH physician 
completed a questionnaire on the basic demographics and clinical characteristics 
of the patient. The stage of dementia was assessed according to the validated 
Global Deterioration Scale (GDS).(17) This instrument identifies three major clinical 
phases: forgetfulness, confusion, and a late dementia phase. These phases are 
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further sub-divided into seven clinically identifiable stages, ranging from stage 1 (no 
cognitive decline) to stage 7 (very severe cognitive decline). Stage 5 represents the 
phase of early dementia, and patients in this stage can no longer survive without 
some assistance. Written information about the characteristics of these seven 
stages was provided to the NH physician for adequate assessment. 
The validated Classification of Diseases for Nursing Home Medicine (CvZ-V),(18) 
was used to classify the main underlying cause of the terminal status on inclusion 
and the main direct cause of death. The CvZ-V is a Dutch standard, based on the 
International Classification of Diseases, tenth edition (ICD-10).(19) However, unlike 
the ICD-10, the CvZ-V contains a general section with codes for diseases, 
disorders, and problems that supersede one particular organ system, as this 
situation is common in NH patients.  
After the death of each patient, the NH physician assessed retrospectively, over 
two time-periods (48-24 and 24-0 hours before death), a number of physical and 
psychosocial symptoms according to the Edmonton Symptom Assessment Scale 
(ESAS) and the observational Resident Assessment Instrument Minimum Data-Set 
Palliative Care (RAI MDS-PC draft 1.8). This instrument has recently been 
developed for inclusion in the RAI instruments.(20) Draft 1.8 was prior to the final 
validation of this instrument, but changes were negligible. Before every 
assessment, the NH physicians could indicate in the questionnaire whether or not a 
patient was conscious. RAI MDS-PC items were assessed in conscious as well as 
unconscious patients, but ESAS items were only assessed in conscious patients.  
The validated ESAS consists of nine 100 mm visual analogue scales (VASs), 
which include pain, activity, nausea, depression, anxiety, drowsiness, appetite, 
well-being and shortness of breath. Scores can range from 0-100 (higher scores 
reflect greater symptom severity).(21) A symptom was considered to be 
burdensome at a cut-off point of 60 or more on this scale. 
 
There are 19 physical symptoms/conditions listed in the RAI MDS-PC. From these, 
15 were selected because the other four symptoms corresponded with the ESAS 
(shortness of breath at rest, shortness of breath with exertion, impaired endurance 
and loss of appetite). Four symptoms were added (death rattle, fatigue, confusion 
and pressure ulcer), and these were assessed in a similar manner as the RAI 
MDS-PC items. To prevent bias in the scoring of variables by the NH physician, the 
extra response category ‘unknown/not assessed’ was added to all ESAS and RAI 
MDS PC items.  
NH physicians and family members rated the quality of death on a VAS, ranging 
from 0 (no gentle death) to 100 (gentle death). After death of their loved one, family 
members received a questionnaire (sent by mail or handed over during an 
aftercare conversation with the NH physician) about the quality of care, in which 
they could among others assess the quality of death. 
 
Statistical analysis 
All analyses were performed in SPSS for Windows version 11.0, and descriptive 
statistics were used to characterize the patients. As most symptom data were 
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missing for the unconscious patients, the analyses were limited on symptom 
development in patients who were conscious at  both time points, 48-24  
and 24-0 hours before death (n=253).  
The outcome variables of the ESAS items and the VAS concerning the quality of 
death were screened for normality. Standard transformations were made, if 
necessary. Two selection criteria were applied for the symptoms in both 
instruments. First, a selection of symptoms was made, which were considered to 
be burdensome in the last 48 hours of life: six out of nine items of the ESAS - pain, 
nausea, depression, anxiety, well-being and shortness of breath; and the RAI 
MDS-PC item - difficulty coughing, constipation, diarrhea, dry mouth, 
nausea/vomiting, end-stage restlessness, offensive odor to patient/family, pruritus, 
urinary retention and fatigue.  
Second, ESAS items were considered to be burdensome at a cut-off point of 60 or 
more on the VAS, range 0-100 (eg, 0 = no pain; 100 = extreme pain). This 
dichotomization is an analytical classification, in order to provide data on 
frequencies on burdensome symptoms, since higher scores reflect greater 
symptom severity. Differences between VAS scores were determined with paired-
samples t-test or Wilcoxon signed ranks test, if necessary. RAI MDS-PC response 
categories (0=not present; 1=present, not distressed; 2=present, distressed) were 
dichotomized: 0 and 1 were combined to category 1, and 2 was category 2. Since 
the patient was distressed by the symptoms in the latter category, they were 
considered burdensome. Differences between dichotomized items were tested with 
the McNemar test for two related samples.  
 
Ethical review 
The Medical Ethics Committee of the VU University Medical Center approved the 
study. Confidentiality of the data was guaranteed by providing only coded 
information to the researchers. Neither the patients nor members of their family 
were interviewed. Because the NH physicians were simply reporting information 
that was collected as part of their usual care observations, informed consent was 
not required. As required by Dutch law, the patients and their families were 
informed about the study through an information flyer, and were given the option to 
refuse the transfer of data. 
 
Results 
 
A total of 463 patients were included. Patients who died suddenly (n=263), who 
recovered unexpectedly (n=57) and those who survived the maximum follow-up 
period of 12 weeks (n=1) were excluded from the study. Representative sampling 
in this study was checked against two parameters: the distribution of physically ill 
and psychogeriatric patients and sex. No significant differences were found 
between the national NH population and the study population for either 
parameter.(22) An additional 272 patients were found to have been incorrectly not 
included in the study and were considered as ‘missed’ patients. The main reasons 
for non-inclusion, given in the shorter questionnaire in order of sequence by the NH 
physicians, were pressure of work, organizational reasons (eg, should have been 
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included during the weekend), forgotten (to be included), other reasons, family had 
objections to inclusion in our study.(22) 
 
Table 1 presents the demographic and clinical characteristics of the patients on 
inclusion. The average age on inclusion was 83.4 years, with a range from 45 to 
100 years and over two thirds (70.8%) of the patients were female. Most of the 
patients were single (67.6%) on admittance to the NH. On inclusion, 34.4% had no 
cognitive decline (normal clinical appearance), 13.3% had very mild (phase of 
forgetfulness) to moderately severe (phase of early dementia) cognitive decline, 
26.5% had severe cognitive decline (middle phase of dementia) and 25.8% had 
very severe cognitive decline (late dementia). The main underlying causes of 
terminal status on inclusion were mental and behavioural disorders (30.5%) and 
diseases of the circulatory system (20.1%). Malignant neoplasms (11.1%) occurred 
most frequently in the digestive system (3.1%), breast and female genital organs 
(2.1%), or were coded as general disorders (1.9%). The median time from inclusion 
until death was three days, but with a wide range (0-62). Of the 463 patients, after 
one week (0-8 days) 384 (82.9%) had died and 79 were alive. After two weeks  
(8-15 days), 35 patients were alive, and after three weeks (15-22 days), 20 patients 
were alive.  
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Table 1   Demographic and clinical characteristics of patients on inclusion (N=463) 
 
 
Demographic characteristics n % 
Age on inclusion (years)   
 Mean age (min-max; SD) 83.4 (45-100; 8.2) 
Gender    
 Male  136 29.2 
 Female 330 70.8 
Actual living status before admittance to nursing home    
 Single 311 67.6 
 Together, with partner 149 32.4 
Clinical characteristics   
No. of days from inclusion until death    
 Median (min–max) 3.0 (0-62) 
Stage of dementia (Global Deterioration Scale)    
 Stage 1 No cognitive decline (normal clinically 
 appearance) 
152 34.4 
 Stage 2 Very mild cognitive decline (phase of 
 forgetfulness) 
4 0.9 
 Stage 3 Mild cognitive decline (earliest clear-cut 
 clinically deficits) 
9 2.0 
 Stage 4 Moderate cognitive decline (clear-cut deficit 
 is apparent) 
12 2.7 
 Stage 5 Moderately severe cognitive decline (phase 
 of early dementia) 
34 7.7 
 Stage 6 Severe cognitive decline (middle phase of 
 dementia) 
117 26.5 
 Stage 7 Very severe cognitive decline (late dementia) 114 25.8 
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continue  Table 1  
 
 
Table 2   Main direct causes of death in NH patients (n=463) 
 
Diseasea n % 
Pneumonia 79 17 
Renal failure 60 13 
Disorders of electrolyte and fluid balance, not classified 
elsewhere (= dehydration) 
60 13 
Cachexia 53 11 
Heart failure  37 8 
Septicaemia 17 4 
Stroke, not specified as haemorrhage  
or infarctions 
17 4 
Unspecified dementia  17 4 
Other and unspecified cerebrovasculair diseases 11 2 
Other  107 23 
Missing  5 1 
a Only data on diseases 2% above the diseases in the total study population are presented 
 
Main underlying cause of terminal status on inclusion (with separate statement of 
malignant neoplasms, including secondary malignant neoplasm) 
 Mental and behavioural disorders 141 30.5 
  - Malignant neoplasms 0 0.0 
 Diseases of the circulatory system 93 20.1 
  - Malignant neoplasms 0 0.0 
 Diseases of the respiratory system 36 7.8 
  - Malignant neoplasms 6 1.3 
 General disorders 34 7.3 
  - Malignant neoplasms 9 1.9 
 Diseases of the digestive system 27 5.8 
  - Malignant neoplasms 15 3.1 
 Diseases of the nervous system 19 4.1 
  - Malignant neoplasms 2 0.4 
 Diseases of the genitourinary system 19 4.1 
  - Malignant neoplasms 2 0.4 
 Endocrine, nutritional and metabolic diseases 14 3.0 
  - Malignant neoplasms 0 0.0 
 Breast and female genital organs 10 2.1 
  - Malignant neoplasms 10 2.1 
 Other systems  18 4.0 
  - Malignant neoplasms 9 1.1 
 Missing 52 11.2 
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Table 2 shows the main direct causes of death in these NH patients, as reported 
by the NH physician. The most prevalent causes of death were pneumonia (17%), 
renal failure (13%), disorders of electrolyte and fluid balance, not classified 
elsewhere (= dehydration) (13%), cachexia (11%) and heart failure (8%). The 
remaining diseases accounted for < 4%.  
 
 
Figure 1   Prevalence of unconsciousness and burdensome symptoms (n=463) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1 shows the prevalence of unconsciousness and one or more burdensome 
symptom(s) in patients in the last two days of their life. Some 12% of patients, 
assessed with ‘no burden’ 48-24 hours before death (23%), developed 
burdensome symptoms 24 hours before death (data not shown). 
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Table 3   Median severities and frequenciesa of symptoms as assessed with the 
Edmonton Symptom Assessment Scale (ESAS)b in the last two days of the life of 
consciousc patients (N=253)  
 
 48-24 hours before 
death 
24-0 hours before  
death 
 
 
Symptoms 
median 
score 
% (> 60 
on VAS)  
 median 
score 
% (> 60 
on VAS) 
  
P-value 
Pain  20.0 30  12.0 22  0.000 
Decreased activity 90.0 86  95.0 91  0.000 
Nausea 5.0 17  4.0 17 ** 0.001 
Depression 10.0 30 ***  5.0 33 ***  0.000 
Anxiety 13.0 25  10.0 21  0.000 
Increased drowsiness  77.0 69  90.0 82  0.000 
Poor appetite 95.0 92  97.0 93 ** 0.000 
Well being 67.5  66 ***  52.0 61 **** 0.003 
Shortness of breath 10.0 21  10.0 23  0.131 
a  Frequencies of symptoms on the Visual Analogue Scale (VAS) at a cut-off point of 60> = burdensome 
b  Range 0 mm (lowest degree of symptoms) – 100 mm (highest degree of symptoms) for all symptoms 
ESAS items were only assessed in conscious patients  
c Conscious 48-24 and 24-0 hours before death  
** Missing data 10-20% 
*** Missing data 20-30% 
**** Missing data 30-34% 
 
Table 3 shows the assessment of ESAS items for patients who were conscious 48-
24 hours before death, as well as 24-0 hours before death. The median VAS 
scores for pain, nausea, depression, anxiety and shortness of breath were low 
(favorable), but the score for the frequency of one or more burdensome 
symptom(s) (> 60) at both points in time remained at 17-33%, eg, pain 30→22%, 
depression 30→33%, shortness of breath 21→23%. The median score of 
decreased activity, increased drowsiness and poor appetite worsened towards 
death. Out of nine ESAS symptoms, eight showed a statistically significant 
difference across the last two days; median score of five symptoms (pain, nausea, 
depression, anxiety and well-being) were decreasing and three (decreased activity, 
increased drowsiness, poor appetite) were increasing. Shortness of breath 
remained the same.  
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Table 4   Prevalence (%) of dichotomized symptoms of the Resident Assessment 
Instrument Minimum Data-Set Palliative Care (RAI MDS-PC) in the last two days of 
the life of conscious patientsa (n=253) 
 
 48-24 hours 
before death 
24-0 hours 
before death 
 
 
Symptoms 
Present, 
distressed (%) 
Present, 
distressed (%) 
 
P-value 
Difficulty coughing 14 6 0.000 
Dry mouth 12 6 0.002 
Fever 7c 2c 0.004 
Infections (eg, pneumonia, UTI) 17c 10 0.004 
Fatigueb 28c 17c 0.000 
Pressure ulcerb 14 8 0.001 
a Conscious 48-24 hours as well as 24-0 hours before death 
b Additional symptoms not listed in RAI MDS-PC, but assessed similarly 
c Missing data 11-19% 
 
Table 4 shows the prevalence of dichotomized RAI MDS-PC items (category 2: 
present, distressed). At both points in time, the prevalence of three out of 16 
symptoms remained higher than 10% (end-stage restlessness, infections, fatigue) 
and for five symptoms it was higher than 5% (difficulty coughing, dry mouth, death 
rattle (excessive pulmonary secretions), confusion, pressure ulcer) (data not 
shown). Statistically significant differences between the two time-points were found 
for difficulty coughing (P =0.000), dry mouth (P =0.002), fever (P =0.004), 
infections (P =0.004), fatigue (P =0.000) and pressure ulcer (P =0.001), all of which 
improved. 
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Figure 2 shows the score for the quality of death, assessed by the NH physician 
on a VAS, ranging from 0 (no gentle death) to 100 (gentle death), was over 50 for 
92% (n=427) of the patients. The state of consciousness 24-0 hours before death 
had a slightly significant influence on this assessment (P =0.001), with a score of 
over 50 for 96% of the unconscious patients and 90% of the conscious patients. 
The score for the quality of death by family members was over 50 for 89.5% 
(n=221) of the patients. 
 
 
Figure 2 Quality of death assessed by the Nursing Home Physician of total 
population (N=463) 
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Discussion 
 
Very little research has focused on the experience of dying in nursing homes 
(NHs).(23) To our knowledge, this is the first study of NH patients that explores the 
state of consciousness prior to death and provides insight into the final 48 hours of 
life with regard to the direct causes of death and the physical and psychological 
symptoms that burden these patients. It gives detailed and robust information 
about the final phase of the life of an increasing number of older people with a 
chronic disease. The large-scale study design and the representativeness of the 
NHs enhance the validity and reliability of these findings, except for the 
unconscious patients, for whom too many missings were registered on symptoms. 
 
However, this study has some limitations. Firstly, the use of proxy data may have 
resulted in under- or over-estimation of symptoms, which could have influenced the 
validity of the data. Symptoms were retrospectively assessed by the NH 
physicians. Self rating scores of patients was not possible, since the exact time of 
death is not to foreseen. Therefore, proxy rating was the only feasible approach 
and the ESAS was the best alternative. In general, proxy ratings of symptoms that 
are directly observable (physical health, disability) are more valid than proxy ratings 
of more subjective symptoms, such as pain, anxiety, depression and dyspnea.(24-
28) In this study, ESAS items have been assessed, which were considered to be 
potentially burdensome in the last 48 hours of life: pain, nausea, depression, 
anxiety, well-being and shortness of breath. Nekolaichuk et al., reported in their 
study on comparison of patient and proxy symptom assessment with the ESAS, 
that proxy assessments of symptom intensity, particularly by physicians, were 
generally lower than patient assessments.(29) This indicates an underestimation of 
symptom intensity in this study. However, the ESAS is an instrument for patient 
and proxy assessment.(30) Our analyses were not focused on the value of the 
symptom itself, but on changes within symptoms. Scoring has been consistent and, 
therefore, allows interpretation. Second, the inclusion of patients could also have 
been subjected to selection bias. However, no significant differences were found 
between included and non-included patients with regard to gender and type of 
ward. Third, the retrospective approach to assess symptoms. Because the NH 
physicians were instructed to fill in the questionnaire soon after death, recall bias 
has possibly been limited. Finally, there was missing information about a large 
number of terminally ill patients. These patients should have been included. 
Although we did not find substantial differences between the study sample and the 
omitted group in demographic variables (age, sex, and ward), we cannot, in case 
physicians selectively missed patients, exclude a possible bias on the outcome 
variables of this study.(22) 
 
In this study population, mental and behavioural disorders (mainly dementia) and 
diseases of the circulatory system dominated as the main underlying cause of 
terminal status on inclusion. This also reflected a non-cancer population, since the 
prevalence of malignant neoplasms in all disease systems remained <11%. The 
most prevalent main and direct causes of death, as assessed by the NH physician, 
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were pneumonia, renal failure, disorders of electrolyte and fluid balance, not 
classified elsewhere (= dehydration) or cachexia. With regard to pneumonia and 
dehydration, the results of the present study are in line with those reported by 
Hanson et al., who found that NH deaths are preceded by a slow trajectory 
punctuated by acute and reversible illnesses, such as pneumonia, sepsis, or 
dehydration.(31) 
 
A quarter (25%) of the patients were unconscious 48-24 hours before death, and 
this percentage increased to 44% 24-0 hours before death. Dutch policy gives 
provision in curative and supportive care for all terminally ill patients according to 
the course of their illness. Nevertheless, two days before their death, 51% of all 
conscious patients suffered from at least one burdensome symptom. This 
decreased to 28% towards death. A minority of patients (12%) developed 
burdensome symptoms 24 hours before their death, whereas they had none 
previously.  
These findings are supportive evidence for the concern of the World Health 
Organization that older, terminally ill patients have many unmet needs, and suffer 
unnecessarily.(32) However, depending on the symptom, there are substantial 
differences in the prevalence of burdensome symptoms. In this study, pain seemed 
to improve in the last 48 hours before death (median 100 point VAS score on 
severity from 20.0 to 12.0), but still 22% were suffering burdensome pain in the last 
day before death. The median severity score for nausea, depression and anxiety 
was quite low (favourable). Well-being increased, but the severity of decreased 
activity, drowsiness, and poor appetite worsened towards death.  
Of all the symptoms in palliative medicine, those concerning respiration are 
considered to be the most excruciating and most difficult to treat.(33) In this study, 
around 20% suffered from shortness of breath in the last 48 hours. In general, the 
number of patients with burdensome symptom(s) stayed roughly the same towards 
death, but there was a significant decrease in difficulty coughing, dry mouth, fever, 
infections, fatigue and pressure ulcer. Despite the high prevalence of fatigue, little 
is known about its pathogenesis, and consequently treatment may be less 
successful than treatment for other symptoms at the end of life.(34) 
 
In 72% of NH patients studied, the last two days of life were accompanied by either 
unconsciousness or burdensome symptoms. Despite the fact that these symptoms 
are sometimes difficult to treat, the quality of dying for the majority of NH patients 
was considered good by the NH physicians and family members.  
In practice, it appears that for many patients the last days of life are spent 
unconscious or conscious with one or more burdensome symptom(s), which 
suggests potential for improvement of symptom management. 
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Abstract 
 
Background 
Medical end-of-life decisions with a certain or possible life shortening effect (ELDs), 
namely non-treatment decision (NTD), alleviation of pain and symptoms with 
possible life-shortening effect (APS) and physician assisted death (PAD), have 
been discussed for several years, but little is known about these decisions in 
terminally ill long-term care patients. 
 
Methods 
Prospective cohort study in 16 nursing homes (NHs) representative for the 
Netherlands. All deceased long-term care patients, assessed by a NH physician to 
have a maximum life- expectancy of 6 weeks, were enrolled in the study (n=467). 
 
Results 
ELDs occurred in 70% of all deaths and 79% among patients with diseases of the 
circulatory system. Withholding of treatment occurred in 26%, withdrawing of 
treatment in 13% and alleviation of pain and symptoms in 30%. In conscious and 
non-demented patients, significantly fewer ELDs were performed than in 
unconscious or demented patients. Withholding of treatment occurred most often 
among unconscious patients. In conscious patients, the frequency of withholding 
medical treatment was significantly higher among demented than among non-
demented patients (30% versus 15%). The frequency of alleviation of pain and 
symptoms with possible life-shortening effect did not differ by state of 
consciousness or stage of dementia. In conscious patients, the symptom burden 
had no influence on ELDs. 
 
Conclusion 
In long-term care of the terminally ill patients in Dutch NHs, the incidence of 
medical ELDs is strongly related to consciousness and the patients’ stage of 
dementia. In incompetent patients significantly more ELDs precede death than in 
competent patients.  
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Introduction 
 
The number of people living to an old age in industrialized countries is rapidly 
increasing and the pattern of morbidity and mortality is changing,(1) leading to 
more deaths from chronic disease.(2) Medical practice will therefore be 
increasingly confronted with the process of dying and of care for the dying. In this 
last phase of life, patients, physicians and families will be confronted with different 
options and will have to discuss end-of-life decisions (ELDs) and their potential 
effects on the patients’ survival.  
 
Since end-of-life research in general has focused primarily on people with a 
diagnosis of cancer, several studies have stressed the lack of information about 
end-of-life issues in nursing homes (NHs).(3-5) Because of growing numbers of 
elderly admitted to NHs (6-8) and the need for quality in palliative care, health care 
providers have to become more knowledgeable about the process of death and 
dying in NHs.(4) ELD incidence studies in the general population have been 
conducted in Europe, United States, Australia and New Zealand.(9-12) These 
studies have shown that ELDs are frequent. Withholding or withdrawing of 
potentially life-prolonging treatments (non-treatment decisions), and the alleviation 
of pain and suffering with opiates with possible life-shortening effects (APS), occur 
most often in those of 80 years and older and in NH patients.(13-15) None of these 
studies has focused on terminally ill long-term care patients or on NH patients. 
 
This study describes the frequency of ELDs in terminally ill long-term care patients 
in Dutch NHs and examines whether ELDs are related to the condition of the 
patient (consciousness, stage of dementia, main direct causes of death, 
burdensome symptoms). It focuses on the two main categories of ELDs in NHs: 
withholding or withdrawal of potentially life-prolonging treatments (non-treatment 
decisions); and the alleviation of pain and suffering with opiates in doses with a 
potential possible life-shortening effect (APS).(14;15) Since research which 
specifically compares withholding and withdrawing of treatment is scarce we will 
also focus on the differences between these two ELD categories.(13) 
 
Methods 
 
Setting and design 
A prospective observational study was carried out in 16 Dutch NHs from November 
2001 to March 2003.(3) In 2000, there were 334 NHs in the Netherlands with a 
total of 58,778 beds.(16) Three types of NHs exist: those for physically ill patients, 
those for psychogeriatric patients and combined types with separate wards for 
each category. The vast majority (96%) of psychogeriatric patients suffer from 
dementia, and will stay in a nursing home until they die.(17) All patients benefit 
from the different NH functions, mainly rehabilitation and long-term care. 
Nevertheless, patients admitted for rehabilitation are not included in our study as 
the majority are usually discharged after 4 to 8 weeks. Staff includes specially 
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trained NH physicians (in general one full-time physician per 100 patients), who 
provide medical care and are employed by the NH.(18) 
The NHs in the present study were deliberately chosen to be representative of all 
NHs in the Netherlands. First, the proportion of the three types of NHs was 
calculated: nine combined NHs, three for physically ill patients and three for 
psychogeriatric patients. Secondly, the mean number of beds for physically ill and 
psychogeriatric patients per NH was calculated, and the NHs were arranged in 
order of this. Finally, the nearest NHs above and below the mean were invited to 
participate in the study. During the course of the data collection, one nursing home 
for physically ill patients stopped collecting data for organisational and capacity 
reasons. It was replaced by another from the same stratum for the remaining 
period. The total number of participating homes was 16, with an average of 103  
NH beds for physically ill patients, 156 for psychogeriatric patients and 157 for 
combined care.  
 
Selection of patients 
This study was introduced in each NH by two researchers (HB, MEO). Written and 
verbal instructions were given to the NH physicians in how to fill in the 
questionnaires. They were asked to include on a daily basis all (physically ill and 
psychogeriatric) patients who met the following criteria:  
(1) expected maximum life-expectancy of six weeks, according to the NH 
physicians’ own clinical assessment; (2) admitted for long-term care (admitted to 
the NH permanently) or (3) previously admitted for rehabilitation but transferred to 
long-term care during their stay (i.e. where it becomes obvious that the patient 
would not leave the nursing home).  
Patients who died suddenly and unexpectedly (i.e. with no clear terminal palliative 
phase) were not included. Patients who recovered unexpectedly, or survived the 
maximum follow-up period of 12 weeks, were excluded from the study.  
The maximum life-expectancy of six weeks is based on prior consultation with the 
NH physician who participated in the study. After the pilot study the NH physicians 
considered that a weekly follow-up registration of six weeks with a maximum 
follow-up of 12 weeks was the longest possible period over which any meaningful 
prediction could be made.  
Measurements 
On inclusion, the NH physician completed a questionnaire for each patient 
concerning basic demographics and disease characteristics (e.g. stage of 
dementia/cognitive decline, main underlying cause of terminal status on inclusion).  
The stage of dementia/cognitive decline was assessed by the NH physician 
according to the validated Global Deterioration Scale (GDS).(19) This instrument 
identifies three major clinical phases: forgetfulness, confusion, and a late phase of 
dementia. These phases are further sub-divided into seven clinically identifiable 
stages, ranging from stage 1 (no cognitive decline) to stage 7 (very severe 
cognitive decline). Stage 5 represents the phase of early dementia, and patients in 
this stage can no longer survive without some assistance. Patients with stage  
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1-4 GDS were considered as ‘not demented’ and stage 5-7 GDS as ‘demented’. 
Written information about the characteristics of these 7 stages was provided to the 
NH physician to assist assessment.  
 
The validated Dutch Classification Codes of Diseases for Nursing Home Medicine  
(CvZ-V)(20) was used by the researchers to classify the main underlying diseases 
on inclusion (disease which was the underlying cause of the disorder on which the 
NH physician based the limited life-expectancy). The CvZ-V is a Dutch standard, 
based on the International Classification of Diseases, 10th Edition (ICD-10),(21) 
with codes for the classification of diseases, intercurrent diseases, disorders, 
injuries, other problems, and causes of death in NH patients. However, unlike the 
ICD-10, the CvZ-V contains a ‘General’ section with codes for diseases, disorders 
and problems which involve more than one particular organ system, because this 
situation is common in NH patients. The strength of this instrument is that the 
Classification of Diseases is tailored to the average NH population. 
 
At the time of death, the NH physician completed for all long-term care patients a 
questionnaire on the occurrence of (possible) life-shortening end-of life decisions 
(ELDs), including an estimate of the time by which life was shortened. 
The questions were essentially the same as those used in several other Dutch  
ELD studies(15,22) in which the questionnaire has been validated.(23) For each 
case of death the NH physician answered ‘yes’ or ‘no’ to all the following questions 
(a) Did you withhold (the same questions were posed  for withdrawing) medical 
treatment 
- if yes, did you do this taking into account the possibility or certainty that this would 
hasten the patient’s death? 
- if yes, did you do this with the explicit intention of hastening the patient’s death?  
(b) Did you intensify the alleviation of pain and suffering  
- if yes, did you do this while taking into account the possibility or certainty that this 
would hasten the patient’s death? 
- if yes, did you do this partly with the intention of hastening the patient’s death? 
(c) Was death the result of the administration, supply, or prescription of drugs with 
the explicit intention of hastening the patient’s death? 
When at least one of the questions (a) was answered ‘yes’ the case was classified 
as a non-treatment decision (NTD). When at least one of the questions (b) was 
answered ‘yes’ the case was classified as alleviation of symptoms with possible 
life-shortening effect (APS). When question (c) was answered ‘yes’ the case was 
classified as physician assisted death. In cases where the physician answered 
‘yes’ more than once, the ‘yes’ answer representing the most explicit intention 
regarding the hastening of the patient’s death was considered to be the most 
important, and within each intention category the last ‘yes’ answer was considered 
to be most important.  
Also at the time of death the NH physician reported the main direct cause of death, 
analogous to the cause-of-death question on Dutch death certificates. For coding 
the researchers used the CvZ-V codes.(20)  
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In the same questionnaire after death, the NH physician assessed retrospectively, 
over two time-periods (48-24 hours and 24-0 hours before death), a number of 
physical and psychosocial symptoms according to the Edmonton Symptom 
Assessment Scale (ESAS)(24) and the observational Resident Assessment 
Instrument Minimum Data-Set Palliative Care (RAI MDS-PC draft 1.8).(25) This 
instrument has recently been developed for inclusion in the RAI instruments. Draft 
1.8 was made prior to the final validation of this instrument, but changes were 
negligible. RAI MDS-PC items were assessed in conscious as well as unconscious 
patients, but ESAS items were only assessed in conscious patients. The validated 
ESAS consists of nine 100 mm VASs including pain, activity, nausea, depression, 
anxiety, drowsiness, appetite, well-being and shortness of breath. Scores can 
range from 0-100 (higher scores reflect greater symptom severity). There are  
19 physical symptoms/conditions listed in the RAI MDS-PC. From these, 15 were 
selected, because the other 4 symptoms corresponded with the ESAS (shortness 
of breath at rest, shortness of breath with exertion, impaired endurance and loss of 
appetite).  
For deceased patients who had not been included in the study, the NH physician 
completed a shorter questionnaire at the time of death checking the reason for 
non-inclusion. 
 
Statistics  
The analyses were performed in SPSS for Windows, version 11.0, and descriptive 
statistics were used to characterise the patients. Eligible patients were those for 
whom questionnaires on inclusion and at the time of death were received. Based 
on the hierarchy of intentions to hasten the end of life, exclusive categories were 
analysed by taking for each patient the highest ranking intention; thus in cases 
where more than one intention applied, the most explicit prevailed. Differences in 
frequencies were tested with the Chi2 test.  
The association of ‘demographics’ (gender, age, marital status, actual living status 
before admittance to nursing home, number of children, religion), ‘disease 
characteristics’ (type of ward on inclusion, stage of dementia/cognitive decline) and 
‘main direct causes of death’ with total ELDs, NTDs and APS, was performed with 
logistic regression analysis.  
 
Analysis of symptom burden 24-0 hours before death 
Because most symptom data were missing for unconscious patients, the analyses 
were limited to conscious patients (n=259). The outcome variables of the ESAS 
were screened for normality and standard transformations were made if necessary. 
Two selection criteria were applied for the symptoms in both instruments. Firstly, a 
selection of symptoms considered to be burdensome in the last 24 hours of life was 
made. Secondly, ESAS items were considered to be burdensome at an arbitrary 
cut-off point of 60 or more on the VAS range 0-100 (e.g., 0 = no pain;  
100 = extreme pain). This dichotomisation is an analytical classification aimed at 
providing data on frequencies of burdensome symptoms, since higher scores 
reflect greater symptom severity. RAI MDS-PC response categories (0=not 
present; 1=present, not distressed; 2=present, distressed) were dichotomized:  
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0 and 1 were combined to category 1, and 2 was category 2. Since they distress 
the patient, symptoms in the latter category were considered to be burdensome.  
 
Ethical review 
The Medical Ethics Committee of the VU University Medical Center approved the 
study. Confidentiality of data was guaranteed by providing only coded information 
to the researchers. No patients or members of their family were interviewed. 
Because the NH physicians were simply reporting information collected as part of 
their usual care observations, no informed consent was required according to the 
VU Medical Ethics Committee. As required by Dutch law, the patients and their 
families were informed about the study through an information flyer, and were 
given the option to refuse the transfer of data.  
 
Results 
 
The total number of deaths studied was 467. For these patients the researchers 
received a complete set of data (questionnaire on inclusion and at the time of 
death) for analysis. An additional 272 deceased patients were found to have been 
incorrectly not included in the study. The main reasons for non-inclusion, given in 
the shorter questionnaire in order of sequence by the NH physicians, were 
pressure of work, organisational reasons (e.g. should have been included during 
the weekend), forgotten (to be included), other reasons (e.g. death not foreseen), 
family had objections to inclusion in the study. 
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Table 1   Demographics and disease characteristics of patients included in the 
study (n=467) 
 
Demographics n % 
Gender (missing=1)   
 Male  136 29.2 
 Female 330 70.8 
Age on inclusion (missing=6)   
 Mean age (min-max; SD*) 83.4 (45-100; 8.2) 
Actual living status before admittance to nursing home 
(missing=3) 
  
 Single 314 67.7 
 Together with partner 150 32.3 
Disease characteristics   
Number of month in nursing home   
Median (min–max) 14.0 (0.0-214.6) 
Reason for admission to nursing home (missing=7)   
 Chronic care 346 75.2 
 Rehabilitation 73 15.9 
 Terminal care 29 6.3 
 Other (e.g. special care) 12 2.6 
Stage of dementia (Global Deterioration Scale)19 
(missing=21) 
  
 Stage 1 no cognitive decline 152 34.1 
 Stage 2 – 4 very mild to moderate cognitive decline 26 5.8 
 Stage 5 moderately severe cognitive decline 34 7.6 
 Stage 6 severe cognitive decline 120 26.9 
 Stage 7 very severe cognitive decline 114 25.6 
Consciousness   
On inclusion (missing=3) 385 83.0 
48 – 24 hours before death (missing=5) 345 74.7 
24 – 0 hours before death (missing=3) 259 55.8 
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continue Table 1 
Main underlying disease on inclusion (CvZ-V codes†)20   
 Mental and behavioral disorder 142 30.4 
 Diseases of the circulatory system  93 19.9 
 Diseases of the respiratory system 36 7.7 
 General disorders 34 7.3 
 Diseases of the digestive system 28 6.0 
 Other systems 81 17.4 
 Missing 53 11.3 
 Malignant neoplasms‡ 54 11.2 
* SD = Standard deviation  
† Only data on diseases 5% above the diseases in the total study population are presented 
‡ Separate statement of malignant neoplasms (including secondary malignant neoplasm), within all 
systems 
 
Table 1 presents the demographics and disease characteristics of patients on 
inclusion. Most of the patients were female (70.8%), with a mean age of 83.4 
years. Patients were predominantly single (67.7%). The median duration of stay in 
the NH was 14 months. One third (34.1%) had no cognitive decline (stage 1 GDS), 
the remaining had mostly stage 6 (26.9%) and stage 7 (25.6%) GDS. On inclusion 
83% of the patients was conscious, which decreased to 74.7% 48-24 hours before 
death and 55.8% 24-0 hours before death. The main underlying diseases on 
inclusion were mental and behavioral disorder (30.4%) and diseases of the 
circulatory system (19.9%).  
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Table 2 shows the frequency of end-of-life decisions (ELDs) in conscious and 
unconscious patients, compared with the Dutch population (only non-sudden 
deaths). The frequency of any ELD in the total study population was 69.8%, which 
is somewhat less than the 74.5% calculated from the database of a previous study 
among a sample of all deaths in the Netherlands. The frequency of non-treatment 
decisions (NTDs), and alleviation of pain and suffering with possible life-shortening 
effect (APS) was 39.2% and 30.0% respectively. The frequency of medical 
treatments withheld was 25.9% and medical treatments withdrawn was 13.3%. 
These percentages correspond approximately to ELD frequencies for all deaths in 
the Netherlands, except for APS which occurred in 30% of deaths studied, 
compared to 37.4% in all Dutch deaths.  
Physician assisted death (PAD) was reported in three cases (0.6%). These cases 
concerned 2 women (89 and 91 years old, with stage 6 and 5 GDS, respectively) 
and 1 man (age missing, with stage 7 GDS). Their stay in the NH varied between 1 
month and 4,5 years. The two female patients had no fluid and nutritional intake, 
the male patient was being tube fed. As direct cause of death cachexia and 
dementia were reported. Twenty-four hours before death two of the patients were 
unconscious, the other patient was conscious and experienced among other 
symptoms, pain (VAS-score 69), shortness of breath (VAS-score 74) and poor 
well-being (VAS-score 74). The NH physicians estimated the life shortening in 
every case differently: 1-7 days, at most 24 hours, and possibly no life shortening.  
In conscious patients with stage 1-4 GDS (group 1) the frequency of ELDs and 
NTDs occurred significantly less often than in conscious patients with stage  
5-7 GDS (group 2) and unconscious patients (group 3): 57.7% versus 70.9% and 
76.1%, respectively. In conscious patients with stage 1-4 GDS (group 1) the 
frequency of NTDs occurred significantly less often than in unconscious patients 
(group3): 29.7% versus 44.9%.  
 
The estimated amount of time by which life was shortened according to the NH 
physicians for NTD cases (n=163) was: ‘at most 24 hours’ for 11% (n=18), ‘1 to 7 
days’ for 36.2% (n=59), ‘1 to 4 week(s)’ for 19.0% (n=31); and for APS cases 
(n=124): 25.8% (n=32), 19.4% (n=24) and 9.7% (n=12), respectively. Life was 
probably not shortened due to a NTD for 20.2% (n=37) and due to an APS for 
40.3% (n=50) of the cases (data not shown). 
In demented patients (stage 5-7 GDS), regardless of their state of consciousness, 
significantly more ELDs (P=0.014) and NTDs (P=0.038) occurred than in not 
demented patients (stage 1-4 GDS). Analysis also showed that significantly more 
demented patients stage 5-7 GDS were unconscious 24 hours before death  
(group 3) (67.2%) than were not demented patients stage 1-4 GDS (32.8%) 
(P=0.008) (data not shown). 
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Table 3 presents the frequency of end-of-life decisions by main direct causes of 
death, as assessed by the NH physician. The most prevalent causes of death were 
general disorders, diseases of the respiratory system and circulatory system. 
Among patients with diseases of the circulatory system significantly more end-of-
life decisions (ELDs) occurred than in patients with other diseases (P=0.020); 
among patients with ‘general disorders’ significantly fewer non-treatment decisions 
occurred than in other groups (P=0.040). Demographics and disease 
characteristics were not significantly associated with the occurrence of an ELD, a 
NTD or APS (data not shown). 
 
Table 4 shows the frequency of end-of-life decisions (ELDs) in conscious and 
unconscious patients and, for conscious patients, by burdensome symptoms 24-0 
hours prior to death. ELDs and NTDs occurred significantly more often in 
unconscious patients than in conscious patients. Burdensome symptoms were not 
related to the frequency of ELDs.  
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Discussion 
 
Medical end-of-life decisions with a certain or possible life shortening effect (ELDs), 
namely non-treatment decision (NTD), alleviation of pain and symptoms with 
possible life-shortening effect (APS) and physician assisted death (PAD) have 
been discussed for several years, but little is known about these decisions in 
terminally ill long-term care elderly. This study succeeded in measuring end-of-life 
decisions among long-term care terminally ill patients dying in Dutch nursing 
homes (NHs).  
 
ELDs occurred in 70% of all deaths and in 79% of patients with disease of the 
circulatory system. Withholding of treatment occurred in 1 in 4 patients, 
withdrawing of treatment in just over 1 in 10 and alleviation of pain and symptoms 
in 3 out of 10 of all studied deaths. Nevertheless, the frequency of NTDs is 
probably higher because they are ‘overruled’ by an APS (according to the 
sequence of ELD classification). In conscious and non-demented patients, 
significant fewer ELDs were performed than in unconscious or demented patients 
(58% vs 76% vs 71%, respectively). Withholding of treatment occurred most often 
among unconscious patients. In conscious patients, the frequency of withholding of 
medical treatment was significantly higher among demented than among non-
demented patients (30% vs 15%). The frequency of alleviation of pain and 
symptoms with possible life-shortening effect did not differ by competence of the 
patient or stage of dementia. Symptom burden in conscious patients, assessed by 
the NH physician, had no relation with ELDs. In this study three cases (0.6%) of 
physician assisted death were reported.  
 
One of the strengths of this study is that most existing studies on end-of-life 
decisions are restricted to one specific NH or the elderly in general, whereas this 
study is performed on a national level in a population-based NH sample. Therefore 
the large-scale design, the representativeness of the NHs and the prospective 
character of the study enhance the validity and reliability of these findings. Given 
the difficulties of measuring sensitive ELDs, this study succeeds in estimating the 
frequency of ELDs. For this we used validated questionnaires used in several other 
studies on end-of-life decisions.(12,15,22) Compared with the overall ELD 
incidence in the Netherlands, previously estimated in robust epidemiological 
studies based on large-scale death certificate sampling, the results of this study 
seem valid and reliable. Except for APS, the overall frequency figures didn’t differ 
from the general population of deaths. The lower frequency of APS can be 
explained by the difference in morbidity of long-term care populations in nursing 
homes, with very few cancer patients and a large group of psychogeriatric patients 
with dementia.  
This study also has some limitations. First, there is missing information about a 
large number of terminal patients, who should have been included. Although no 
substantial differences were found between the study sample and the non-included 
group with regard to gender and type of ward, a possible bias on the outcome 
variables of this study cannot be excluded.(3) Secondly, though medical practices 
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regarding ELDs in the Netherlands are discussed openly, we cannot fully exclude 
the possibility of a response bias, especially an under-reporting of specific ELDs 
such as physician-assisted dying. Thirdly, the specific medical (non) treatment 
decisions (e.g. forgoing artificial nutrition or hydration, withholding or withdrawal of 
antibiotics) and motives for ELDs did not fit into the scope of the present study, 
therefore we could not gather additional information about these subjects and 
relate these to actual practice.  
 
As this study shows, ELDs occurred frequently in Dutch NHs. The frequency of 
physician assisted death (the administration of drugs with the explicit intention of 
shortening the patient’s life) without the patient’s explicit request, was low (0.6%, 
n=3), similar to the frequency of all deaths in the Netherlands (0.9%).(26) Those 
reported cases involved demented patients of whom two were unconscious in the 
last day of life and one experienced severe pain and shortness of breath. Although 
the estimated life-shortening effect in these patients was very small, the NH 
physicians explicitly intended to hasten death.  
The frequency of ELDs was significantly different between competent and 
conscious non-demented patients (58%), conscious demented patients (71%) and 
unconscious patients (76%). In this study, medical ELDs seem to be influenced by 
the consciousness or competency of the patient: there is uncertainty whether these 
life ending actions were made by the NH physicians with the involvement of the 
competent patients or without the involvement of the incompetent patients. 
Pijnenborg et al. (1995) reported in their nationwide study on the occurrence of 
withdrawal or withholding of treatment at the end of life, that 19% of non-treatment 
decisions (NTDs) were made at the explicit request of the patient, 22% after 
discussion with the patient or after a previous wish, or without involvement of the 
patient (59%). Of this last group, 87% were not competent.(27) Similar findings 
were found by Deliens et al. (2000) who stated that the withdrawal or withholding of 
treatment mainly occurred among incompetent patients.(14)  
Within the non-treatment decisions (NTDs), the frequency of withholding medical 
treatment occurred more often than withdrawing medical treatment (26% vs 13%). 
This tendency was also found in a study of Bosshard et al. (2005) on forgoing 
treatment at the end of life in six European countries, which found a ratio of 
treatments withheld to treatments withdrawn of 60% to 40%.(13) The estimated life 
shortening effect for NTDs was, in more than one third of patients, 1 to 7 days and 
for one fifth 1 to 4 weeks. But again, withholding medical treatment occurred 
significantly less often in conscious, competent patients than in incompetent 
patients. 
Patients’ competence is of no relevance in the category of alleviation of pain and 
symptoms with possible life-shortening effect (APS). In one third of the study 
population APS was applied and the distribution among competent and 
incompetent patients was approximately the same (28%-31%). The estimated life 
shortening effect for APS was in a quarter of patients less than 24 hours and for 
one fifth 1-7 days, but for 40% had no life shortening effect. The data suggests that 
pain management and symptom relief are standards of palliative care and 
acceptable to NH physicians, even when premature death is a likely consequence. 
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Of all palliative treatments available, the NH physician chooses the least harmful 
alternative. Demographics, burdensome symptoms and most main direct causes of 
death apparently were not related to the performance of ELDs.  
 
During their stay in a NH, patients can become unable to express their wishes in 
several ways and this study shows, ELDs are affected by the competence of the 
patient. This raises the question of whether these ELDs were supported by 
communication with the patient, their family or by a living will. Decreased 
consciousness frequently develops in the terminal phase, due to metabolic 
disturbances or unintended side effects of intensifying symptom treatment.  
Patients and/or their families should be aware of the consequences of decreased 
consciousness in order to make an informed decision on treatment which concerns 
patients’ autonomy. The best option to comply with the wish of the patient seems to 
be advance care planning (ACP). Considering illness trajectories as reported by 
Murray et al. (2005) and The et al. (2002)(28,29) and planning appropriately may 
be helpful in developing the highest possible standards for palliative care.(28) More 
research on the quality of advance care planning related to the experience of the 
terminal phase is needed, concerning the extent to which patients and/or their 
families are involved in planning future end-of-life situations. 
 
In conclusion, in long-term care of the terminally ill patients in Dutch nursing 
homes, the incidence of medical ELDs is strongly related to consciousness and the 
patient’s stage of dementia. In incompetent patients significantly more ELDs 
precede death than in competent patients.  
3
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Introduction  
 
Nursing home care in the Netherlands aims at good curative, supportive and 
palliative care for patients according to the course of their illness and therefore 
terminal care is provided according to the principles of palliative care. The general 
goal of this thesis was to increase information and knowledge of Dutch NH patients 
regarding palliative care and the quality of dying in NHs. The focus of this thesis 
was to gain insight into the incidence and quality of care of terminally ill patients in 
Dutch nursing homes (NHs).  
This chapter addresses the main questions, discusses the main findings and 
describes strengths and limitations. Finally, implications for health policy and 
practice and further research are drawn. 
 
The main questions addressed in this thesis are: 
 
Part 1 Identification and prognostication of the terminal phase 
 
  Research question 1 (chapter 2) 
What symptoms, signs, problems and diseases are the direct causes of the 
terminal phase and what is the incidence of terminal care in nursing 
homes? 
 
Research question 2 (chapter 3) 
How does the estimated length of survival accord with the actual survival 
period? 
 
Part 2  Problems, symptoms and quality of palliative care  
Research question 3 (chapter 4) 
What are the psychosocial and spiritual problems found in the terminal 
phase? 
 
Research question 4 (chapter 5)  
What is the quality of palliative care in the terminal phase in a nursing 
home? 
 
   Research question 5 (chapter 6)  
What morbidity and symptoms are present in the last two days of life of 
nursing home patients?  
 
Part 3  End-of-life decisions 
 
Research question 6 (chapter 7) 
What is the frequency and character of end-of-life decisions in terminally ill 
nursing home patients? 
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Main findings  
The main findings of the study are presented and discussed chronologically 
following the first three parts of this study: the identification and prognostication of 
the terminal phase (Part 1), problems, symptoms and quality of palliative care in 
the last days of life (Part 2) and end-of-life decisions (Part 3). 
 
 
Part 1   Identification and prognostication of the terminal phase (chapter 2 
and chapter 3) 
 
In chapter 2 the first research question concerned symptoms, signs, problems and 
diseases which are the direct cause of the terminal phase, and the incidence of 
terminal care. Inclusion in the study was decided on the basis of clinical daily 
practice by the NH physician and was the first step taken in the study. A major 
challenge was the prognostication of survival time, with a maximum life-expectancy 
of six weeks or less (chapter 3). 
 
The four most frequently reported symptoms, signs, or problems in the terminal 
phase of NH patients, which physicians identified as related to the terminal illness, 
were problems of low fluid intake and nutritional intake, generalized weakness and 
respiratory problems or dyspnea (chapter 2). Together with this patients were 
frequently in a state of somnolence  and suffering from recurrent fever. At this point 
the NH physician decides that the patient has entered the terminal phase. The 
direct causes of the terminal phase, accompanied by the previous  symptoms, 
were diseases of the respiratory system (24.4%), mostly pneumonia, and disorders 
of a general nature (23.8%) such as cachexia, malaise, coma, fever and 
septicaemia.  
The two main underlying diseases of the terminal phase were mental and 
behavioral disorders  (mostly dementia) (30.2%) and diseases of the circulatory 
system (20.5%). Only 12% of patients had cancer as the underlying disease, which 
was also present in a different symptom pattern compared to the non-cancer 
population. Contrary to non-cancer patients, patients with cancer more often 
experienced generalized weakness (47% vs 28%), cachexia/anorexia (27% vs 
10%), (extreme) tiredness (27% vs 10%), vomiting 12 : 1, nausea 13 : 1 and feeling 
sick 5:1. The identified period of terminal illness was limited; median survival was 3 
days. Within seven days 82.9% of the patients had died and after 14 days 92.2%. It 
was estimated that in an NH with 100 beds, 34 patients would enter the terminal 
phase each year. In other words, for every 3 beds, an NH can expect 1 patient per 
year to reach a terminal phase requiring palliative care.  
When NH physicians identified a patient as having a limited life-expectancy, they 
had to give an estimation of the survival time (chapter3). The physicians, except 
when death was imminent, inaccurately predicted the survival of patients. 
Prediction was accurate in more than 90% of cases when death occurred within 7 
days. Predicted and actual survival became substantially less accurate over a 
period longer than seven days. Accurate prediction decreased to 16% (predicted 
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survival 1-3 weeks) and 13% (predicted survival 4-6 weeks). In the categories 1-3 
weeks survival and 4-6 weeks survival, 69% and 52% respectively died earlier. 
 
These findings reflect a mainly non-cancer population with less definable illness 
trajectories, in contrast to most cancer patients, which makes identification and 
prognostication difficult. The death of these patients was preceded by a slow 
trajectory punctuated by acute and reversible illnesses such as pneumonia, sepsis, 
or dehydration.(1) AM The et al. (2003) in their ethnographic study of the 
withholding of artificial administration of fluids and food from patients with 
dementia, also described different illness trajectories. They identified a ‘slow 
downward curve’ (the natural course for patients with dementia) ‘the interruption’ 
(slow downward curve interrupted by an acute illness, such as pneumonia) and 
‘unexpected fluctuation in the illness process’ (sudden illness followed by death or 
unexpected recovery).(2) Although this study concerned patients with dementia, it 
reflects the course of death of many NH patients without dementia as well.  
 
As well as the difficulty of identifying a ‘terminal phase’, the study revealed an 
interrelated problem, namely the prediction of life-expectancy (in this study set at 
six weeks or less). The length of survival is an important aspect, when decisions 
have to be made concerning further burdensome treatment, beginning or forgoing 
supportive care etc. Identification might give the patient the opportunity to prepare 
for death and the ending relationships with loved ones. When patients were 
included as entering a terminal disease phase, death was only a few days off. 
These findings are in line with Oxenham et al. (1998) who reported in their study of 
survival in a hospice that members of the clinical staff were able to predict the 
imminent death of patients with diagnosis of advanced malignant disease with 
significant accuracy, either based on increased knowledge of the individual 
patients or on the stage of the illness.(3) One might expect a better prognostication 
of long-term survival from NH physicians because of their profound knowledge of 
the patient. This study indicates that intimate knowledge of the patient is no 
guarantee of accuracy; because predictions over a longer period of time (longer 
than 7 days) were prone to inaccuracy, in more than half of cases patients died 
earlier. Within 14 days after inclusion more than 90% of patients were deceased. 
Christakis et al. (2000) associated prognostic inaccuracy with a stronger doctor-
patient relationship and the majority of predictions in his study were over-estimated 
(63%).(4) Nevertheless, the reason for this difficulty in prediction of life-expectancy 
may be due to the fact that NH patients become frail and die from multifactorial 
causes (comorbidity and intercurrent diseases). Deterioration in one health area 
influences other health areas, resulting in a cumulative negative effect on the 
patient’s overall health condition and thus making prognostication inaccurate. 
Moreover, two-third of the patients in this study had dementia (stage 5-7 of the 
Global Deterioration Scale [GDS])(5), a complicated disease with an unpredictable 
course. 
It may be concluded that even the advantage that the physicians are employed by 
the NH and therefore know the patient well (probably over a longer period of time) 
0
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appears to be no guarantee of an accurate prediction; this therefore continues to 
be a challenging task for physicians.  
 
NH staff have the difficult task of providing palliative care while living up to the 
principles formulated by the World Health Organization.(6) Since the identified 
period of terminal illness is limited, the question remains whether palliative care is 
sufficiently addressed, to this phase of rapid changes. Perhaps it is more difficult to 
provide appropriate palliative care for elderly patients with chronic diseases than 
for patients with cancer, because the course of chronic disease is difficult to predict 
in contrast to that of cancer. This indicates that the traditional focus of palliative 
terminal care on patients with cancer needs to be extended and adapted to the 
specific needs of elderly patients without cancer, which is also a public health 
challenge of the World Health Organization.(7) The reported symptoms, signs and 
problems (chapter 2) may be an indication that the patient is approaching death 
and may serve as a cue to the physician, patient, and family that the person is 
dying. However, this must be confirmed in future research with specific prognostic 
models.  
The incidence of NH patients who will require palliative terminal care is high and 
already gives an indication of the difficult challenges NHs have to face, because 
these patients and their families require more attention from staff and more 
financial resources than ‘regular’ patients. The gathering of information about 
incidence is useful for policymaking and for assessment of the requirements of 
terminal care.  
 
 
Part 2   Problems, symptoms and quality of palliative care (chapter 4,  
chapter 5 and chapter 6) 
 
Palliative care concerns assessment and treatment of pain and other problems, 
physical, psychological and spiritual. Chapter 4, chapter 5 and chapter 6 indirectly 
describes the quality of palliative care in daily practice, and addresses research 
question 3 (psychosocial and spiritual problems), question 4 (quality of palliative 
care), and question 5 (what symptoms are present in the last two days of life). 
These chapters give at least an indication of the current state of affairs in Dutch 
NHs. They are not meant as normative judgments of the quality of palliative care, 
but perhaps give clues for a broader discussion. 
 
Psychosocial and spiritual needs  
Results, gathered with the Resident Assessment Instrument Minimum Data-Set 
Palliative Care (RAI MDS-PC draft 1.8),(8) revealed high psychosocial and spiritual 
needs in the last days of life of NH patients (chapter 4). Almost a quarter (22%) of 
the conscious NH patients with stage 1-5 dementia, according to the Global 
Deterioration Scale (GDS),(5) did not seem to be at peace with life in the last three 
days of their lives. Half of patients showed sad, pained, worried facial expressions, 
one-third exhibited expressions of fear and expressed feelings of sadness or 
depression. One-fifth suffered from insomnia or change in the usual sleep pattern.  
1
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At the same time NH physicians reported significant improvement in depression, 
anxiety and well being (psychological needs) nearer death. This may be due to the 
alleviation of pain and symptoms with opiates, frequently reported in patients (30%) 
(chapter 7). Nurses had knowledge of the more concrete wishes of the patient with 
regard to religious or spiritual guidance or support. They reported that more than 
four out of 10 patients (44.8%) wished for religious or spiritual guidance or support.  
 
Quality of palliative care  
On average the outcomes on palliative care, measured with the Palliative care 
Outcome Scale (POS),(9) (chapter 5) appeared to be favourable for both non-
demented and demented patients. Pain and other symptoms (e.g., nausea, 
coughing or constipation) seemed to be under control, information given to the 
patient and their family or friends was sufficient, little time was wasted on health 
care (e.g., waiting around for transport or repeating tests), and financial or personal 
affairs were adequately addressed. With regard to symptom control, a key point of 
attention in palliative care, these results are not in line with other findings. Mitchell 
et al. (2004) concluded that NH residents in their study did not receive optimal 
palliative care.(10) There has to be acknowledged that from the recently published 
literature review of McPherson & Addington-Hall (2003) the following conclusions 
about the validity of reports of significant others can be drawn: Levels of agreement 
tend to be good for quality of services, and on observable symptoms. With respect 
to proxy reports on health and well-being, agreement is best on more overt 
symptoms, e.g. immobility, activities of daily life and symptoms such as fatigue, 
dyspnoea and vomiting. Agreement is poorest for aspects of the patient’s 
experience which are more subjective, like pain and affective status.(11) So there 
is a possibility that staff over estimated the care they provided. 
 
Symptoms  
Burdensome symptoms were present to a high extent in dying NH patients  
(chapter 6). In 72% of NH patients studied, either unconsciousness or burdensome 
symptoms accompanied the last two days of life. Two days before death, 51% of all 
conscious patients suffered from at least one burdensome symptom, which 
decreased 24 hours before death to 28%. A minority of patients (12%) developed 
burdensome symptoms 24 hours before their death, whereas they had none 
previously. Pain, measured with the Edmonton Symptom Assessment Scale 
(ESAS),(12) decreased significantly in the last 48 hours before death (median VAS 
score on severity from 20 to 12), but still one out of 5 patients (22%) was suffering 
burdensome pain in the last day before death. This supports the assumption that 
staff probably over estimated the outcome of palliative care with regard to pain 
(chapter 5). Also Zerzan et al. (2000) stated that dying residents experience high 
rates of untreated pain and other symptoms.(13) These findings underpin the 
concern of the World Health Organization that older terminally ill patients have 
many unmet needs, and suffer unnecessarily.(14) In a study on barriers to effective 
pain management for NH residents Jones et al. (2005) concluded that staff nurses 
need to make more effort to systematically assess pain and offer pain medication 
to residents rather than to rely on resident requests.(15) Nevertheless, one should 
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be cautious of interpreting pain as the main parameter of quality of care, because 
this could be a misinterpretation according to Weiss et al. (2001). They stated that 
the conclusion regarding the extent of pain as a sign of poor end-of-life care is 
questionable and might be not the best outcome measure. About one third of the 
patients they studied seemed to balance the experience of pain with the desire to 
avoid troublesome side-effects of treatment, and therefore were willing to tolerate 
pain.(16)  
Although the prevalence of burdensome symptoms in this study was high, the 
quality of dying for the majority of NH patients was considered by the NH 
physicians and family members to be good. This may be plausible because of the 
high prevalence of unconscious patients, 44% one day before death, and the 
frequently-reported alleviation of pain and symptoms with opiates. The number of 
patients with burdensome symptom(s) stayed roughly the same towards death, but 
the frequency of difficulty coughing (14%6%), dry mouth (12%6%), fever 
(7%2%), infections (17%10%), fatigue (28%17%) and pressure ulcer 
(14%8%) decreased significantly.  
 
An interesting finding of this study was the high frequency of ‘non-scores’ (‘not 
applicable’ and ‘unknown’ together) in the less observable psychosocial and 
spiritual aspects of palliative care. As an evaluation of palliative care these results 
give an indication of the quality of care.  
Results with the Minimum Data-Set Palliative Care (chapter 4) showed that in 33% 
of the non-score cases the NH physician had no knowledge of whether patients 
were at peace with life or not and in 25% of non-scores, of whether they expressed 
feelings of sadness or depression (psychosocial needs). Non-scores were even 
higher for spiritual needs when compared to psychological needs. Nurses did not 
know whether patients were struggling with the meaning of life (54%) or felt anger 
towards God, religion or fate (52%) (spiritual needs).  
For the Palliative care Outcome Scale, used to assess the palliative care  
(chapter 5), high non-scores were given for the items patient anxiety 
(psychosocial), support of patient, life worthwhile and self-worth (spiritual domain). 
Within the group of patients with dementia (stage 5, 6 and 7 of the Global 
Deterioration Scale)(5) non-scores were, in relation to the sequence of the stages 
of dementia, highest in patients with stage 7 dementia. These results show that the 
Palliative care Outcome Scale can be used to assess a considerable subgroup of 
demented patients. As communication with the patient and proxy (e.g. family, 
nurses, doctors) is hampered by the presence of cognitive disorders, it could be 
expected that differences will exist in the Palliative care Outcome Scale-scores 
between patients with and without dementia. However, further research is needed 
to determine to what stage of dementia palliative care can be assessed validly with 
the Palliative care Outcome Scale; in dementia stage 7 the use of the Palliative 
care Outcome Scale is apparently questionable.  
On the basis of the available results it may be concluded that palliative care in 
Dutch NHs was weakest in psychosocial and spiritual support for the dying, 
because staff find it difficult to assess subjective aspects in patients. It is known 
that during the dying process the spiritual domain is an unmet need among 
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patients, which is confirmed by this study. These aspects receive insufficient 
attention and staff, whether or not in cooperation with family or other relatives, 
should learn more about these needs. This is supported by Georges et al. (2005) 
who stress in their prospective study on symptoms, treatment and ‘dying 
peacefully’ in cancer patients, that attention should be paid to psychosocial well-
being in the dying process of the terminally ill.(17) 
Burdensome symptoms are present in high frequencies and need improvement. 
Also, non-scores (no assigned score) might be seen as an indicator of quality of 
care. In this study healthcare providers had insufficient knowledge of these needs, 
which suggests potential improvement of assessment in end-of-life care. The 
question of whether these results were due to lack of knowledge of the patients 
and/or the absence of feasible assessment instruments is unanswered. In any case 
it can be concluded that psychosocial and spiritual aspects of care should be better 
integrated into the continuing professional education and training of health 
professionals.  
 
 
Part 3   End-of-life decisions (chapter 7) 
 
When the health condition of patients declines and death becomes imminent, 
caregivers are confronted with end-of-life decisions (ELDs), i.e. decisions that may 
have a potential life-shortening effect.(18)  
As a response to the last research question of this thesis, chapter 7 discussed two 
main end-of-life decisions common in the daily practice of NHs, namely withholding 
or withdrawal of potentially life-prolonging treatments (non-treatment decisions or 
NTD) and the alleviation of pain and symptoms with opiates in doses with a 
possible life-shortening effect (symptom alleviation or APS). 
 
End-of-life decisions, such as NTD and APS, are frequently made in Dutch 
NHs.(19) This indicates a general attitude in Dutch NH physicians of predominately 
striving for quality of life at the expense of survival. According to the definition of 
palliative care by the World Health Organization (WHO)(6) euthanasia and 
physician-assisted suicide are not part of palliative care. In this study, the 
frequency of physician-assisted death (the administration, prescription or supply of 
drugs with the explicit intention of shortening the patients’ life or enabling the 
patient to shorten his or her life) was rare (0.6%, n=3). In this study no case of 
euthanasia was reported and all were cases of active life ending without the 
patient’s explicit request.  
ELDs occurred in 70% of all non-sudden deaths. Most frequent ELDs in this study 
were non-treatment decisions (NTD) (39% of all non-sudden deaths), and 
alleviation of pain and symptoms with possible life-shortening effect (APS) (30% of 
all non-sudden deaths). Within the NTDs, withholding medical treatment occurred 
more often than withdrawing medical treatment (26% versus 13%). This tendency 
was also found in a study of Bosshard et al. (2005) in six European countries, 
which found a ratio of treatments withheld to treatments withdrawn of 60% to 
40%.(20)  
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In this study, there was a significant difference in the frequency of end-of-life 
decisions between unconscious patients (76%), incompetent demented patients 
(71%) and conscious competent non-demented patients (58%). Therefore, medical 
end-of-life decisions seem to be partly determined by the consciousness or 
competency of the patient. This opens the question whether these decisions were 
supported by communication with the patient, family or a living will. At the end of 
life a physician, has to evaluate medical and non-medical burdens and benefits. To 
do this properly, the patient should be involved whenever possible. A study 
performed in the Netherlands by Pijnenborg et al. revealed that in 19% of the 
cases NTDs were made at the explicit request of the patient, in 22% after 
discussion with the patient or after a previous wish and 59% without involvement of 
the patient.(20) Decisions made by NH physicians without involvement of the 
patient mainly occurred among incompetent patients.(21;22) As discussed earlier 
in the section on ‘Identification and prognostication of the terminal phase’ these 
results are significant for implementation of advance care planning (ACP) in NHs.  
 
During their stay in a NH patients can become unable to express their wishes in 
several ways, either becoming unconscious or demented. Georges et al. (2005) 
reported in their study that in general over 20% of people who die of cancer 
become unconscious before death.(17) In this study 44% were unconscious in the 
last 24 hours of life (chapter 6). Patient involvement  and discussion should not be 
postponed until the patient has become incompetent. Decreased consciousness 
frequently develops in the terminal phase, due to the metabolic consequences of 
disease or the unintended side effect of intensifying symptom treatment. Ideally, 
the patient should be aware of the consequences of decreased consciousness 
before it occurs in order to make an informed decision on treatment; this is an issue 
of patient autonomy. Doctor-patient and doctor-family relationships are often 
longstanding and therefore allow for early and personal discussions on end-of-life 
care. It may be difficult for relatives and NH physicians to make end-of-life 
decisions when they are not sure what the patient would have wanted. However, 
uncertainty can be prevented and medical decisions can reflect the patient’s 
wishes. A way for the NH physician to anticipate possible future end-of-life 
situations is to discuss these with the patient and/or family, preferably soon after 
admission to the NH. In this study patients in 15 cases (3.2%) had a written living 
will.  
Alleviation of pain and symptoms with possible life-shortening effect (APS), was 
applied equally in competent and non-competent patients. This may be due to the 
fact that this practice is in accordance with the inherent goal of alleviating patients’ 
symptoms, and therefore enhancing quality of  life. In daily practice pain 
management and symptom relief are standards of palliative care and acceptable to 
NH physicians, even when they sometimes result in a hastening of death.  
In this study life was shortened due to the alleviation of pain and symptoms with 
opiates in doses with a possible life-shortening effect, by approximately 24 hours in 
26%, 1-7 days in 19%, and 1-4 week(s) in 10% of the cases.  
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Strengths and limitations  
 
This study generates information on an important and under-researched area. The 
NH population is large and growing and has significant impact on the national 
health care system. The study provides useful information on terminally ill patients 
who suffer mostly from diseases other than cancer. The design was prospective 
observational, which minimised recall bias. Representative sampling in this study 
was checked against two parameters: the distribution of physically ill and 
psychogeriatric patients, and gender. No significant differences were found 
between the national NH population and the study population for either parameter. 
Furthermore, most studies are restricted to one specific NH or elderly people in 
general, whereas this study is performed at national level in a population-based  
NH sample. Therefore, the prospective character, representativeness and large-
scale design of this study enhances the validity and reliability of its findings. 
 
However, the study design had limitations, which may have affected the quality of 
the data. A main limitation of the study was that it relied on the reports of proxies, 
namely caregivers. Hence, the patient’s experiences can be biased, because these 
proxies may have under-reported or over-reported the patient’s symptoms and 
other preferences concerning palliative care. However, several studies have 
evaluated the use of proxy reports on the quality of life, and the quality of care in 
elderly patients with and without dementia.(11;23-26) In general, these studies 
focusing on the reliability of proxy ratings show different outcomes. Assessments 
made by significant others and health care providers are reasonably accurate, and 
nurses may be the most suitable source of proxy information. Fairly good 
agreements between patient and proxy are reported with regard to physical 
functioning and cognitive status, but agreement is poorest for subjective aspects of 
the patient’s experience such as pain, anxiety and depression. In patients with 
dementia, agreement decreased with the increasing severity of the dementia and 
therefore proxy assessments should be interpreted with caution.(24) 
A second limitation is missing information on a large number of terminal patients 
who should have been included in the study but who were not. The main reasons 
for non-inclusion in order of sequence, given by the NH physicians, were: pressure 
of work, organizational reasons (e.g. should have been included during the 
weekend), forgotten (to be included), other reasons, and family had objections to 
inclusion in the study. Although we did not find substantial differences between the 
study sample and the non-included group with regard to gender and type of ward, 
we cannot exclude selection bias, in case physicians selectively missed patients 
(e.g., in complicated cases).  
A third limitation is the physicians’ judgment of sudden and unexpected death. 
Although sudden and unexpected death was an exclusion criterion, different 
physicians may have possibly missed the signs of nearing death and mistakenly 
described patients as having died suddenly. However, we believe that NH 
physicians have not deliberately misclassified patients.  
6
 139 
Furthermore, the data collected by the NH physician perceived as having a limited 
life-expectancy of six weeks or less may have led to individual interpretations, but 
was decided on the basis of clinical daily practice. 
A fourth limitation is the retrospective approach to assessment of burdensome 
symptoms in the last two days of life by the NH physician. However, because NH 
physicians were instructed to fill in the questionnaire soon after death, we assume 
that recall or retrospective bias has been limited.  
Finally, the underlying disease of the terminal phase was assessed with a question 
analogous to the cause of death question on the Dutch death certificate.(27) The 
NH physicians who participated in the study might have had difficulties in reporting 
the underlying disease of the terminal phase and therefore may have incorrectly 
registered the cause of death on the death certificates. It is known that problems 
occur mainly with regard to the sequence of the primary and secondary causes of 
death, and the primary cause (underlying disease) cannot always be 
determined.(28;29) 
 
 
Implications for health policy and practice 
 
Part 1 Identification and prognostication of the terminal phase 
 
Within the gradual decline in physical and psychosocial functioning, common in NH 
patients, it remains difficult to determine whether a patient has entered an 
irreversible terminal stage. A more accurate prognostication of survival contributes 
to appropriate end-of-life care, although the principles of palliative care should not 
be influenced by the estimate of survival. Reported symptoms, signs, or problems 
prior to death may be an indication of approaching death (chapter 2) and therefore 
need special attention in daily care. The Resident Assessment Instrument 
Minimum Data-Set Palliative Care (RAI MDS-PC),(8) developed for quality of NH 
care is one of the few instruments which measure e.g. nutritional state, nutritional 
and fluid intake, and appears to be helpful in assessing the moment of entering the 
terminal phase.  
Once it is acknowledged that the patient is approaching death, the NH physician 
has the difficult task of estimating life-expectancy and providing patients and their 
families with accurate information about future expectations. In the terminal phase 
the frequent evaluation and adaptation of the patients’ policy (care plan), owing to 
the apparent speed of deterioration, is important. In Dutch NHs the most important 
instrument of prognosis is the clinical experience of NH physicians. Multivariable 
prognostic models, another use of prognostication in defining the end-of-life, do not 
seem to be a feasible option, because they require a substantial array of laboratory 
tests and Dutch NH practice is known for its low-technology interventions.(30) An 
instrument like the RAI MDS-PC, which allows among other things scrutiny 
monitoring of patients’ functional status, is needed in Dutch NHs.  
 
 
 
7
 140 
Part 2 Problems, symptoms and quality of palliative care 
 
According to this study, palliative care for NH patients seems to be a challenge and 
there is still potential for improvement. There is evidence suggesting that there are 
considerable differences in quality of care between Dutch NHs.(31) Systematic 
monitoring the quality of palliative care in NHs in the Netherlands could be the first 
step towards improvement. However, it is not a standard activity, and procedures 
for evaluation of the quality of end-of-life care are absent in many NHs.  
Current instruments for evaluation of different dimensions of care are the Resident 
Assessment Instrument Minimum Data-Set Palliative Care (RAI MDS-PC),(8) the 
Support Team Assessment Schedule (STAS),(32) Palliative care Outcome Scale 
(POS),(9) and the Edmonton Symptom Assessment Scale (ESAS).(12) Rather 
than developing new ones, it is advisable to use some of these instruments on a 
regular basis. Some of these instruments have proved their value within the field of 
palliative care, as stated by the Council of Europe expert committee in their report 
on organization of palliative care.(33) The POS,(9) the RAI MDS-PC,(8) and the 
ESAS(12) have been used in this study as assessment instruments and have been 
workable in daily clinical practice in NHs. For further development of the concept of 
palliative care for non-cancer patients, it is advisable to start a discussion with 
groups of experts and national professional associations in order to develop 
evidence-based guidelines.  
This study revealed that the psychological and spiritual dimensions of care 
especially lacked the appropriate attention of health care providers, whereas the 
more physical and observable dimensions like pain, giving information to family 
and patient etc. were well addressed. In international research spirituality has been 
even less frequently investigated than psychosocial needs. We assume that lack of 
knowledge about psychological and spiritual aspects has led to these results. 
Current practice in Dutch NHs will not easily change, but skills in the observation of 
subjective, less observable needs of patients could be developed. Possibilities for 
improvement rely primarily on education and training at medical school and nursing 
school and in post-academic courses on palliative care.  
 
Part 3 End-of-life decisions 
 
In the traditional model of health care, physicians made decisions for their patients. 
In the current model, physicians increasingly make decisions together with their 
patients. As shown, end-of life decisions were frequently made in NHs and will 
probably increase with growing numbers of elderly dying in NHs. Undoubtedly, 
end-of-life issues should be discussed openly with the patient and family, 
preferably at an early stage after admission. The best option to comply with the 
wishes of the patient is advance care planning (ACP). ACP depends upon 
forecasting the challenges that the patient and family will face due to illness, 
medical treatment or other concerns. When an important decision can be 
anticipated, the decision-making process includes a prediction of the situation, 
awareness of alternative care plans (different scenarios), and the formulation of 
preferences. As reported by Murray et al. (2005) thinking in terms of illness 
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trajectories (how patients may die) and then planning appropriately may be helpful 
in developing the highest possible standards for palliative care.(34) Earlier studies 
revealed that advance care planning is common in Dutch NHs and it would be 
advisable that the plan is made shortly after admission, with a recurrent evaluation 
due to changes in patients condition.(35) Nevertheless aspects of discussion are 
the quality of advance care planning. Several issues need attention, like how fare 
patient/family is involved in this planning, how advanced written directives are 
addressed, keeping agreements, and what effect advance care planning has on 
the experience of the terminal phase from the viewpoint of the family.  
 
 
Implications for further research 
 
The World Health Organization has acknowledged that research into older people 
health information, the quality of care received and policy concerned with their 
needs in the last years of life is scarce.(7) Recommendations for further research 
should be concentrated on more targeted research in NHs. 
Improved knowledge on end-of-life care in NHs will facilitate the quality and 
effectiveness of palliative care in NHs. Reliable information about NH patients’ 
symptoms, emotions, treatment, and health as they approach death is largely 
unknown. Yet such information is essential in planning health services, educating 
practitioners, guideline development, medical audits, and in framing problems. 
Medical literature includes little information about dying; only the growing literature 
on palliative care for patients with cancer provides tested and reliable information. 
In the Netherlands, these patients are mostly admitted to hospices or hospitals and 
to a lesser degree to NHs.  
Even the advantage that the physicians are employed by the NH, and therefore 
know their patients very well, is no guarantee for an accurate prediction of life-
expectancy. The difficulty of defining non-cancer patients as terminally ill or 
predicting their life-expectancy has been recognized in several studies.(36-38) As 
is shown in chapter 2, NH patients suffer mostly from chronic diseases and their 
deaths are mostly preceded by trajectories of slow decline with periodic crises and 
a less well-defined terminal phase. Additional studies of the direct causes of death 
in relation to observed symptoms, signs and specific problems prior to death in 
prognostic models may help for a better identification of the terminal disease phase 
and the prediction of life-expectancy. 
Another issue that requires further research concerns psychosocial and spiritual 
needs. These needs were mostly unknown by healthcare providers and the 
assumption is that this was due to, either lack of knowledge and/or lack of feasible 
instruments to measure this specific aspects. Therefore, these aspects of palliative 
care merit special emphasis. Firstly, the assumption of lack of knowledge should 
be subject of further research. The level of knowledge about palliative care and 
their aspects, especially those of psychosocial and spiritual needs, could be 
starting point for targeted improvement. Whether education is helpful is described 
by Hutt et al. (2006) who conducted an intervention study to improve pain practices 
in NHs. Results of the effect of the intervention were measured with the Pain 
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Medication Appropriateness Scale (PMAS). PMAS sores were better for residents 
in homes where nurses’ knowledge of pain assessment and management 
improved or stayed the same during the intervention.(39)  
Secondly, research should pay attention to the development, improvement and 
testing of measurement instruments which take into account the different 
dimensions of care. Rather than developing new ones, we recommend using and 
improving existing ones, e.g. the instruments used in this study. Nevertheless, 
developing instruments is an ongoing process and we think that subjective 
concepts such as psychosocial and spiritual needs deserve more attention in 
palliative care assessment scales, especially for patients with dementia. 
Finally, further research is needed concerning the relief of burdensome symptoms. 
As shown in chapter 6, two days before death 51% of all conscious patients 
suffered from at least one burdensome symptom. In many cases dying will 
inevitably be accompanied by suffering; nevertheless there is potential for the 
decrease in the symptom burden. Nonetheless, the findings of this study provide 
supportive evidence for the concern of the World Health Organization that older 
terminally ill patients have many unmet needs, and suffer unnecessarily.(14) 
Symptoms concerning respiration are considered to be the most excruciating and 
most difficult to treat. Around 20% of the study population suffered from shortness 
of breath in the last two days of life. Pain, depression, anxiety, shortness of breath 
was present in high frequencies. A high quality of symptom control and 
organization of palliative care in NHs is needed due to the apparent speed of 
deterioration and therefore a steep increase in symptoms. We believe that more 
research into interventions addressing these problems is justified. Research on 
barriers(15) or facilitators to effective symptom management is justified, and will 
contribute to a better quality of end-of-life care. 
0
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Inleiding  
 
De populatie in Nederland veroudert en net als in andere Westerse landen 
overlijden steeds meer mensen op hoge leeftijd. De Nederlandse populatie telt op 
dit moment ongeveer 16.2 miljoen mensen, waarvan 13.3% 65 jaar en ouder is. 
Naar verwachting zal dit percentage 65+ in 2040 tot 25% gestegen zijn. In 2005 
overleed 22.2% van de totale Nederlandse populatie in een verpleeghuis. Met het 
groeiend aantal ouderen zal er een toename naar de behoefte van palliatieve zorg 
in verpleeghuizen plaatsvinden.  
Palliatieve zorg is door de Wereld Gezondheidsorganisatie in 2002 gedefinieerd 
als: een benadering die de kwaliteit van het leven verbetert van patiënten en hun 
naasten die te maken hebben met een levensbedreigende aandoening, door het 
voorkomen en verlichten van lijden, d.m.v. vroegtijdige signalering en zorgvuldige 
beoordeling en behandeling van pijn en andere problemen van lichamelijke, 
psychosociale en spirituele aard. 
 
Traditioneel is palliatieve zorg gericht op patiënten met kanker, maar de meeste 
ouderen in verpleeghuizen overlijden ten gevolge van andere chronische ziekten. 
Er is een groeiend besef dat relatief weinig onderzoek is gedaan naar de 
behoeften van ouderen aan palliatieve zorg.  
 
De beginselen voor een professionele stervensbegeleiding dateren uit de 70er 
jaren van de vorige eeuw. Pas vanaf de negentiger jaren is de ontwikkeling van de 
palliatieve zorg in Nederland in een stroomversnelling gekomen, resulterend in de 
oprichting van de eerste hospices.  
De Nederlandse gezondheidszorg beschikt momenteel over een breed scala aan 
diensten die palliatieve zorg verlenen. Het principe is dat goede kwaliteit van 
palliatieve zorg voor iedere terminale zieke patiënt en diens familie toegangbaar en 
beschikbaar moet zijn (generalistische benadering). Binnen de intramurale zorg telt 
het verpleeghuis tot de grootste dienstinstelling waarin palliatieve zorg verleend 
wordt. Met het stijgend aantal ouderen wordt verwacht dat in de nabije toekomst 
het verpleeghuis een steeds belangrijker plaats zal worden voor het geven van 
palliatieve zorg aan stervenden.  
Omdat er tot op heden geen representatieve data beschikbaar waren over de 
incidentie en kwaliteit van de palliatieve terminale zorg in Nederlandse 
verpleeghuizen, heeft het COPZ (Centrum voor Ontwikkeling van Palliatieve Zorg) 
dit onderzoek, dat onderwerp is van dit proefschrift, geïnitieerd.  
 
Dit proefschrift richt zich op verschillende aspecten van palliatieve zorg 
(symptomen, psychosociale en spirituele problemen, medische beslissingen rond 
het levenseinde) aan patiënten in de terminale fase, opgenomen in een 
verpleeghuis. Het hoofddoel is het vergroten van inzicht in de situatie van 
Nederlandse verpleeghuispatiënten met betrekking tot de palliatieve zorg. De 
resultaten kunnen bijdragen aan een verbetering van de kwaliteit van sterven in 
verpleeghuizen.  
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Van November 2001 tot maart 2003 werden in een representatieve steekproef van 
16 verpleeghuizen alle verblijfspatiënten geïncludeerd, die volgens het oordeel van 
de verpleeghuisarts een maximum levensverwachting van 6 weken of minder 
hadden. Deze patiënten werden tot aan hun overlijden gevolgd, met een maximum 
follow-up van 12 weken, tenzij zij herstelden. Revalidatiepatiënten en patiënten die 
plotseling waren overleden, werden niet geïncludeerd.  
De resultaten richten zich naast de identificatie en prognose van de terminale fase 
(inclusief de incidentie van de terminale fase), op problemen en symptomen in 
deze fase, de kwaliteit van de palliatieve zorg en beslissingen rond het levenseinde.  
De beschrijving van de resultaten bestaat uit drie delen: in deel 1 worden de 
identificatie en prognose van de terminale fase beschreven (hoofdstukken 2 en 3). 
Deel 2 beschrijft problemen, symptomen en de kwaliteit van de palliatieve zorg 
(hoofdstukken 4, 5 en 6). In deel drie komen medische beslissingen rond het 
levenseinde aan bod (hoofdstuk 7).  
 
 
Deel 1 (hoofdstuk 2 en hoofdstuk 3) 
 
Hoofdstuk 2 beschrijft de symptomen, verschijnselen, problemen en 
ziekten/aandoeningen die de directe oorzaken zijn van de terminale fase 
(identificatie van de terminale fase). Daarnaast komt de incidentie van de terminale 
fase in Nederlandse verpleeghuizen aan bod.  
Bij inclusie van een patiënt werd de verpleeghuisarts gevraagd maximaal 3 van de 
belangrijkste symptomen, verschijnselen, problemen in volgorde van belangrijkheid 
te geven, die voor de arts aanleiding zijn om bij deze patiënt van een beperkte 
levensverwachting van 6 weken of korter te spreken. De vier meest voorkomende 
symptomen, verschijnselen, problemen die de terminale fase markeerden, waren 
(zeer) weinig of géén vochtinname, (zeer) weinig of géén voedselinname, 
(algehele) verzwakking en ademhalingsmoeilijkheden/dyspnoe. Deze symptomen 
gingen frequent gepaard met somnolentie (slaperigheid) en (recidiverende) koorts.  
De ziekten/aandoeningen die rechtstreeks aanleiding waren voor de beperkte 
levensverwachting en de eerder genoemde symptomen, verschijnselen, 
problemen, waren ziekten van het ademhalingsstelsel (24.4%)(meestal 
pneumonie) en algemene aandoeningen (23.8%) zoals chachexie, malaise, coma, 
koorts en sepsis. De onderliggende aandoeningen die deze problemen 
veroorzaakten waren psychische stoornissen (30.2%), meestal dementie, en 
ziekten van het hartvaatstelsel (20.5%). Slechts bij 12% van de patiënten was 
kanker als onderliggende oorzaak aangegeven. Patiënten mét kanker vertoonden 
duidelijk een ander symptomenpatroon dan patiënten zónder. In tegenstelling tot 
de niet-kanker patiënten vertoonden patiënten met kanker vaker (algehele) 
verzwakking) (47% versus 28%), chachexie/anorexia (27% versus 10%), (extreme) 
vermoeidheid (27% versus 10%), braken 12 : 1, misselijkheid 13 : 1 en zich ziek 
voelen 5 : 1. Uit de resultaten blijkt dat de verpleeghuispopulatie uit hoofdzakelijk 
patiënten met een chronische aandoening bestaat. Het ziektetraject van chronisch 
zieken is minder goed te voorspellen dan dat van patiënten met kanker. Hun 
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ziektetraject wordt gekenmerkt door een langzame achteruitgang, die onderbroken 
wordt door acute en omkeerbare ziekten zoals pneumonie, sepsis of dehydratie. 
De gerapporteerde symptomen zouden voor de verpleeghuisarts een goede 
voorspeller kunnen zijn van het naderende overlijden.  
 
De door de verpleeghuisarts onderkende terminale fase was kort, met een 
mediaan van 3 dagen. Binnen zeven dagen was 82.9% van de patiënten overleden 
en binnen veertien dagen 92.2%. De incidentie van de terminale fase was 0.34. Dit 
betekent dat in een verpleeghuis met honderd bedden per jaar 34 patiënten in de 
terminale fase raken. Met andere woorden, voor elk derde bed kan een 
verpleeghuis een patiënt verwachten die in de terminale fase komt en extra zorg 
nodig heeft. De hoge incidentie van verpleeghuispatiënten die palliatieve terminale 
zorg nodig hebben, geeft aan dat de verpleeghuizen een moeilijke taak te vervullen 
hebben. Deze patiënten en hun families vereisen immers meer aandacht en zorg 
dan de ‘gewone’ patiënten. Deze informatie is belangrijk voor het beleid van het 
verpleeghuis en de vaststelling van de benodigde terminale zorg.  
 
Hoofdstuk 3 gaat in op de voorspelling van de levensverwachting door de 
verpleeghuisarts, m.a.w. de duur van de terminale fase tot aan het overlijden 
(prognose van de terminale fase). De voorspelling werd vergeleken met de 
werkelijke overlevingsduur. Verpleeghuisartsen konden met een nauwkeurigheid 
van 90% een juiste schatting van de levensverwachting geven als de patiënten 
binnen 7 dagen overleden. De overeenstemming tussen geschatte en werkelijke 
levensverwachting werd onnauwkeuriger naarmate de voorspelde 
levensverwachting langer dan zeven dagen was. De nauwkeurigheid daalde tot 
16% (voorspelde levensverwachting 1-3 weken) en 13% (voorspelde 
levensverwachting 4-6 weken). In deze categorieën overleden de patiënten eerder 
dan voorspeld. Dit was in de categorie 1-3 weken 69% en in de categorie 4-6 
weken 52%. Het voordeel dat de verpleeghuisarts, omdat hij in dienst is bij het 
verpleeghuis, de patiënten goed kent, is geen garantie van een juiste inschatting 
van de levensverwachting.  
Een juiste inschatting is belangrijk voor beslissingen die betrekking hebben op 
verdere belastende behandelingen of het stoppen, respectievelijk starten van 
ondersteunende behandelingen. Bovendien geeft het de patiënt de mogelijkheid 
zich op de dood voor te bereiden en het leven af te ronden (in hoeverre dit nog niet 
gebeurt is).  
 
 
Deel 2 (hoofdstuk 4, hoofdstuk 5, hoofdstuk 6) 
 
In hoofdstuk 4 worden psychosociale en spirituele behoeften in de laatste dagen 
van bewuste niet-demente patiënten gemeten. 
Volgens de verpleeghuisarts vertoonde in de laatste dagen van hun leven ruim de 
helft (51.6%) van de patiënten een droevig, pijnlijk en zorgelijk gelaat, een derde 
liet uitingen van angst (36.4%) en een gevoel van droefheid of depressie (29.1%) 
zien. Eenvijfde (21.2%) leed aan slapeloosheid of een verandering in het 
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gebruikelijke slaappatroon. Tegelijkertijd hadden ongeveer de helft (44.7%) van de 
patiënten vrede met het leven. Verpleeghuisartsen rapporteerden een significante 
verbetering van depressie, angst en welbevinden bij de naderende dood.  
Spirituele behoeften werden door de verzorgenden beoordeeld. Meer dan 
tweevijfde (44.8%) van de patiënten wenste religieuze of spirituele begeleiding of 
bijstand, maar 15.8% had moeite met de betekenis van het leven.  
Wat opviel was het hoge percentage van de score ‘onbekend’ (niet-scores). Zo 
was voor de verpleeghuisarts bij 33% van de patiënten onbekend of deze vrede 
met het leven hadden en bij 25% was onbekend of ze een gevoel van droefheid of 
depressie vertoonden (psychosociale behoeften). In vergelijking met psychosociale 
behoeften was het percentage niet-scores voor de spirituele behoeften zelfs hoger. 
Spirituele aspecten van zorg bleken bij het grootste deel van de verzorgenden 
onbekend te zijn, zoals moeite hebben met de betekenis van het leven (54%) of 
boos zijn op God, godsdienst of het noodlot (52%). Deze resultaten laten ruimte 
voor verbetering van de beoordeling van psychosociale en spirituele behoeften. 
 
Hoofdstuk 5 beschrijft de beoordeling van de palliatieve zorg in de laatste drie 
dagen voor overlijden van niet-demente en demente patiënten met de Palliatieve 
care Outcome Scale (POS) (oorspronkelijk ontwikkeld voor patiënten met kanker). 
Er zijn geen noemenswaardig verschillen in de beoordeling van palliatieve zorg 
tussen niet-demente en demente patiënten gemeten. Pijn en andere symptomen 
(b.v. misselijkheid, hoesten of verstopping) bleken goed onder controle te zijn. Er 
was voldoende informatie aan de patiënt en diens familie of vrienden gegeven, er 
was weinig tijd verloren gegaan aan afspraken die in verband stonden met de zorg 
voor de patiënt (b.v. wachten op vervoer of herhaalde onderzoeken) en praktische 
zaken ten gevolge van de ziekte van de patiënt (financieel of persoonlijk) waren 
behandeld. Verschillen in de gemiddelde POS-scores tussen beide groepen waren 
klein en werden voornamelijk in de subjectieve aspecten van zorg gevonden, 
namelijk ‘heeft de patiënt zijn of haar gevoelens met familie of vrienden kunnen 
delen’, ‘heeft de patiënt het gevoel gehad dat zijn of haar leven de moeite waard 
is’, ‘heeft de patiënt een goed gevoel over zichzelf gehad’ (spirituele domein). De 
verzorgenden beoordeelden deze aspecten gemiddeld negatiever bij demente 
patiënten dan bij niet-demente.  
Sociodemografische aspecten speelden evenmin een rol bij de zorg tussen beide 
groepen patiënten. De resultaten lieten zien dat de POS een geschikt instrument is 
voor de evaluatie van palliatieve zorg voor niet-kanker patiënten én patiënten tot 
een bepaald stadium van dementie.  
Terwijl over het algemeen de fysieke en praktische zaken van palliatieve zorg 
positief beoordeeld werden, werden de meeste tekortkomingen in de subjectieve, 
minder goed observeerbare psychosociale (‘voelde de patiënt zich angstig of 
maakte zich zorgen over zijn ziekte of over de behandeling’) en spirituele 
domeinen gemeten (‘is de patiënt in staat geweest zijn gevoelens met familie of 
vrienden te delen’; ‘heeft de patiënt het gevoel gehad dat zijn of haar leven de 
moeite waard is’; ‘heeft de patiënt een goed gevoel over zichzelf gehad’).  
Hoofdstuk 6 is gericht op het meten van morbiditeit en symptomen in de laatste 
twee dagen voor het overlijden. 
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Ná het overlijden van een patiënt werd aan de verpleeghuisarts gevraagd, welke 
ziekte rechtstreeks de dood tot gevolg had, en retrospectief een beoordeling van 
symptomen 48-24 uur en 24-0 uur voor overlijden te geven. Als de meest 
belangrijke oorzaak voor de terminal fase (bij inclusie) werden psychische 
stoornissen (meestal dementie) en ziekten van het hartvaatstelsel gerapporteerd. 
In minder dan 11% werd kanker als oorzaak genoemd. Tot de meest prevalente 
rechtstreekse ziekten die de dood ten gevolge hadden hoorden pneumonie, 
nierinsufficiëntie, electrolyten- en vochtstoornissen (meestal dehydratie) of 
cachexie. Een kwart (25%) van de patiënten was 48-24 uur voor het overlijden niet 
bij bewustzijn en dit percentage steeg tot 44% 24-0 uur voor het overlijden. Twee 
dagen voor het overlijden leed 51% van alle patiënten die bij bewustzijn waren aan 
tenminste één belastend symptoom en dit percentage verminderde tot 28% 24-0 
uur voor overlijden. Een klein deel van de patiënten (12%) ontwikkelde 24 uur voor 
het overlijden belastende symptomen, terwijl deze symptomen een dag van 
tevoren niet aanwezig waren. Met de naderende dood verminderde de intensiteit 
van pijn, maar de frequentie van patiënten mét pijn, één dag voor het overlijden, 
was nog steeds 22%. De mediaan voor misselijkheid, depressie en angst was laag 
(de intensiteit van symptomen nam af). Het welbevinden verbeterde, maar de ernst 
van verminderde activiteit, dufheid en slechte eetlust verslechterde. Met de 
naderende dood bleef het aantal patiënten met belastende symptomen ongeveer 
gelijk. Er was wel een significante vermindering van de frequentie van symptomen 
48-24 uur en 24-0 uur voor overlijden: moeite met ophoesten (14%6%), droge 
mond(12%6%), koorts (7%2%), infecties (17%10%), moeheid (28%17%) 
en decubitus (14%8%).  
Op basis van de resultaten is te zien dat bij 72% van de verpleeghuispatiënten in 
de laatste twee dagen van hun leven sprake was van bewusteloosheid of 
aanwezigheid van tenminste één belastend symptoom. Dit suggereert dat er meer 
aandacht moet komen voor symptoombestrijding in de terminale fase. Ondanks het 
feit dat de symptomen vaak moeilijk te behandelen zijn, werd de kwaliteit van 
overlijden van de meeste verpleeghuispatiënten door de verpleeghuisarts en de 
familie als goed beoordeeld.  
 
 
Deel 3 (hoofdstuk 7) 
 
Hoofdstuk 7 heeft betrekking op de frequentie en de aard van medische 
beslissingen rond het levenseinde (MBLs).  
Medische beslissingen rond het levenseinde zijn dagelijkse praktijk in Nederlandse 
verpleeghuizen. In dit onderzoek ging in 70% een MBL aan het overlijden vooraf 
en in 79% bij patiënten met ziekten van het hartvaatstelsel. Binnen de niet-
behandel besluiten (afzien of staken van medisch handelen) werd vaker van een 
medische behandeling afgezien (26%) dan dat deze gestaakt werd (13%). De 
geschatte levensverkorting was voor 36% van de patiënten 1-7 dagen, en voor 
19% 1-4 weken. 
In 30% van de gevallen werd de pijn- en / of symptoombestrijding d.m.v. 
medicamenten geïntensiveerd. De geschatte levensverkorting was voor 26% van 
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de patiënten korter dan 24 uur en voor 19% korter dan 1-7 dagen, maar had voor 
40% geen levensverkortend effect.  
Bij patiënten die bij bewustzijn én niet-dement (= wilsbekwaam) waren, werden 
significant minder MBLs gemeten dan bij bewusteloze of demente patiënten  
(= wilsonbekwaam) (respectievelijk 58%, 76% en 71%). Bij bewusteloze patiënten 
werd het vaakst van een behandeling afgezien. Binnen de groep patiënten die bij 
bewustzijn waren, werd bij dementen significant vaker van een behandeling 
afgezien dan bij niet-dementen (30% versus 15%). De frequentie van de 
intensivering van pijn- en / of symptoombestrijding was gelijk (rond de 30%) tussen 
alle groepen patiënten (wel/niet bewusteloos, wel/niet dement). De aanwezigheid 
van belastende symptomen, zoals pijn, misselijkheid, depressie angst, 
kortademigheid, vermoeidheid waren niet van invloed op het nemen van een 
medische beslissing. In deze studie werden 3 gevallen (0.6%) van actieve 
levensbeëindiging door de arts (gebruik van een middel met het uitdrukkelijke doel 
het levenseinde te bespoedigen) gerapporteerd.  
 
De incidentie van medische beslissingen rond het levenseinde lijkt samen te 
hangen met de wilsbekwaamheid (wel/niet bewusteloos, wel/niet dement) van een 
patiënt. Aan het overlijden van een wilsonbekwame patiënt (bewusteloos of 
dement) ging significant vaker een medische beslissing vooraf dan bij een 
wilsbekwame patiënt (bij bewustzijn en niet dement).  
In de terminale fase worden vaak medische beslissingen genomen die invloed 
hebben op de levensduur van de patiënt. Het is belangrijk dat deze conform de 
wens van de patiënt en/of diens familie genomen worden. De beste manier om dit 
te bereiken is anticiperend zorgbeleid (= advance care planning). Anticiperend 
zorgbeleid is erop gericht toekomstige scenario’s betreffende ziekte en medische 
behandelingen met de patiënt en/of diens familie te bespreken en vervolgens te 
besluiten hoe er in een bepaalde situatie gehandeld dient te worden.  
Het laatste hoofdstuk 8 geeft tenslotte de resultaten van de eerdere hoofdstukken 
samengevat weer en bespreekt de belangrijkste beperkingen van het onderzoek. 
Dit hoofdstuk wordt afgesloten met enkele aanbevelingen voor de praktijk en 
beleid, en voor toekomstig onderzoek. Deze worden hier kort samengevat.  
 
 
Aanbevelingen voor de praktijk en het beleid 
 
Deel 1 Identificatie en prognose van de terminale fase 
 
Voor een optimale palliatieve zorg is het van belang de signalen van de naderende 
dood te onderkennen en een enigszins betrouwbare voorspelling van de 
resterende levensduur te kunnen geven. Bepaalde symptomen bleken een 
indicatie voor de terminale fase te zijn: (zeer) weinig of géén vochtinname, (zeer) 
weinig of géén voedselinname, (algehele) verzwakking en 
ademhalingsmoeilijkheden/dyspnoe. Een instrument als de Resident Assessment 
Instrument Minimum Data-Set Palliative Care (RAI MDS-PC)(8) is geschikt voor 
het nauwkeurig monitoren van de functionele status (o.a. voedselinname, 
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voedingsstatus, vochtinname en voedingtoestand) van verpleeghuispatiënten. Het 
is aan te bevelen om dit instrument (standaard) in verpleeghuizen in te voeren en 
te gebruiken. Voor een schatting van de levensverwachting van patiënten is de 
verpleeghuisarts op zijn klinische ervaring aangewezen. Andere mogelijkheden, 
zoals multivariate prognosemodellen, vereisen een substantieel aantal testen. Ze 
lijken geen standaard optie voor de Nederlandse verpleeghuispraktijk, want deze 
staat bekend om haar lage technologische interventies.  
 
 
Deel 2 Problemen, symptomen en de kwaliteit van palliatieve zorg 
 
De studie heeft laten zien dat de kwaliteit van de palliatieve zorg in Nederlandse 
verpleeghuizen verbeterd kan worden. Met name de psychologische en spirituele 
aspecten verdienen meer aandacht. Voor de evaluatie van de verschillende 
dimensies van palliatieve zorg staat een aantal instrumenten ter beschikking die 
hun waarde in de praktijk hebben bewezen. Dit zijn de Resident Assessment 
Instrument Minimum Data-Set Palliative Care (RAI MDS-PC), Support Team 
Assessment Schedule (STAS), Palliative care Outcome Scale (POS) en de 
Edmonton Symptom Assessment system (ESAS). Met uitzondering van de STAS, 
zijn alle genoemde instrumenten in dit onderzoek toegepast. Deze instrumenten 
hebben hun waarde binnen de palliatieve zorg bewezen en het is aan te bevelen 
deze instrumenten verder te ontwikkelen, eerder dan geheel nieuwe te ontwerpen.  
Psychologische en spirituele aspecten kregen, waarschijnlijk door gebrek aan 
kennis, onvoldoende aandacht van de verpleeghuisartsen en verzorgenden. Er zal 
geïnvesteerd moeten worden in de opleiding en training van 
verpleegkundigen/verzorgenden en artsen in het ontwikkelen van vaardigheden die 
betrekking hebben op deze aspecten van palliatieve zorg. Daarover zouden 
specifieke bij- en nascholingen voor deze groepen ontwikkeld en gegeven moeten 
worden.  
 
 
Deel 3 Medische beslissingen rond het levenseinde 
 
Het aantal medische beslissingen rond het levenseinde (MBLs) zullen met het 
groeiende aantal ouderen toenemen. Vanzelfsprekend moeten deze open met de 
patiënt en/of diens familie besproken worden. De beste manier om aan de wensen 
van de patiënt en/of familie tegemoet te komen, is de ontwikkeling van een 
anticiperend zorgbeleid (advance care planning, oftewel ACP). ACP is zeer 
gebruikelijk in Nederlandse verpleeghuizen. Een punt van blijvende aandacht is de 
kwaliteit van de ACP. Er zal verder uitgezocht moeten worden in hoeverre, 
wanneer en hoe bijvoorbeeld de familie bij de planning betrokken wordt en of 
afspraken nagekomen worden.  
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Aanbevelingen voor toekomstig onderzoek 
 
Toekomstig onderzoek zou zich vanwege het huidige gebrek aan informatie over 
ouderen in de laatste levensjaren meer op verpleeghuizen kunnen richten. Dit 
impliceert relatief meer onderzoek in niet-kanker populaties die hoofdzakelijk aan 
andere chronische ziekten lijden. De meeste informatie rondom overlijden is 
beschikbaar over patiënten met kanker. In verschillende studies is onderkend dat 
het moeilijk is om een terminale fase bij niet-kanker patiënten te definiëren of de 
levensverwachting te voorspellen. De resultaten van deze studie bevestigen dit. 
Een verbetering van de prognosetechnieken voor het vaststellen van de 
levensverwachting is wenselijk, want die is belangrijk voor de patiënt, diens familie, 
de verpleeghuisarts en verpleegkundigen/verzorgenden. Dit maakt bovendien een 
planning van adequate medische zorg makkelijker.  
Meer onderzoek zou gericht moeten zijn op de ontwikkeling van geschikte 
instrumenten die betrekking hebben op psychosociale en spirituele behoeften. In 
deze studie waren deze behoeften meestal onbekend bij de verpleeghuisartsen en 
de verpleegkundigen/verzorgenden of ontbrak het aan geschikte instrumenten. De 
instrumenten in deze studie bleken bruikbaar te zijn maar zouden verder 
ontwikkeld moeten worden voor specifieke doelgroepen, zoals patiënten met 
dementie.  
Tot slot is meer aandacht nodig voor de oorzaken van belastende symptomen. 
Twee dagen voor overlijden leed 51% van de patiënten aan tenminste één 
belastend symptoom. Dit bevestigt het beeld dat vele behoeften van de oudere 
terminale zieke patiënten niet onderkend worden en dat sprake is van onnodig 
lijden. Gericht onderzoek naar interventies bij belastende symptomen en 
bevorderende en belemmerende factoren voor symptoom controle is wenselijk, 
allen gericht op een betere kwaliteit van zorg aan het levenseinde. 
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